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ABSTRACT 
The biological wastewater treatment study was performed to treat non-penicillin 
pharmaceutical wastewater. The study was conducted in two phases. The Phase I 
focussed on a preliminary study to determine the feasibility of biological treatment for 
treating pharmaceutical wastewater. The biological treatment in Phase I consisted of 
two treatment trains; Train I which consisted of a semi-anaerobic baffle reactor 
(SABR) followed by an activated sludge process (ASP) reactor while Train 2 
consisted of only an ASP reactor. The Phase II was carried out on anaerobic 
treatment processes. Anaerobic biological treatment of pharmaceutical wastewater 
was performed using upflow anaerobic sludge blanket (UASB) and hybrid upflow 
anaerobic sludge blanket (HUASB) reactors. The UASB and HUASB reactors were 
operated under mesophilic (35±2°C) and thermophilic (55±2°C) conditions. Four 
hydraulic retention times (HRTs) i.e., five, four, three and two days were applied for 
all reactors. The sludge from an aerobic sewage treatment plant was used as seed 
biomass in all reactors. 
In Phase I, the reactors were fed with influent chemical oxygen demand (COD) 
concentration of 607-1953 mg/L. Train I (SABR-ASP reactor) achieved higher COD 
removal in treating high strength wastewater (COD 1953 mg/L); however, Train 2 
(ASP reactor) achieved higher COD removal in treating low strength wastewater 
(COD 635 mg/L). The aerobic biomass from a sewage treatment plant was 
successfully used as seed biomass in aerobic and semi-anaerobic reactors in treating 
non-penicillin pharmaceutical wastewater. 
In Phase II, the reactors were fed with low strength influent (COD 458-526 mg/L) and 
high strength influent (COD 1770-2217 mg!L). The reactors obtained higher COD 
removals in treating high strength wastewater. The results show that the reactor 
performance was significantly affected by type of reactor, HRT and temperature. 
Both mesophilic UASB and HUASB reactors obtained higher COD and biochemical 
oxygen demand 5 days (BODs) removals in treating pharmaceutical wastewater. The 
highest average COD and BODs removals were achieved by the mesophilic HUASB 
reactor treating high strength pharmaceutical wastewater at HRT of five days (average 
OLR 0.43 g CO DIL-day); average COD removal was 90%, average effluent COD was 
133 mg!L, average BODs removal was 97% and average effluent BODs was 51 mg!L. 
The COD and BODs removals decreased when the HRT was decreased. The 
concentration of ammonia-nitrogen (NH3-N) and total phosphorous (TP) increased 
during this study whereas the concentration of nitrate-nitrogen (N03-N) was constant 
and the concentration of total Kjeldahl nitrogen (TKN) slightly reduced. 
Three kinetic models i.e. Monad, modified Staver-Kincannon and Grau second-order 
were applied in this study to determine the kinetics of pharmaceutical wastewater 
treatment using UASB and HUASB reactors. The results of kinetic model analysis 
indicated that Grau second-order fits well for estimates of kinetic coefficients in all 
reactors. High R2 values (R2>0.9) were obtained for a and b determinations for all 
reactors. 
ABSTRAK 
Kajian rawatan air buangan secara biologi telah diusahakan untuk merawat a1r 
buangan farmaseutikal selain daripada penisilin. Kajian telah dilakukan dalam dua 
fasa. Fasa pertama tertumpu pada kajian permulaan untuk menentukan kemungkinan 
rawatan biologi untuk merawat air buangan farmaseutikal. Rawatan secara biologi 
pada fasa pertama terdiri daripada dua tren rawatan; Tren I terdiri daripada satu 
"semi-anaerobic baffle reactor" (SABR) yang diikuti oleh sebuah "activated sludge 
process" (ASP) reaktor, sementara Tren 2 terdiri daripada satu ASP reaktor sahaja. 
Fasa kedua dijalankan pada proses-proses perawatan secara anaerob. Rawatan biologi 
anaerob air buangan farmaseutikal diusahakan menggunakan reaktor-reaktor "upflow 
anaerobic sludge blanket" (UASB) dan "hybrid upflow anaerobic sludge blanket" 
(HUASB). Reaktor UASB dan HUASB dioperasikan pada kondisi mesophilik 
(35±2°C) dan termophilik (55±0 C). Empat waktu tinggal hidrolik (HRT) 
diaplikasikan pada semua reactor. Lumpur daripada satu loji rawatan air kumbahan 
domestik aerob digunakan sebagai benih biomasa pada semua reaktor. 
Pada fasa pertama, reaktor-reaktor diisi dengan konsentrasi "chemical oxygen 
demand" (COD) ialah 607-1953 mg!L. Tren I (SABR-reaktor ASP) memperoleh 
penyisihan COD lebih tinggi pada rawatan air buangan konsentrasi tinggi 
(COD 1953 mg!L), tetapi Tren 2 memperoleh penyisihan COD lebih tinggi pada 
rawatan air buangan konsentrasi rendah (COD 635 mg!L). Biomasa aerob daripada 
satu loji rawatan air buangan domestik Ielah berjaya untuk digunakan sebagi benih 
biomasa pada reaktor-reaktor aerob dan semi-anaerob pada rawatan air buangan 
farmaseutikal selain daripada penisilin 
Pada fasa kedua, reaktor-reaktor diisi dengan influen konsentrasi rendah 
(COD 458-526 mg!L) dan influen konsentrasi tinggi (COD 1770-2217 mg!L). 
Reaktor-reaktor mendapatkan penyisihan COD yang lebih tinggi pada rawatan air 
kumbahan dengan influen konsentrasi tinggi. Hasil-hasil kajian menunjukkan bahawa 
performa reaktor dipengaruhi secara signifikan oleh jenis reaktor, HRT dan 
temperatur. Reaktor UASB dan HUASB mesophilik menunjukkan penyisihan COD 
dan "biochemical oxygen demand 5 days" (BODs) yang lebih tinggi pada rawatan air 
buangan farmaseutikal. Purata penyisihan COD dan BODs tertinggi diperoleh reaktor 
HUASB mesophilik pada penyisihan air buangan konsentrasi tinggi dengan HRT lima 
hari. Purata penyisihan COD ialah 90%, purata COD effluen ialah 133 mg/L, purata 
penyisihan BODs ialah 97%, dan purata BODs effluen ialah 
51 mg/L Penyisihan COD dan BODs berkurang bilamana HRT dikurangkan. 
Konsentrasi ammonia-nitrogen (NH3-N) dan total phosphorous (TP) meningkat pada 
kajian ini, sedangkan konsentrasi nitrate-nitrogen (N03-N) konstan dan konsentrasi 
total Kjeldahl nitrogen (TKN) menunjukkan sedikit penurunan. 
Tiga model kinetik, yaitu Monod, modified Slover-Kincannon, dan Grau second-order 
diaplikasikan pada kajian ini untuk menentukan kinetik-kinetik rawatan air buangan 
farmaseutikal dengan menggunakan reaktor UASB dan HUASB. Hasil kajian model 
kinetik menunjukkan bahawa Grau second-order sesuai untuk pengiraan koefisien 
kinetik pada semua reaktor. Nilai R2 yang tinggi (R2>0.9) didapatkan untuk 
penentuan a dan b untuk semua reaktor. 
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The predominance of various diseases, the growth of population and the increase of 
healthcare product requirements were factors that ensured a steady growth of 
pharmaceutical industries. In Malaysia, the requirement of cosmetics and other 
pharmaceutical products, e.g. vitamins and food supplements also increased. 
Furthermore, the Malaysian consumers who were turning from conventional drugs to 
herbal products increased (NPCB, 2007). Therefore, not only the penicillin 
pharmaceutical products, but also the non-penicillin pharmaceutical products (both 
quantity and type) increased. The growth of non-penicillin pharmaceutical products 
influenced the manufacturing processes in the pharmaceutical industry. 
Raw materials used by the pharmaceutical industry might be from medicinal plants, 
herbs, fruits, flowers, leaves, stems, roots, gums, etc. (Nandy and Kaul, 200 I). The 
processes involved in pharmaceutical productions can be broken down into five 
categories which are (a) fermentation, (b) biological and natural extractions, 
(c) chemical synthesis, (d) m1xmg, compounding and formulating and 
(e) pharmaceutical research (US EPA, 2006). Therefore, the composition of 
pharmaceutical wastewater can vary widely from one effluent to another. 
It is mandatory to treat wastewater to meet effluent discharge standards before its 
release into the environment. Physical, chemical and biological methods are widely 
used in wastewater treatment. Biological treatment methods can be divided into 
aerobic and anaerobic types. Aerobic processes, which are widely used for 
wastewater treatment, at least have two distinct disadvantaged such as relatively 
high-energy requirement and high excess sludge production requires handling, 
treatment and disposal. Anaerobic processes, on the other hand, generate energy in 
the form of biogas and produce less sludge than aerobic processes. Therefore, 
2 
anaerobic treatment can be a lucrative alternative for treatment of pharmaceutical 
wastewater. 
Anaerobic reactors can be influenced by environmental and/or operating conditions. 
Typical responses in anaerobic reactors include decrease in performance, 
accumulation of volatile fatty acids (VFA), drop in pH and alkalinity, change in 
biogas production and composition and sludge washout (Leitao et al., 2006). 
Methane-forming bacteria are strict anaerobes and are extremely sensitive to the 
presence of dissolved oxygen and changes in environmental and/or operating 
conditions such as alkalinity, pH and temperature. Therefore, the operation 
conditions must be periodically monitored and maintained within optimum ranges 
(Gerardi, 2003). However, there are certain unclear technical and design operation 
conditions which are necessary for the improvement of the stability and reliability of 
anaerobic treatment, especially treatment for specific wastewaters. 
Several configurations of anaerobic treatment can be the alternatives for wastewater 
treatments system including an upflow anaerobic sludge blanket (UASB) reactor 
(Seghezzo, 2004). The UASB concept relies on the establishment of a dense sludge 
bed in the bottom of the reactor, in which all biological processes take place. The 
UASB reactor may replace the primary settler, the anaerobic sludge digester, the 
aerobic step (activated sludge, trickling filter, etc.) and the secondary settler of 
a conventional aerobic treatment plant. However, the effluent of UASB reactor 
usually needs further treatment, in order to remove remaining organic matter, 
nutrients and pathogens. The other configuration of anaerobic treatment is hybrid 
upflow anaerobic sludge blanket (HUASB) reactor. The HUASB combines the 
advantages of the UASB and anaerobic filter (AF) concepts. The HUASB consisting 
ofUASB and AF has been applied to various industrial wastewater. The performance 
of UASB and HUASB reactors were influenced by many factors including organic 
loading rate (OLR), hydraulic load, sludge retention time (SRT), as well as 
operational temperature (Leitao, 2004). The OLR applied to the reactors depends on 
the influent concentration, flow rate and reactor volume; therefore also on the 
imposed hydraulic retention time (HRT). 
3 
Kinetic process has been used for the mathematical description of both anaerobic 
biological treatment processes (Seghezzo, 2004 ). Kinetic models of the anaerobic 
system can help to gain more insight into the process. The understanding of process 
kinetics is essential for the rational design and operation of biological wastewater 
treatment system and for predicting the system stability and treatment efficiency. 
Kinetic process plays an important role in the development and operation of anaerobic 
treatment systems. 
1.2 Problem Statement 
Pharmaceutical wastewater can affect the environment adversely, if discharged 
without proper treatment. Biological treatment is often carried out to reduce its 
organic content. In Malaysia, however, the use of anaerobic system for wastewater 
treatment is still not common. High rate anaerobic reactors such as UASB and 
HUASB can be attractive alternatives for pharmaceutical wastewater treatment. 
1.3 Objectives of Study 
a. To observe the performance of semi-anaerobic and aerobic reactors in treating 
non-penicillin pharmaceutical wastewater 
b. To evaluate the performance of UASB and HUASB reactors m treating 
non-penicillin pharmaceutical wastewater 
c. To evaluate the effect of HRT and temperature on the performance of UASB 
and HUASB reactors 
d. To determine the kinetics of pharmaceutical wastewater treatment usmg 
UASB and HUASB reactors 
1.4 Scope of Study 
This study presents the performance of biological treatment, specifically anaerobic 
treatment for treating non-penicillin pharmaceutical wastewater. The study was 
divided into two phases. The first phase was conducted to observe the performance of 
semi-anaerobic and aerobic system. The second phase evaluated the anaerobic 
4 
treatment using UASB and HUASB reactors. Wastewater used m this study was 
taken from a non-penicillin based factory. 
The study focused on the operating conditions of anaerobic treatment (i.e. HRT and 
temperature) and highlighted the use of different type of anaerobic reactors. The 
experimental investigation was performed using four bench-scale reactors. The two 
UASB reactors and two HUASB reactors were operated under mesophilic and 
thermophilic temperatures. The seed biomass for the reactors was taken from aerobic 
based sewage treatment plant. 
1.5 Thesis Organisation 
This thesis has been organized into the following five chapters: 
Chapter I introduces the context of study about non-penicillin pharmaceutical 
wastewater biological treatment. Problem statement, objectives and scope of the 
study are presented in this chapter. 
Chapter 2 presents a brief review of pharmaceutical wastewater and biological 
treatment to treat pharmaceutical wastewater. Factors that effect anaerobic treatment 
and reactor configurations are also reviewed in this chapter. 
Chapter 3 presents the methodology of study that was applied to treat non-penicillin 
pharmaceutical wastewater. 
Chapter 4 shows the results viz. Phase I used semi-anaerobic and aerobic treatment 
and Phase II was based on UASB and HUASB reactors. The experiment results are 
also discussed. 
Chapter 5 summarizes the findings of the study on non-penicillin pharmaceutical 
wastewater biological treatment. 
CHAPTER2 
LITERATURE REVIEW 
This chapter presents a brief review of pharmaceutical wastewater. Basic concepts 
and theories of biological treatment, especially anaerobic treatment are also 
introduced. 
2.1 Pharmaceutical Wastewater 
The prevalence of various diseases, the growth of population and the increase of 
healthcare needs were factors that ensured a steady growth of pharmaceutical 
industry. The key drivers that boosted the Malaysian pharmaceutical industries are 
medical tourism, specialist therapy, generic and over-the-counter drugs and food 
supplements. The current self-managing trend among Malaysian consumers is 
a major factor that has broadened the over-the-counter drug market, which is mainly 
driven by vitamin and dietary supplements. Malaysian consumers who are turning 
from synthetic allopathic drugs (conventional drugs) to herbal products to maintain 
health and prevent illnesses are on the increase (Kok, 2008). 
In the year 2007, 27974 product registration applications were received by the 
National Pharmaceutical Control Bureau (NPCB) Malaysia that was established to 
implement quality control testing of pharmaceutical products. The numbers of 
prescription drugs, non-prescription drugs, traditional products and cosmetics 
registered by the Drug Control Authority (DCA) of NPCB were 449, 413, 1342 and 
28403, respectively. Manufacturers layout plants which consist of 7 prescription 
manufacturers, 7 non prescription manufacturers, 13 traditional manufacturers, 
I 0 cosmetic manufacturers and 2 veterinary manufacturers were evaluated by the 
Good Manufacturing Practices (GMP) of NPCB and a total of 30 I manufacture 
licences were issued in the year 2007 (NPCB, 2007). 
The composition of wastewater from industrial operations varies widely depending on 
the function and activity of the particular industry. Because of variation of flow rate 
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and water quality, it is often difficult to define the operation conditions for industrial 
activities (Metcalf & Eddy, 2003). Pharmaceutical industry includes manufacture, 
extraction, processing, purification and packaging chemical materials that are used as 
medications for humans or animals. Pharmaceutical manufacturing can be divided 
into two major stages: production of the active ingredient or drug and secondary 
processing or conversion of the active drugs into products suitable for administration 
(Cheremisinoff, 2001). 
The major manufactured groups include: 
a. Antibiotics such as penicillin, streptomycin, tetracyclines, chloramphenicol 
and antifungal 
b. Other synthetic drugs, including sulfa drugs, anti-tuberculosis drugs, 
anti-leprotic drugs, analgesics, anesthetics and anti-malarials 
c. Vitamins 
d. Synthetic hormones 
e. Glandular products drugs of vegetable origin, such as quinine, strychnine and 
brucine, emetine and digitalis glycosides 
f. Vaccines and sera 
g. Other pharmaceutical chemicals 
Their composition varies, depending on the product manufactured, the materials used 
in the process and other process details (Cheremisinoff, 2001 ). 
Pharmaceutical wastewater, which include several organic solvents and other toxic 
chemicals, are generally treated aerobically. The alternative treatment is the 
anaerobic route that has lower cost of treatment and generates methane gas that can be 
used as energy. However, there are few reports on the anaerobic treatment of the 
pharmaceutical effluents. The most important merits of anaerobic treatment are the 
ability to treat high strength wastewater, low energy and space requirement, low 
sludge production, low operation cost and net benefit of energy generation. The 
production of biogas in the anaerobic organic degradation makes this process 
a feasible alternative to aerobic treatment methodology (Mohan et al., 2001 ). 
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The raw material used by the pharmaceutical factory might be from medicinal plants, 
herbs, fruits, flowers, leaves, stems, roots, seeds, gums, etc. In almost all 
pharmaceutical industries, the production processes are in batches. Therefore, the 
processes have a lack of homogeneity that leads to variation in wastewater quality and 
quantity. The wide fluctuations on the treatment units in terms of organic and 
hydraulic loadings might have a harmful effect on anaerobic processes and cause 
destabilization of the microbial populations leading to volatile fatty acids (VF A) 
accumulation that can acidify the reactor and inhibit methanogenic microorganisms 
(Nandy and Kaul, 200 l ). 
2.2 Biological Wastewater Treatment 
Biological methods of wastewater treatment can be either aerobic (in the presence of 
oxygen) or anaerobic (in the absence of oxygen). Aerobic processes, which are 
widely used for wastewater treatment, at least have two distinct disadvantages viz., 
relatively high-energy requirement and high excess sludge production. Excess sludge 
production requires handling, treatment and disposal. Anaerobic processes generate 
energy m the form of biogas (methane) and produce less sludge than aerobic 
processes. However, a certain prejudice against using anaerobic processes exists in 
tropical countries. Another reason is a serious lack of knowledge by the engineers on 
the design and operation of anaerobic systems (Seghezzo, 2004). The main 
advantages and drawbacks of anaerobic treatment are shown in Table 2.1 (Hall, 1992; 
Lettinga, 1996; Seghezzo, 2004; Seghezzo et al., 1998). 
2.2.1 Anaerobic Process 
Three different groups of bacteria are involved m the transformation of complex 
orgamcs into simple molecules such as methane and carbon dioxide 
(Wiesmann et al., 2007). They are involved in three basic steps in the complete 
anaerobic oxidation process: hydrolysis, fermentation (also known as acidogenesis) 
and methanogenesis (Metcalf & Eddy, 2003; Vaccari et al., 2006). The three steps are 
illustrated schematically in Figure 2.1. 
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Table 2.1 Advantages and disadvantages of anaerobic treatment 
Advantages 
a. Low biological sludge production. The excess sludge is generally significantly lower than aerobic 
process, due to the slow growth rates of anaerobic bacteria. The excess sludge is generally well 
stabilized. 
b. High treatment efficiency. High removal efficiency can be achieved in anaerobic process, even at 
high organic loading rate (OLR). The anaerobic treatment is feasible for a wide range of waste and 
wastewater, i.e. complex in composition, a low and very high strength, low and high temperatures 
c. Low energy consumption, As long as no heating requirement is needed to reach the operational 
temperature and all reactor operations can be operated by gravity, the energy consumption for the 
reactor is almost negligible. 
d. Methane production. Instead of consuming energy, biogas is produced. 
e. Low nutrient and chemical requirements. An adequate and stable pH can be maintained without 
the addition of chemical. 
f. Valuable nutrients (nitrogen and phosphorus) arc conserved which give high potential for 
irrigation. 
g. Low space requirement. When high OLR are applied, the area requirement for anaerobic reactor is 
small. 
h. Anaerobic biomass can be preserved without feeding for long period without any serious 
deterioration of their activity. 
i. Simple and flexible. The construction and operation of anaerobic reactor is relatively simple and 
can be applied on either a very large or a small scale. 
Disadvantages 
a. Low nutrient and pathogen removal. Nutrient removal is negligible and pathogens are only 
partially removed, especially when the anaerobic reactor is operated in low temperature. 
b. Require post treatment. Post treatment of the anaerobic effluent is generally required to achieve 
the discharge standard for organic matter, nutrients and pathogens. 
c. Long start-up. Due to the low growth rate of methanogcnic organism, the start up takes longer as 
compared to aerobic processes, especially when no good inoculums is available. 
d. Possible bad odours. Hydrogen sulphide is produced during the anaerobic process, especially 
when there are high concentrations of sulphate in the wastewater. 







Amino acids and peptides 
Lower fatty acids 
Purines and pyrimidines 
~~ower fatty acids I 
Ethanol 
Acetate 1 Hydrogen 
CH,+C02 I CH,+2H,O 
Figure 2.1 Anaerobic process schematic 
(Metcalf & Eddy, 2003; Wiesmann eta!., 2007) 
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The first step for most fermentation is hydrolysis in which particulate material is 
converted to soluble compounds that can then be hydrolyzed further to simple 
monomers. The monomers are used by bacteria that perform fermentation 
(Metcalf & Eddy, 2003). During hydrolysis step, macromolecular organic 
compounds entering the system are transformed hydrolytically from large and in 
many instances solid phase macromolecular materials (e.g., cellulose, grease, protein, 
microbial cells) into their smaller, soluble building blocks (e.g., amino acids released 
from protein, carbohydrates from polysaccharides, fatty acids from lipids and fats) 
(Vaccari et al., 2006). The monomers are directly available to the next group of 
bacteria (Bitton, 2005). During subsequent fermentation maintained by the anaerobic 
digestion process, one fraction of these hydrolyzed organics will eventually be 
oxidized to carbon dioxide, another fraction will be reductively converted to methane 
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and a third, comparatively smaller fraction will be assimilated anabolically into a new 
anaerobic cell mass (Vaccari eta!., 2006). 
The second step is fermentation where in amino acids, sugar and some fatty acids are 
degraded further (Metcalf & Eddy, 2003). Two different types of acidogenic 
reactions are involved: one and two-step conversions. The first mechanism produces 
acetate primarily (i.e., by means of an acetogenic conversion, encompassing reactions 
that produce organic acids directly). The second fermentative conversion involves 
intermediate production of volatile fatty acids (e.g., butyric and proprionic acid) and 
alcohols, which are converted subsequently to acetate, hydrogen and carbon dioxide 
(Vaccari et a!., 2006). Acidogenic bacteria produce extracellular enzymes 
(exoenzymes) for the hydrolysis of complex organic molecules. Carbohydrates are 
hydrolyzed down to monosaccharide and disaccharides, proteins into amino acids and 
lipids into fatty acids. These compounds are transformed to acetate and longer chain 
fatty acids as well as C02 and H2. The most important organics in wastewater are 
proteins, lipids and hydrocarbons. All can be utilized by acidogenic bacteria, which 
encompass a very large group of different, mostly facultative anaerobic bacteria 
(Wiesmann et a!., 2007). 
Proteins are hydrolyzed into ammo acids by proteases, which function as 
exo-enzymes. A small amount of amino acids is used directly for growth 
(anabolism), while a large amount is converted to lower fatty acids, C02, H2 as well 
as NH4 + and is excreted (catabolism). Lipids are esters formed from glycerine, an 
alcohol with valence of three and fatty acids. These have been hydrolyzed previously 
by lipase enzymes. Glycerine can be partially used for anabolic reactions and is 
converted in part to lower alcohols (catabolism). Fatty acids cannot be used by 
acidogenic bacteria and are excreted. One part is totally used for protein synthesis 
and bacterial growth, while another part is converted into lower fatty acids 
{Wiesmann et a!., 2007). 
Acetogenic bacteria transform lower fatty acids such as butyrate and propionate into 
acetate, C02 and H 2. It is of great importance that H 2 is oxidized by other anaerobic 
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bacteria. Otherwise, propionate concentrations would continually increase. Only 
a part of acetate is formed directly during fermentation (Wiesmann eta!., 2007). 
The third step, methanogenesis, is carried out by a group of methanogenic organisms 
(Metcalf & Eddy, 2003). Methanogenesis converts low molecular weight organic 
precursor species into gaseous end products at both ends of the carbon oxidation state 
range, including fully reduced methane and fully oxidized carbon dioxide. At this 
point, therefore, the overall process of anaerobic digestion will have biochemically 
converted a sizable fraction of an initial sludge residual into a far more kindly, 
possibly even energetically useful gaseous product (Vaccari et al., 2006). 
Hydrogen and acetate must be utilized by methanogenic bacteria. They exhibit two 
main products of catabolic metabolism (Wiesmann et al., 2007). Two groups of 
methanogens are involved in methane production. One group, termed aceticlastic 
methanogens, split acetate into methane and carbon dioxide. The other group, termed 
hydrogen-utilizing methanogens, use hydrogen as the electron donor and C02 as the 
electron acceptor to produce methane. Anaerobic bacteria, termed acetogens, are also 
able to use C02 to oxidize hydrogen and form acetic acid. However, the acetic acid 
will be converted to methane, so the impact of this reaction is minor 
(Metcalf & Eddy, 2003). 
Methane is not very soluble in water and carbon dioxide is in equilibrium with HC03-
and C032. as a function of pH. Most of the C02 and nearly all of the methane 
produced are desorbed, forming biogas bubbles, which can be recovered for 
utilization. Lower fatty acids such as butyrate and propionate can only be mineralized 
if the two catabolic products of acetogenic bacteria, i.e. hydrogen and acetate, are 
consumed by methanogenic bacteria. The methanogens are very old microorganisms, 
living on earth smce before the oxygen-rich atmosphere was formed 
(Wiesmann eta!., 2007). 
The by-product from the anaerobic decomposition of organic matter in wastewater is 
methane gas. Normally, large quantities are not encountered in untreated wastewater 
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because even small amounts of oxygen tend to be toxic to the organisms responsible 
for the production of methane (Metcalf & Eddy, 2003). 
2.3 Factors Affecting Anaerobic Treatment 
Methane-forming bacteria are strict anaerobes and are extremely sensitive to changes 
in environmental and/or operation conditions such as alkalinity, pH and temperature. 
Therefore, the operation conditions must be periodically monitored and maintained 
within optimum ranges (Gerardi, 2003). 
2.3.1 pH and Alkalinity 
Most methanogens function well in a pH range of 6. 7 to 7 .4, but optimally at pH of 
7.0 to 7.2 and the process may fail if the pH is close to 6.0. Acidogenic bacteria 
produce organic acids that decrease the pH of the bioreactor. Under normal operating 
conditions, this pH reduction is buffered by bicarbonate produced by methanogens. 
Under poor environmental conditions, the buffering capacity of the system can be 
upset, eventually stopping methane production. Acidity has more inhibitory effect to 
methanogens than to acidogenic bacteria. An increase in volatile acids level thus 
serves as an early indicator of system upset. The ratio of total volatile acids (as acetic 
acid) to total alkalinity (as calcium carbonate) has been suggested to be maintained 
below 0.1 (Bitton, 2005). 
Alkalinity m wastewater results from the presence of the hydroxides (OH"), 
carbonates (CO/") and bicarbonates (HC03") of substances such as calcium, 
magnesium, sodium, potassium and ammonia. Borates, silicates, phosphates and 
similar compounds can also contribute to alkalinity (Metcalf & Eddy, 2003). One 
method for restoring the pH balance is to increase alkalinity by adding chemicals such 
as lime, anhydrous ammoma, sodium hydroxide, or sodium bicarbonate 
(Bitton, 2005). Alkalinity helps to resist changes in pH caused by the addition of 
acids. It is determined by titrating against a standard acid. In practice, alkalinity is 
expressed in terms of calcium carbonate (CaC03) (Metcalf & Eddy, 2003). 
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The most significant negative factor that can affect the economics of anaerobic versus 
aerobic treatment is the possible need to add alkalinity. Alkalinity concentrations of 
2000 to 3000 mg/L as CaC03 may be added in anaerobic processes to maintain an 
acceptable pH with the high gas phase C02 concentration. If the amount of alkalinity 
is not available in the influent wastewater or can not be produced by the degradation 
of protein and amino acid, a significant cost may be incurred to purchase alkalinity, 
which can affect the overall economic of the process (Metcalf & Eddy, 2003). 
With the high C02 content (typically in the range from 30 to 50 percent) in the gas 
produced in anaerobic treatment, alkalinity concentration in the range from 
2000 to 4000 mg/L as CaC03 is typically required to maintain the pH at or near 
neutral (Metcalf & Eddy, 2003). 
2.3.2 Temperature 
Temperature is very important tn assesstng the overall efficiency of a biological 
treatment process. Temperature not only influences the metabolic activities in the 
microbial population but also has a strong effect on gas-transfer rates 
(Seghezzo, 2004). There are two optimal ranges for process operation to produce 
methane: from 30 to 40°C (the mesophilic range is from 15 to 40°C) and 50 to 60°C 
(the thermophilic range is for temperatures above 40°C). The psychrophilic range is 
temperatures below 15 to 20°C (Droste, 1997). Methane production has been 
documented under a wide range of temperatures ranging between 0°C and 97°C 
(Bitton, 2005). Methane has been produced at temperatures down to I 0°C or lower, 
but for reasonable rates of methane production, temperatures should be maintained 
above 20°C. Rates of methane production approximately double for each I 0°C 
temperature rise (Droste, 1997). Reactor temperatures of 25 to 35°C are generally 
preferred to support optimal biological reaction rate and to provide stable treatment 
(Metcalf & Eddy, 2003). Methanogens are very sensitive to even small changes in 
temperature. Thus, mesophilic digesters must be designed to operate at a temperature 
of 30 to 35°C for their optimal functioning. As regards the utilization of volatile acids 
by methanogens, a decrease in temperature leads to a decrease of the maximum 
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specific growth rate Cuma,), while the half-saturation constant K, increases 
(Bitton, 2005). 
Loading rates must decrease as temperature decreases to maintain the same extent of 
treatment (Droste, 1997). Thermophilic treatment allows higher loading rates and is 
also beneficial to greater destruction of pathogens (Bitton, 2005). However, operation 
in the thermophilic range is not generally practical because of the high heating energy 
requirement (Droste, 1997). 
2.3.3 Hydraulic Retention Time (HRT) 
The operating hydraulic retention time (HRT), which depends on wastewater 
characteristics and environmental conditions, must be sufficient to allow metabolism 
by anaerobic microorganisms in digesters (Bitton, 2005). 
2.3.4 Chemical Composition of Wastewater 
There are significant differences in nutrient requirements between aerobic and 
anaerobic biological treatment processes. These differences are due to the unique 
needs of methane-forming bacteria and the lower cell (sludge) yield of fermentative 
bacteria as compared to aerobic bacteria. These two treatment requirements may be 
grouped as macronutrients and micronutrients. Macronutrient requirement for 
anaerobic biological treatment processes are much lower than the requirement for 
aerobic biological treatment (Gerardi, 2003 ). 
Phosphorus is important in cellular energy transfer mechanisms via adenosine 
triphosphate {A TP) and polyphosphates. Biological phosphorus removal is realized 
by creating conditions favorable for the growth of phosphate-accumulating organisms 
(PAOs). The PAOs assimilate acetate and produce intracellular polyhydroxybutyrate 
(PHB) storage product using energy available from stored polyphosphate. An initial 
anaerobic zone allows the PAOs to take up VF As into their cells and store them as 
PHB. The polyphosphate stored just prior to this is oxidized and used as an energy 
source, producing ATP; and it is thereby released into the liquid phase (Figure 2.2). 
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The anaerobic uptake of organic matter is inherently related to the accumulated 
polyphosphate. Some glycogen that contained in the cell is also used. Concurrent 
with the acetate uptake is the release of orthophosphate (0-P04), as well as 
magnesium, potassium and calcium cations. The PHB content in the PAOs increases 
while the polyphosphate decreases (Metcalf & Eddy, 2003; Wiesmann et at., 2007). 
In anaerobic zone, concentrations of orthophosphate as high as 40 mg!L can be 
measured in the liquid as compared to wastewater influent concentration of 
5 to 8 mg!L. The high concentration of O-P04 can be taken as indication that 
phosphorus release by the bacteria has occurred in this zone. Significant amounts of 
poly-J3-hydroxybutyrate (PHB) are found stored m bacteria cells 
(Metcalf & Eddy, 2003). 
PO, 
Anaerobic Aerobic 
Figure 2.2 Mechanism of biological phosphorus removal 
(Wiesmann et at., 2007) 
2.4 Uptlow Anaerobic Sludge Blanket (UASB) Reactor 
C02+ H20 
The UASB process uses suspended biomass, but the gas-liquid-solids separation 
system is integral with the bioreactor. More importantly, the environmental 
conditions created in the bioreactor can result in the development of large, dense, 
readily settleable particles called granules, which allow very high concentrations of 
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suspended solids to be accumulated. These high suspended solids concentrations 
allow significant separation between the sludge retention time (SRT) and HRT and 
operation at relatively short HRT, often on the order of two days or less 
(Grady et al., 1999). 
Influent wastewater enters the bottom of the bioreactor through a distribution system 
that is designed to provide relatively uniform flow across its cross section. A dense 
slurry of granules forms in the lower portion of the bioreactor and the combined 
effects of the influent wastewater distribution and gas production result in mixing of 
the influent wastewater with the granules. Treatment occurs within the dense blanket 
of granules (Grady et al., 1999). Inside these porous particles, fatty acids and biogas 
are formed. The reaction rate of the process is controlled by diffusion, convection and 
reaction inside the pores. Ascending biogas bubbles keep the particles partially 
fluidized (Wiesmann et al., 2007). For some wastewaters, a much less dense 
flocculent sludge also develops and this accumulates on top of the blanket of granules. 
Other wastewaters contain suspended solids that are not trapped in the granular sludge 
and these solids also accumulate as a flocculent sludge blanket overlying the granules 
(Grady et al., 1999). 
The treated effluent exits the granular and flocculent sludge zones and flows upward 
into the gas-liquid-solids separator. A variety of configurations can be used for this 
device. The device often consists of a gas collection hood with a settler section above 
it (Grady et al., 1999). At the top of the UASB, the gas bubbles are separated from 
the water in hoods and the rising floes, which show a lower settling rate, are carried 
up by the gas/liquid flow. Gas is collected in the hoods and removed 
(Wiesmann et al., 2007). Gas bubbles cause some granular and flocculent solids 
(particularly small granules) to rise through the bioreactor and enter the gas-liquid-
solids separator. Gas separation occurs in the hood area, thereby allowing some of 
this suspended material to return directly to the solids blanket. Gas collects is in the 
upper inverted V section of the hood and is removed from the bioreactor. Liquid with 
some entrained solids flows out of the hood into the settler section where liquid-solids 
separation occurs. Clarified effluent overflows to the weirs and effluent is discharged 
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while separated solids settle back into the reaction zone. Design of the gas-liquid-
solids separation device requires insight into the physical processes occurring there 
and experience with specific devices in a variety of applications (Grady et al., 1999). 
The example ofUASB schematic diagram is shown in Figure 2.3. 
Gas outlet 
1 I /' 7 Influent Granular sludge I I I 
~ ... 
Wasted sludge 
Figure 2.3 UASB Reactor 
(Grady et al., 1999; Wiesmann et al., 2007) 
2.5 Hybrid Uplow Anaerobic Sludge Blanket (HUASB) Reactor 
Biofilm reactors utilize a fixed film approach for efficient anaerobic treatment of 
wastewater. Support media (rock, gravel, plastics, etc.) or biomass carrier is added to 
favour the microorganisms growth on the surface of media (Bitton, 2005; 
Wiesmann et al., 2007). The bulk of anaerobic microorganisms grow attached to the 
filter media; however, some form floes that become trapped inside the filter media. 
The upflow system in the reactor helps to retain suspended solids in the column. The 
physical attachment prevents biomass washout, hence it leads to high values of sludge 
concentration and SRT. The example of anaerobic fixed film and HUASB reactors 







recycle recycle floes 
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Figure 2.4 (a) Anaerobic fixed film reactor and (b) HUASB reactor 
(Wiesmann et al., 2007) 
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The HUASB combines the advantages of the UASB and anaerobic filter concepts. 
The HUASB consisting of UASB and AF has been applied to various industrial 
wastewater such as palm oil mill effluent (POME) (Najafpour et al., 2006), chemical 
synthesis pharmaceutical (Oktem et al., 2007), complex phenolic mixture simulated 
coal (Ramakrishnan and Gupta, 2008), bulk drug pharmaceutical 
(Sreekanth et al., 2009), etc. On the top of an UASB reactor, a fixed bed reactor with 
a relatively short bed of synthetic media is installed and it was operated as HUASB 
reactor (Wiesmann et al., 2007). The HUASB reactors could also become a preferred 
option for pharmaceutical wastewater due to its operation, advantages over other 
reactor configurations (Oktem et al., 2007). 
2.6 Pharmaceutical Wastewater Anaerobic Treatment 
Table 2.2 shows the previous studies on anaerobic treatment of pharmaceutical 
wastewater. Oktem et al. (2007) studied the performance of a lab-scale HUASB 
reactor treating pharmaceutical wastewater. The pharmaceutical wastewater was 
collected from a chemical synthesis based pharmaceutical factory, whose main 
products were bacampicilline and sultampicilline tosylate. The HUASB consisted of 
a UASB portion and an anaerobic filter portion and was operated under different 
operating conditions. Polypropylene pall rings were used as filter media. The reactor 
was seeded by a granular sludge taken from a full-scale UASB reactor treating an 
alcohol distilling industry wastewater. 
Table 2.2 Pharmaceutical wastewater treatment studies 
Temp Initial COD Removal COD 
Type of treatment Wastewater HRT Reference (OC) (mg/L) (%) 
UASB and activated 30 Biosynthetic pharmaceutical 2.3 d 7140-10410 92.2% (UASB) (Jenicek et al., 
sludge (semi-pilot plant) 1996) 
UAFF (bench scale) 35 Herbal based pharmaceutical 6, 5, 1.5, 5000-80000 76-98 (Nandy and Kaul, 
1.25 d and 2001) 
20 h 
HUASB (UASB-AF) N/S Chemical synthesis based 1-3 d 6000-27000 65-83 (Oktem et al., 
(bench scale) pharmaceutical 2007) 
HUASB (UASB-AF) 55±3 Bulk drug pharmaceutical N/S 13000-15000 65-75 (Sreekanth et al., 
(bench scale) (OLR 1-12 g COD/L) 2009) 
Anaerobic batch reactor 37 Pharmaceutical, brewery, 1950-9230 (Martinez et al., 
paper and amino acid 2005) 
producing industries (diluted) 
Anaerobic suspended 35±2 Bulk drug manufacturing 8d 23700-24500 30-82 (Mohan et al., 
film contact (bench 2001) 
scale) 
Expanded granular 15 Pharmaceutical containing 48, 24, 12 5-20 kg COD/m3 day 60-80 (Enright et al., 
sludge bed anaerobic solvent and 6 h. (OLR) 2005) 
reactor 
-\0 
Table 2.2 (Continued) 
Type of treatment 
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airlift suspension 








Organic synthesis N/S 
pharmaceutical 
Pharmaceutical (untreated) 96 h 
Antibiotic pharmaceutical 1.25 d and 
2.5 d'; 5.0-
12.5 h' 
Initial COD Removal COD 
(mg!L) (%) 
23000-31000 mg/L 80-98 
7320±160 38-62% 
(30 C-60 C) 
9736-19862 87% 
Reference 
(Nacheva et al., 
2006) 
(Lapara et al., 
2001) 





The OLR was gradually increased from 3 to 9 kg COD/m3 day to determine the 
relationship between COD removal and OLR in HUASB reactor. The COD removal 
efficiency was found to decrease gradually with increase in OLR. The COD removal 
efficiencies of 83% and 79% were achieved at OLR of 4 kg COD/m3 day and 
5 kg COD/m3 day, respectively. Moreover, at the OLR of 6 kg COD/m3 day and 
HRT of two days, the COD removal efficiency was 75%. When the OLR 
increased from 6 to 7 kg COD/m 3 day, the HUASB reactor performance 
did not decline significantly. On the other hand, when the OLR increased from 
8 to 9 kg COD/m3 day, the COD removal efficiency showed a drastic decrease from 
65 to 28% (Oktem et al., 2007). 
Sreekanth et al. (2009) investigated the performance of a thermophilic HUASB 
reactor at different OLRs. The HUASB reactor was used to treat wastewater from 
a bulk drug pharmaceutical industry whose main product was terbinafine 
hydrochloride. A 17 L lab scale HUASB reactor with PVC rings at the middle of the 
reactor was used. The seed sludge was taken from a full-scale UASB reactor that 
treated a slaughterhouse wastewater. The COD concentration varied from 
13000 to 15000 mg/L and BODs concentration varied from 7000 to 7500 mg/L. The 
BOD: COD ratio ranged from 0.45 to 0.6, which was pleasant to biological treatment. 
The HUASB reactor was studied at different OLRs. The COD and BODs removals 
ranged from 65 to 75% and 80 to 94%, respectively, were obtained at the optimum 
OLR of 9 kg COD/m3·d. The methane content ranged from 60 to 70% and specific 
methanogenic activity (SMA) was 320 mL CHJg VSS·d. The biogas production 
ranged from 300 to 500 mL/g COD. Sreekanth et al. reported that the VF A 
concentrations varied from I 00 to 400 mg/L as acetic acid at the OLR of 
I to II g CODIL·day, respectively. It indicated no loss of methanogenic potential in 
the mixed biomass. However, when the OLR increased suddenly from 
2 to 5 g CODIL·day, the VFA concentration also increased from 400 to 2500 mg/L as 
acetic acid. It indicated methanogenic inhibition due to toxicity of bulk drug 
industrial effluent. 
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The application of hybrid reactors to the treatment of pharmaceutical wastewater is 
limited. No study was carried out on the thermophilic treatment of bulk drug 
pharmaceutical wastewater, although thermophilic process offers several benefits 
such as an increased degradation rate for organic solids, a high gas production rate, 
improved solid liquid separation, increased disinfection of pathogenic organisms and 
eliminating the cooling process for effluent of high temperature wastewater. 
Jenicek et a!. ( 1996) reported the anaerobic treatment of biosynthetic pharmaceutical 
wastewater using a semi pilot scale UASB reactor and an activated sludge system. 
The UASB reactor was operated at 30°C and obtained a COD removal of 92.2%. The 
residual COD in the anaerobic effluent was about 800 mg!L. Moreover, the UASB 
and activated sludge process obtained the COD removal of 97.5% at HRT of 
2.3 days. The average COD and BODs concentrations were 7140 and 4500 mg/L, 
respectively. The BODs/COD ratio was 0.63, which was relatively high and indicated 
good biodegradability. Jemicek et al. (2001) also reported that in the pharmaceutical 
factory, the fluctuation of the wastewater characteristics was very high 
(COD 2500-31500 mg!L). 
Biotreatability of pharmaceutical wastewater usmg an anaerobic suspended film 
contact reactor was studied by Mohan et a!. (200 I). The reactor was designed to 
achieve effective contact with the anaerobic biomass in suspended form with the 
organic load. The BODs/COD ratio of the pharmaceutical wastewater from a large 
bulk drug-manufacturing unit was in the range of 0.4 to 0.6, which is amenable to 
anaerobic treatment. The reactor was operated at HRT of eight days with a working 
volume of 8 L. Mohan et a!. (200 I) confirmed that the increase in OLR from 
2 to I 0 g COD/day increased the COD removal rate. The COD removal ranged from 
30 to 82%. However, at OLR of 20 g COD/day, the COD removal decreased. This 
was attributed to the micro toxic effect of high organic load on the microorganisms. 
The pH value of the effluent ranged from 6.8 to 8.2, which were well within the 
optimum pH range for methanogenesis. The methane content in the reactor was 
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found to be 60 to 70%. The gas analysis showed it was composed of 70% methane, 
26% C02 and 4% N2 (Mohan et al., 2001). 
Applicability of anaerobic treatment of herbal-based pharmaceutical wastewater was 
studied at laboratory-scale by Nandy and Kaul (2001). An upflow anaerobic fixed 
film (UAFF) reactor was used to treat influent COD concentration of 
5000-80000 mg/L. The COD removals ranged from 70 to 97% and 58 to 94% at 
HRTs of 5 and 2.5 days, respectively. The UAFF reactor was operated at 35°C. 
Herbal pharmaceutical wastewater distinguishes itself due to its high content of 
organic pollutant and its high acidic nature. Among the wide range of anaerobic 
reactor systems developed for the treatment of high strength wastewaters, UAFF 
reactor system has emerged with more successful operation (Nandy and Kaul, 2001 ). 
Biological degradation of organic synthesis pharmaceutical wastewater was studied 
by Nacheva et al. (2006) using packed bed anaerobic mesophilic reactors. The 
pharmaceutical wastewater contained high organic matter and very low TSS. Five 
different support materials were used in the anaerobic reactor to treat pharmaceutical 
wastewater with influent COD concentration of 23000 to 31000 mg/L at temperature 
of 35±2°C. The reactors were fed with wastewater from organic synthesis processes 
that were performed in a chemical pharmaceutical plant. COD removal of 80 to 90% 
was obtained in the reactors with sand, anthracite and black tezontle at OLR of 
3.6 kg!m3·day. Whereas, the reactor with granular activated carbon (GAC) had 
a better performance, which had COD removal higher than 95% and 80% at OLR of 
17 and 26 kg/m3 day, respectively. The reactor that used GAC as support material, 
obtained greater biodegradation rates than the rest of the materials and process was 
more resistant to organic load mcreases, inhibition effects and toxicity 
(Nacheva et al., 2006). 
Enright et al. (2005) studied low temperature anaerobic biological treatment of 
solvent containing pharmaceutical wastewater. Two identical expanded granular 
sludge bed (ESGB) anaerobic reactors were operated at l5°C and OLR of 
5 to 20 kg COD/m3·day. COD removal efficiencies of 60-70% were achieved in these 
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studies. The reactors were operated at HRTs of 48, 24, 12 and 6 hours and the COD 
removal increased from 78 to 85% at a decreasing HRT of 48-24 hours. However, 
the COD removal decreased while the HRTs were decreased from 24 to 12 hours and 
12 to 6 hours. The methane content decreased with decreasing HRT 
(Enright et al., 2005). 
An active methanogenic biomass developed with a rapid start up with seeded sludge 
from an anaerobic reactor treating citric acid production wastewater and from an 
anaerobic reactor treating industrial alcohol production wastewater, even though the 
seed sludge was taken from different operation temperatures. Overall, the results of 
the study indicated the feasibility of psychrophilic (<20°C) treatment of 
pharmaceutical solvent containing. 
Anaerobic and aerobic treatment of high strength pharmaceutical wastewater was 
evaluated by Zhou et al (2006). A batch test was performed to study the 
biodegradability of wastewater and based on the batch test, a pilot scale system 
composed of anaerobic baffled reactor followed by a biofilm airlift suspension reactor 
was conducted. The anaerobic bioreactor was operated at the temperature of 35°C 
and the influent COD influent ranged from 9736 to 19862 mg!L. The anaerobic 
baffled reactor results showed the effluent COD ranged from 1432 to 2397 mg!L at 
HRT of 1.25 day and 979 to 1749 mg!L at HRT of2.5 day, respectively. On the other 
hand, the effluent from the aerobic reactor varied between 256 and 355 mg!L at HRTs 
of 5 to 12.5 hours. The wastewater also contained antibiotic substances with 
ampicillin and aureomycin concentrations of 3.2 and 1.0 mg!L, respectively. The 
anaerobic bioreactor could partially degrade the antibiotics while the aerobic reactors 
showed insignificant antibiotics removal. The ampicillin and aureomycin removal 
efficiencies in the anaerobic reactor were 16.4% and 25.9% at HRT of 1.25 days and 
42.1% and 31.3% at HRT of 2.5 days, respectively, while in the aerobic reactor, the 
removal efficiencies of the antibiotics were less than 10% (Zhou et al., 2006). 
The effect of temperature in aerobic biological pharmaceutical wastewater treatment 
was studied by La para et a!. (200 I) using batch reactors. The reactors were operated 
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at 5°C intervals from 30 to 70°C. Soluble COD removal efficiency declined as 
temperature increased from 30 (62%) to 60°C (38%). Aerobic biological treatment 
failed to occur at temperature higher than 60°C (Lapara et al., 2001). 
2. 7 Anaerobic Reactor Seeded with Aerobic Sludge 
Due to limited number of thermophilic anaerobic digesters in operation, it was often 
difficult to start up a new one using sludge from an existing reactor as seed. 
However, most researchers consider mesophilic anaerobic sludge to be a satisfactory 
inoculum for the thermophilic anaerobic reactor, because it is grown in a similar 
anaerobic environment (Kim and Speece, 2002). 
Kim and Speece (2002) evaluated the start up performance of anaerobic digestion 
using two different sources of seed sludge. Anaerobic digester sludge {ADS) and 
aerobic waste activated sludge (WAS) were used as seed sludge for anaerobic 
digesters at mesophilic {35°C) and thermophilic (55°C} conditions. The study was 
conducted in two experiments. First, thermophilic anaerobic reactors were used to 
investigate start-up performance with a feed of calcium acetate and calcium 
propionate. The WAS seeded reactor started to produce CH4 soon after acetate 
feeding without a lag time, while the ADS seeded reactor had a lag time of I 0 days. 
The experiment was conducted without temperature acclimation for the thermophilic 
sludge. The results indicated that the WAS reactor had a significant capacity to 
biodegrade acetate anaerobically (Kim and Speece, 2002). 
Kim and Speece (2002) also compared the methanogenic activity of anaerobic 
digestion seeded by the WAS and ADS. Both reactors were operated under 
mesophilic and thermophilic temperatures. The WAS seeded reactor produced more 
CH4 per unit amount of seeded VSS than the ADS reactor. The WAS reactor 
performance was better than the ADS reactor at both mesophilic and thermophilic 
conditions. The WAS reactor at mesophilic temperature biodegraded propionate 
much faster than at thermophilic temperature. When acetate was used as the feed, the 
WAS reactor started producing CH4 within five days at both mesophilic and 
thermophilic reactors. On the other hand, the mesophilic ADS reactor started 
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producing CH4 very soon, i.e. within one day while the thermophilic ADS reactor 
started producing CH4 very late, i.e. within 30 days (Kim and Speece, 2002). 
The results showed the validity of WAS as a seed source for anaerobic digestion. The 
WAS reactor obtained much better performance than the ADS reactor at both 
mesophilic and thermophilic temperatures for both acetate and propionate 
degradations. Kim and Speece (2002) hypothesized that there might be anaerobic 
bacteria with high activity in the WAS. The other was that dominant bacteria in WAS 
might function in micro zones with anaerobic conditions and that methanogens and 
propionate degrading organism might be much more tolerant of aerobic conditions 
than previously thought. 
CHAPTER3 
METHODOLOGY 
This study was conducted to evaluate the performance of biological treatment for 
treating non-penicillin based pharmaceutical wastewater. The study was conducted in 
two phases; Phase I used two trains of reactors (semi-anaerobic-aerobic and aerobic), 
meanwhile Phase II used four anaerobic reactors. Phase I was performed as 
a preliminary study of pharmaceutical wastewater treatment. In this phase, an aerobic 
biomass from a sewage treatment plant was evaluated as seed biomass in biological 
process reactor. In Phase II, only anaerobic reactors seeded by using the same source 
of biomass as in Phase I were investigated. Figure 3.1 shows the schematic diagram 
of this study. 
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Figure 3 .I Schematic diagram of study 
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3.1 Phase 1: Treatment of Pharmaceutical Wastewater Using Semi-
anaerobic and Aerobic Reactors 
3.1.1 Phase I Experimental Procedure 
The biological treatment in this study consisted of two treatment trains; Train I which 
consisted of a semi-anaerobic reactor followed by an aerobic reactor while Train 2 
consisted of only an aerobic reactor. A schematic diagram of the treatment trains 









Figure 3.2 Phase I experimental diagram 
3.1.2 Semi-anaerobic Baffle Reactor (SABR) 
A laboratory-scale semi-anaerobic baffle reactor was used in Train I. The acrylic 
reactor was fabricated with internal dimensions of 48 em x 20 em x 29 em 
(L x B x H). The total volume was 27.8 Land the working volume was 23 L (liquid 
height of 24 em). The reactor was operated as vertical flow and under ambient 
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temperature (27±3°C). The reactor consisted of seven baffle walls and without cover 
at the top. The Train 1 SABR used in this study is shown in Figure 3.3a. 
Figure 3.3 (a) Train 1 SABR and (b) Train I ASP reactor 
3.1.3 Activated Sludge Process (ASP) Reactor 
Laboratory-scale activated sludge process (ASP) reactors were used in Train I and 
Train 2. The acrylic ASP reactors consisted of two sections: aeration and settling 
sections. The aeration section had internal dimensions of 40 em x 20 em x 29 em 
(L x B x H). The total volume was 23.2 L and the working volume was 19.2 L 
(liquid height of 24 em). The settling section had internal dimensions of 
8 em x 20 em x 24 em (L x B x H). The slope of settling section was 45°. The flow 
was introduced in the settling section at the bottom. Samples of the effluent were 
taken from the settling section. Diffuse aerators were used in the activated sludge 
reactors. The Train 1 ASP reactor and Train 2 ASP reactor used in this study are 
shown in Figure 3.3b and Figure 3.4, respectively. 
3.1.4 Source of Wastewater 
Pharmaceutical wastewater was collected from a non-penicillin based pharmaceutical 
factory in Seri Iskandar, Perak, Malaysia. Wastewater samples were collected every 
two or three weeks. The biological reactors were fed with the pharmaceutical 
wastewater without pre-treatment. The wastewater was stored in a cold room at 4°C 
before use. The characteristics of pharmaceutical wastewater during Phase I are 
shown in Table 3.1. 
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Figure 3.4 Train 2 ASP reactor 
Table 3.1 Characteristic of pharmaceutical wastewater (Phase I) 






Total Phosphorus 2.54-6.57 
pH 5.17-6.65 
3.1.5 Seed Biomass and Acclimatization Phase 
The seed biomass for ASP reactors was taken from return activated sludge (RAS) of 
Universiti Teknologi PETRONAS's (UTP) Sewage Treatment Plant (STP), while the 
seed biomass for semi-anaerobic reactor was taken from sludge thickener. The 
semi-anaerobic reactor was inoculated with 8.5 L sludge and ASP reactors were 
inoculated with 10 L sludge. The seed biomass for semi-anaerobic reactor was taken 
from sludge thickener in order to obtain high sludge concentration. For initial 
acclimatization, all reactors were batch-fed daily with pharmaceutical wastewater for 
7 days. After 7 days, both trains were continuously fed with pharmaceutical 
wastewater at a flow rate of7.7 Llday. 
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3.2 Phase II: Treatment of Pharmaceutical Wastewater Using UASB and 
HUASB Reactors 
3.2.1 Phase II Experimental Procedure 
The experimental investigation was carried out utilising four reactors. Two reactors 
were UASB and two reactors were HUASB. The schematic diagrams of the four 5 L 
UASB and HUASB laboratory-scale reactors used in this study are shown in 
Figure 3.5 and Figure 3.6, respectively. One UASB and one HUASB were operated 
under mesophilic conditions (35±2°C) and the others were under thermophilic 
conditions (55±2°C). Temperatures were maintained by heating jackets that were 
connected to temperature control devices. Each temperature control device worked 
based on temperature inside the reactor, which was measured by a thermometer. 
Pharmaceutical wastewater was continuously fed to the reactors using a peristaltic 
pump (Master Flex, Cole Palmer). Four HRTs i.e. five, four, three and two days were 
used for all reactors during this study. A stirrer was used in feed tank to ensure 
a homogeneous wastewater influent. 
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Figure 3.6 Phase II schematic diagram ofHUASB reactors 
3.2.2 UASB Reactors 
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The UASB reactors (Armfield Anaerobic Digester W8) with total liquid volume of 
5 L (empty volume 5.5 L) were used throughout the study (Figure 3.7a). The UASB 
reactors were made from an acrylic column with 140 mm of diameter (internal) and 
355 mm of height (330 mm water depth). A perforated plate of 3 mm thickness with 
perforations of 8 mm diameter was placed at the bottom of the column in order to 
ensure proper distribution of flow through the reactor. The wastewater entered at the 
centre of the UASB reactors and flowed upward through the perforated plate. Sludge 
sampling ports were provided at the bottom of each reactor. The UASB reactors had 
2 em clear gap above the outlet to separate the gas from the wastewater, so the empty 
volume of reactors was 5.5 L. 
3.2.3 HUASB Reactors 
The HUASB reactors had a UASB portion (3.75 L) under a fixed film portion 
(1.25 L) (Figure 3.7b). The HUASB reactors were UASB reactors (Armfiled 
Anaerobic Digester W8) with some modifications inside the column. Plastic balls of 
25 mm diameter were used as fixed film media. 
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Figure 3.7 (a) UASB reactor and (b) HUASB reactor 
3.2.4 Operation of the Reactors 
The reactors were fed by pharmaceutical wastewater from a non-penicillin based 
product factory at Bangi, Malaysia without pre-treatment and dilution. Wastewater 
samples were collected every three to four weeks from a common sump by grab 
sampling. PVC containers were used to store wastewater in a cold room at 4°C before 
use. The stored wastewater was transferred to an influent tank daily for feed. The 
characteristics of the pharmaceutical wastewater are summarized in Table 3.2. 
The UASB reactors were fed with low strength wastewater 
(COD 400-500 mg/L) for 75 days at HRTs of five and three days. From day 76 to 
day 170, it was then fed with high strength wastewater (COD 1773-2217 mg/L) at 
HRTs of five, four, three and two days. 
The HUASB reactors were started 62 days after the UASB reactors. For the first 
12 days of the operation of HUASB reactor, the reactors were fed with low strength 
wastewater at HRT of four days. On the day 13 of operation, the HUASB reactors 
were then fed with high strength wastewater at HRTs of five, four, three and two 
days. 
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Table 3.2 Characteristic of pharmaceutical wastewater (Phase II) 







Total Phosphorus 4.8-19.4 
Alkalinity 309-377 
pH 4.76-6.04 
3.2.5 Seed Biomass 
The seed biomass was obtained from a sludge thickener of the activated sludge 
process based sewage treatment plant (STP) at the Universiti Teknologi PETRONAS 
(UTP), Malaysia. The TVSS concentrations after seeding were measured as 
16277 mg!L and 17335 mg!L in UASB and HUASB reactors, respectively. Activated 
sludge was chosen to seed the UASB reactor because of the validity of such sludge as 
seed for anaerobic reactor (Kim and Speece, 2002). 
The reactors were inoculated with 2.5 L of sludge. In order to acclimatize the sludge 
with pharmaceutical wastewater, the reactors were batch feed with 2.5 L of 
pharmaceutical wastewater (COD 400-500 mg!L) for 14 days and with continuous 
flow for 14 days. The acclimation period allows reduction of oxygen levels to 
prevent inhibition of anaerobic bacteria as well as for the bacteria population to adjust 
to the feed wastewater. 
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3.3 Analytical Methods 
3.3.1 Measurement of pH 
The pH was measured with a Hach pH meter (Model Sension 4) using Platinum 
Series pH Electrode (Model 51910). The pH meter was calibrated with pH 4.0, 7.0 
and I 0.0 buffers. 
3.3.2 Measurement of Alkalinity 
Alkalinity was measured by Standard Methods Section 2320 B Titration Method 
(APHA, 2005). The pH value of 4.5 is suggested as the equivalence points for the 
corresponding alkalinity concentrations. The alkalinity analysis was performed using 
a properly calibrated auto titration (Metrohm 702 SM Titrino) at room temperature. 
3.3.3 Measurement of Chemical Oxygen Demand (COD) and Biochemical 
Oxygen Demand 5 days (BODs) 
COD was measured by the reactor digestion method (Method 8000) usmg Hach 
reagent kit (Hach, 2002). High range COD digestion reagent vials were used for this 
purpose. Colorimetric determination of COD was carried out at 620 nm using a Hach 
spectrophotometer DR 2000. BOD5 was measured by Standard Methods 
Section 5210 B 5 Day BOD Test (APHA, 2005). Dissolved oxygen (DO) was 
measured using a YSI 5100 Dissolved Oxygen Meter. 
3.3.4 Measurement of Total Suspended Solids (TSS) and Total Volatile 
Suspended Solids (TVSS) 
TSS was determined according to the Standard Methods Section 2540 D Total 
Suspended Solids Dried at 103-105°C Method (APHA, 2005). For TVSS 
measurement, the residue from the TSS measurements was ignited to constant weight 
at 550°C in the muffle furnace (Nabertherm Ll5112/P320) according to Standard 
Methods Section 2540 E Fixed and Volatile Solids Ignited at 550°C Method 
(APHA, 2005). Mixed Liquor Suspended Solids (MLSS) was measured by TSS 
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method and Mixed Liquor Volatile Suspended Solids (MLVSS) was measured by 
TVSS method with proper dilution. 
3.3.5 Measurement of Ammonia Nitrogen (NH3-N), Nitrate Nitrogen (N03-N) 
and Total Phosphorus (TP) 
NH3-N was measured by Nessler Method (Method 8038), N03-N by Cadmium 
Reduction Method (Medium Range) using Hach Powder Pillow and TP by PhosVer 3 
(Ascorbic Acid) Method using Hach Powder Pillow (Hach, 2002). 
3.3.6 Measurement of Total Kjeldahl Nitrogen (TKN) 
The macro-kjeldahl method was applied to measure TKN according to Standard 
Methods Section 4500-Norg B Macro-Kjeldahl Method (APHA, 2005). For digestion, 
Buchi K-424 Digestion Unit and Buchi B-414 Scrubber Unit were used, whereas for 
distillation, Buchi K-314 Distillation Unit was used. Selenium catalyst tablets were 
used in TKN measurement. For ammonia nitrogen measurement, Standard Methods 
Section 4500 C Titrimetric Method (APHA, 2005) was used. Titration was performed 
using a properly calibrated auto titration (Metrohm 702 SM Titrino) at room 
temperature. 
3.3.7 Measurement of Volatile Fatty Acids (VFA) 
VFA was measured by esterification method (Method 8196) usmg a DR 2000 
spectrophotometer (Hach, 2002). The sample was centrifuged by Heraeus Biofuge 
Primo before it was analyzed. All volatile acids present are reported as their 
equivalent mg/L as acetic acid (HOAC). 
3.3.8 Measurement of Methane Gas Production 
Methane production was monitored by liquid displacement. The top of each reactor 
was connected to a gas tank for gas collection. The displacement liquid was a 5% 
NaOH solution with thymol blue as indicator. NaOH was chosen because it absorbs 
C02 and allows CH4 to pass through it. The blue colour of indicator will be 
discharged when the C02 absorption capacity of the solution is exhausted 
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(!sa et al., 1993; Leitao, 2004). However, the methane production data was not 
included in the results and discussion because there appeared to be some faults with 
the gas collection system. The methane production was only about 50% of the 
theoretical values based on stoichiometry calculation (350 mL CH4/g COD). 
3.4 Data Analysis 
Statistical analysis, analysis of variance (ANOV A) was applied to the data obtained 
from the different reactors and in different operation condition in order to assess cause 
distinct effects on the performance of the reactors. One-way and two-way ANOV A 
were used to determine the significant difference between data that were obtained 
from each variable of the experiments. 
CHAPTER4 
RESULTS AND DISCUSSION 
4.1 Phase I Results: Treatment of Pharmaceutical Wastewater using 
Semi-anaerobic and Aerobic Reactors 
The Phase I study was conducted to observe the performance of semi-anaerobic and 
aerobic system treating non-penicillin pharmaceutical wastewater. The study was 
performed using a semi-anaerobic baffled reactor (SABR) and two activated sludge 
process (ASP) reactors. The reactors were divided into two trains; Train I 
(SABR-ASP reactor) and Train 2 (ASP reactor). The performance of each reactor 
was evaluated in terms of COD and BODs removal efficiencies. The nutrients and 
biomass in the reactors were also monitored. 
4.1.1 COD and BODs in Semi-anaerobic and Aerobic Reactors 
The COD removal and COD concentration in Phase I are shown in Figure 4.1 and 
Figure 4.2, respectively and the overall COD removal in Train I and Train 2 is shown 
in Figure 4.3. For the first ten days, the influent COD concentration varied from 
1853 to 1953 mg/L. The COD removal ranged from 86 to 93% and the effluent COD 
concentration varied from 142 to 265 mg!L in SABR. The Train I ASP reactor that 
received wastewater from the SABR achieved COD removal of 33-82%. 
Furthermore, the overall COD removals ranged from 95 to 98% and 81 to 89% for 
Train I and Train 2, respectively. The final COD concentrations varied from 
45 to 96 mg/L and 207 to 364 mgfL for Train I and Train 2, respectively. 
From day II to day 28, the influent COD concentration varied from 791 to 987 mg/L. 
The COD removal ranged from 71 to 92% and the effluent COD concentration varied 
from 70 to 246 mg!L in SABR. The Train I ASP reactor achieved a COD removal of 
3 1-72%. The overall COD removals ranged from 90 to 94% and 85 to 92% for 
Train I and Train 2, respectively. The final COD concentrations varied from 
48 to I 02 mg/L and 66 to 140 mg/L for Train I and Train 2, respectively. 
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Figure 4.1 Phase I influent COD concentration and COD removal in the reactors 
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Figure 4.2 Phase I influent and effluent COD concentrations in the reactors 
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Figure 4.3 Influent COD concentration and Train I and Train 2 COD removal 
From day 29 to day 50, the influent COD concentration ranged from 
607 to 706 mg/L. The COD removal ranged from 84 to 87% in SABR, whereas the 
effluent COD concentration varied from 77 to I 09 mg/L. The Train I ASP reactor 
achieved a COD removal of 36-49%. Furthermore, the overall COD removals ranged 
from 90 to 93% and 88 to 91% for Train I and Train 2, respectively. The final COD 
concentrations varied from 45 to 61 mg/L and 54 to 77 mg/L for Train I and Train 2, 
respectively. 
For the last II days, the influent COD concentration varied from 905 to 913 mg/L. 
The COD removal ranged from 85 to 86% and the effluent COD concentration varied 
from 124 to 133 mg/L in SABR. The Train I ASP reactor achieved a COD removal 
of 15-19%. The overall COD removals ranged from 88 to 89% and 87 to 88% for 
Train I and Train 2, respectively. The final COD concentrations varied from 
102 to 112 mg/L and 110 to 122 mg/L for Train I and Train 2, respectively. 
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The performance of each reactor was also evaluated in terms of the BODs 
concentration. The BODs removal and BODs concentration in Phase I are shown in 
Figure 4.4 and Figure 4.5, respectively and the overall BODs removal in Train I and 
Train 2 is shown in Figure 4.6. For the first ten days, the average influent BODs 
concentration was 1299 mg/L. The average BODs removal was 83% and the average 
effluent BODs concentration was 225 mg/L in SABR. The Train I ASP reactor that 
received wastewater from the SABR achieved an average BODs removal of 85%. 
Furthermore, the overall BODs removals were 97% and 83% for Train I and Train 2, 
respectively. The final BODs concentrations were 34 mg/L and 226 mg/L for Train I 
and Train 2, respectively. From day II to day 28, the influent BODs concentration 
varied from 588 to 717 mg/L. The BODs removal ranged from 66 to 85% and the 
effluent BODs concentration varied from 70 to 246 mg/L in SABR. The Train I ASP 
reactor achieved a BODs removal of 66-85%. The overall BODs removals ranged 
from 89 to 92% and 84 to 89% for Train I and Train 2, respectively. The final BODs 
concentrations varied from 48 to 77 mg/L and 69 to 118 mg/L for Train I and Train 2, 
respectively. 
2000 day I to day 10; 
1800 -
~ 1600 -
Cll 1400 -!, 
rS 1200 







day II to day 28 day 29 to day 50 day5ltoday61 100 
-- 80 











0 I 0 20 30 40 50 60 
Days 
-----Influent BOD, (mg/L) 
__._Train I ASP BOD, Removal(%) 
--+--Train I SABR BOD, Removal(%) 
.......-Train 2 ASP BOD, Removal (0/o) 
Figure 4.4 Phase I Influent BODs concentration and BODs removal in the reactors 
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Figure 4.5 Phase I influent and effluent BODs concentrations in the reactors 
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Figure 4.6 BODs removal in Train 1 and Train 2 
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From day 29 to day 50, the influent BODs concentration varied from 
462 to 487 mg!L. The BODs removal ranged from 81 to 85% and the effluent BODs 
concentration varied from 69 to 89 mg!L in SABR. The Train I ASP achieved 
a BODs removal of 50-57%. Furthermore, the overall BODs removals ranged from 
92 to 93% and 87 to 88% for Train I and Train 2, respectively. The final BODs 
concentrations varied from 33 to 39 mg!L and 56 to 61 mg!L for Train I and Train 2, 
respectively. 
For the last II days, the average influent BODs concentration was 645 mg/L. The 
average BODs removal was 83% and the average effluent BODs concentration was 
88 mg!L in SABR. The Train I ASP reactor achieved average BODs removal of 
30%. The average BODs removals were 88% and 84% for Train I and Train 2, 
respectively. The average final BODs concentrations were 77 mg!L and I 03 mg!L for 
Train I and Train 2, respectively. 
4.1.2 Total Suspended Solids (TSS) Analysis 
In the 61 days, the reactors were fed with influent TSS concentration of 7-38 mg!L. 
The influent and effluent TSS concentrations during Phase I are shown in Figure 4.7. 
The effluent TSS concentration in SABR ranged from 18 to 58 mg!L while effluent 
TSS concentrations of 12-31 mg!L and 17-31 mg!L were found in Train I ASP 
reactor and Train 2 ASP reactor, respectively. The TSS concentrations increased 
because the settling sections of the reactors were not enough to settle the TSS. 
However, the effluent TSS concentrations in both ASP rectors were still low 
(less than 50 mg!L) 
4.1.3 Mixed Liquor Suspended Solid (MLSS) and Sludge Retention Time 
(SRT) 
In the acclimatisation period, approximately 0.5 L of mixed liquor was wasted daily 
to maintain a MLSS of 2000-4000 mg!L. Based on calculation, the SRT was 
approximately 38.4 days. During the 61 days, the MLSS concentration in Train I 
ASP reactor was lower than in Train 2 ASP reactor. Figure 4.8 shows the profile of 
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MLSS concentration and SRT during this study. In Train I, the MLSS concentration 
varied from 2000 to 4367 mg/L while in Train 2, the MLSS concentration varied from 
3083 to 5250 mg/L. The actual SRT varied from 32.35 to 36.81 days and 
33.36 to 36.45 days for Train I ASP reactor and Train 2 ASP reactor, respectively. 
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Figure 4. 7 Phase I influent and effluent TSS concentrations in the reactors 
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Figure 4.8 Phase I MLSS concentration and SRT in ASP reactors 
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4.1.4 Mixed Liquor Volatile Suspended Solid (MLVSS) and Food to 
Microorganism Ratio (F/M Ratio) 
In the 61 days, the Train I ASP reactor was fed with influent BODs of 69-225 mg/L 
while the Train 2 ASP reactor was fed with influent BODs of 462-1299 mg!L. The 
MLVSS in ASP reactors ranged from II 00 to 2517 mg/L and 1850 to 3567 mg!L for 
Train I and Train 2, respectively. Based on calculations, the FIM ratios 
m ASP reactors ranged from 0.02 to 0.05 g BODs/g MLVSS and 
0.07 to 0.19 g BODs/g MLVSS for Train I and Train 2, respectively. The FIM ratio 
of Train I ASP reactor was lower than the FIM ratio of the Train 2 ASP reactor 
because former received partially treated wastewater from the SABR. The lower F/M 
ratio also resulted in the lower concentration of biomass in Train I ASP reactor. The 
ML VSS concentrations varied in accordance with the organic content of the 
pharmaceutical wastewater. The MLVSS concentrations and F/M ratios in ASP 
reactors during the Phase I study are shown in Figure 4.9. 
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Figure 4.9 Phase I MLVSS concentration and F/M ratio in ASP reactors 
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4.1.5 Nutrients Analysis 
Figure 4.10 to Figure 4.14 show the influent and effluent nutrient concentrations 
(NH3-N, N03-N and TP) in Phase I. For the first ten days, the influent NH3-N 
concentration ranged from 22.6 to 24.8 mg/L. The NH3-N removal ranged from 
46 to 52% and the effluent NH3-N concentration varied from 11.4 to 13.4 mg/L in 
SABR. The Train I ASP reactor that received wastewater from the SABR achieved 
a NHyN removal of 69-74%. Furthermore, the overall NH3-N removals ranged from 
85 to 86% and 78 to 80% for Train I and Train 2, respectively. The final NH3-N 
concentrations ranged from 3.2 to 3.5 mg/L and 4.65 to 5.32 mg!L for Train I and 
Train 2, respectively. The influent TP concentration ranged from 3.03 to 3.63 mg/L. 
The TP concentrations in SABR slightly decreased with effluent TP of 
1.66-2.98 mg/L. The Train I ASP reactor that received wastewater from the SABR 
achieved the TP removal of 36-49%. The overall TP removals ranged from 
49 to 65% and 36 to 46% for Train I and Train 2, respectively. The final TP 
concentrations ranged from 1.07 to 1.86 mg/L and 1.78 to 1.97 mg/L for Train I and 
Train 2, respectively. 
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Figure 4.11 Influent NH3-N concentration and NH3-N removal in Train I and Train 2 
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Figure 4.14 Phase I influent and effluent N03-N concentrations in the reactors 
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From day II to day 28, the influent NH3-N concentration was lower than the influent 
at the first ten days. The influent NH3-N concentration ranged from 7.4 to 10.6 mg/L. 
The NH3-N removal ranged from 3 to 59% and the effluent NH3-N concentration 
varied from 3.7 to 8.0 mg!L in SABR. The Train I ASP reactor achieved the NH3-N 
removal of 42-66%. The overall NH3-N removals ranged from 68 to 81% and 
55 to 69% for Train I and Train 2, respectively. The final NH3-N concentrations 
ranged from 1.80 to 2. 70 mg!L and 2.27 to 4.02 mg/L for Train I and Train 2, 
respectively. The influent TP concentration ranged from 2.54 to 6.57 mg/L. The TP 
concentrations in SABR slightly increased with effluent TP of 2.18-9.10 mg/L. The 
Train I ASP reactor achieved the TP removal of 36-70%. Furthermore, the overall 
TP removals ranged from 12 to 72% and 55 to 82% for Train I and Train 2, 
respectively. The final TP concentrations ranged from 0.86 to 5.81 mg/L and 
1.02 to 1.50 mg/L for Train I and Train 2, respectively. 
From day 29 to day 50, the influent NH3-N concentration was similar with the 
influent at the last eleven days. From day 29 to day 50, the influent NH3-N 
concentrations ranged from 9.3 to 11.9 mg/L whereas at the last eleven days, the 
influent NH3-N concentration ranged from 10.5 to 10.8 mg/L. The NH3-N 
concentration at SABR increased and the effluent NH3-N concentration varied from 
9.9 to 18.4 mg/L. The Train I ASP reactor achieved a NH3-N removal of 54-71%. 
Furthermore, the overall NH3-N removals ranged from 59 to 68% and 56 to 69% for 
Train I and Train 2, respectively. The final NH3-N concentrations ranged 
from 3.07 to 6.43 mg/L and 2.93 to 5.20 mg/L for Train I and Train 2, respectively. 
From day 29 to day 50, the influent TP concentration ranged from 3.90 to 6.08 mg!L 
whereas it ranged from 5.00 to 6.33 mg/L for the last eleven days. The TP 
concentration at SABR increased and the effluent TP concentration varied from 
8.17 to I 0.12 mg/L. The Train I ASP reactor achieved a TP removal of 43-68%. The 
overall TP removals ranged from 4 to 54% and 55 to 83% were for Train I and 
Train 2, respectively. The final TP concentrations ranged from 2.90 to 5.16 mg/L and 
0.84 to 2.31 mg/L for Train I and Train 2, respectively. 
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Under anaerobic conditions, phosphorus accumulating orgamsms (PAOs) will 
assimilate fermentation products (e.g. volatile fatty acids) into storage products within 
the cells with concomitant release of phosphorus from storage polyphosphates. Under 
aerobic conditions, energy is produced by the oxidation of storage products and 
polyphosphate storage within the cell increases (Metcalf & Eddy, 2003). 
The average influent N03-N concentration ranged from 0.3 to 0.8 mg!L. The result 
from all reactors showed that the N03-N concentrations increased. The effluent 
N03-N concentration in SABR varied from 0.9 to 2.3 mg!L. The final N03-N 
concentrations ranged from 3.1 to I 0.2 mg!L and 1.9 to I 0. 7 mg/L for Train I and 
Train 2, respectively. For the last 30 days, the effluent NH3-N concentration 
increased and the effluent N03-N concentration was constant in SABR because 
nitrification did not occur. 
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4.2 Phase II Results: Treatment of Pharmaceutical Wastewater Using UASB 
and HUASB Reactors 
In Phase II study, biological treatments were evaluated to treat non-penicillin 
pharmaceutical wastewater using UASB and HUASB reactors under mesophilic 
(35±2°C) and thermophilic (55±2°C) conditions. The reactors were fed with low 
strength and high strength influent at HRTs of five, four, three and two days. The 
performance of each reactor was evaluated in terms of COD and BODs removals. 
The nutrients, VF A, alkalinity and pH in the reactors were also monitored. 
4.2.1 COD and BODs in Mesophilic and Thermophilic UASB Reactors 
In the first 13 days, the reactors were fed with influent COD concentration of 
458-499 mg/L at HRT of five days. The COD concentration in UASB reactors during 
this study is shown in Figure 4.15 and the UASB reactors performance in this study is 
shown in Figure 4.16. 
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Figure 4.16 OLR and COD removal in UASB reactors 
The mesophilic reactor reached steady state in the first week with effluent COD of 
43-71 mg/L while the steady state of thermophilic reactor was reached after nine days 
with effluent COD of 78-101 mg/L. The COD removal efficiencies ranged from 
86 to 91% and 80 to 83% for mesophilic and thermophilic UASB reactors, 
respectively. The average COD removal efficiencies and average effluent COD 
concentration at steady state condition in mesophilic UASB reactor were 88% and 
60 mg/L, respectively and in thermophilic UASB reactor were 82% and 95 mg!L, 
respectively. Statistical analysis (ANOV A; P<O.OS) showed that COD removal was 
significantly higher at the mesophilic UASB reactor than at the thermophilic UASB 
reactor. 
After 13 days, the HRT was decreased from five to three days. The UASB reactors 
were operated with average influent COD concentration of 505 mg/L. The organic 
loading rate (OLR) increased from 0.10 to 0.17 g CODIL·day at which the COD 
removals ranged from 80 to 91% and 71 to 87% for mesophilic and thermophilic 
UASB reactors, respectively. The removal efficiency of the mesophilic UASB 
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dropped slightly when the HRT of the reactor was reduced; however, that of the 
thermophilic UASB reactor decreased sharply and thereafter the efficiencies started to 
increase slowly in the following three weeks. The mesophilic UASB reactor reached 
steady state with average COD removal of 87% while the average COD removal of 
the thermophilic UASB reactor was 80%. The average effluent COD concentration at 
steady state was 65 mg!L and 83 mg!L for mesophilic and thermophilic UASB 
reactors, respectively. The mesophilic UASB reactor had higher COD removal than 
the thermophilic UASB reactor. A similar observation was also made by Chung 
( 1997) in the treatment of a synthetic wastewater. The COD removals were found to 
be 83% and 76% in mesophilic and thermophilic UASB reactors, respectively 
(Chung, 1997). In present study, the mesophilic and thermophilic UASB reactors 
showed no significant change in COD removal (ANOVA; P<0.05) as the HRT was 
decreased from five to three days with low strength pharmaceutical wastewater. 
Furthermore, at HRT of four days, COD removal was significantly greater at the 
mesophilic temperature than at the thermophilic temperature (ANOVA; P<0.05). The 
detail of one-way ANOV A analysis is shown in APPENDIX B: Table B.l. 
From day 76, the UASB reactors were fed with high strength wastewater 
(COD 1770-2217 mg/L) at HRTs of five, four, three and two days. The OLR 
increased from 0.39 to 0.94 g CO OIL· day with the feed of high strength wastewater. 
The HRT was initially increased from three to five days to avoid shock loading in the 
reactors. From day 76 to day 93, the UASB reactors were operated at HRT of 
five days with influent COD concentration of 1970-2217 mg!L. Though the HRT was 
increased but the average OLR was still increased from 0.17 to 0.43 g CODIL·day due 
to the higher influent COD concentration of the wastewater collected from the 
factory. The COD removal efficiencies varied from 89 to 96% and 85 to 95% for 
mesophilic and thermophilic UASB reactors, respectively, while the effluent COD 
concentrations ranged from 76 to 234 mg!L and 115 to 305 mg!L for mesophilic and 
thermophilic UASB reactors, respectively. The COD removal efficiency of both 
UASB reactors increased rapidly, although the effluent COD concentration increased 
sharply in the two days. After four days, the COD removals were decreased slightly. 
The average COD removal efficiencies at steady state conditions were 93% and 90% 
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for mesophilic and thermophilic UASB reactors, respectively. The average effluent 
COD concentration in mesophilic UASB reactor was 158 mg!L while that in 
thermophilic UASB reactor was 213 mg!L. The results indicated that the 
thermophilic UASB reactor was more stable worked with high strength wastewater, 
unlike the mesophilic reactor that was steady in both characteristics of wastewater. 
Furthermore, higher COD removal efficiencies were achieved by both reactors when 
treating a higher concentration wastewater at HRT of five days. The mesophilic and 
thermophilic UASB reactors showed a significantly higher COD removal 
(ANOV A; P<0.05) as the HRT was increased from three to five days and as OLR 
increased due to the increase of COD concentration. However, the COD removal in 
mesophilic temperature at HRT of five days was not significantly difference from that 
at thermophilic temperature (ANOV A; P<0.05). The detail of one-way ANOV A 
analysis is shown in APPENDIX B: Table B.l. 
From 94 day to day 145, the UASB reactors were operated at HRT of four days. The 
OLR increased from 0.43 to 0.50 g CODIL·day and the influent COD ranged from 
1853 to 2073 mg!L. The COD removal decreased rapidly in both UASB reactors in 
four days because of COD shock loading, although, in the next four days the COD 
removal increased faintly. The COD removal efficiencies ranged from 81 to 89% and 
81 to 87% for mesophilic and thermophilic UASB reactors, respectively. The effluent 
COD concentrations ranged from 225 to 353 mg!L and 237 to 386 mg!L for 
mesophilic and thermophilic UASB reactors, respectively. The average effluent COD 
concentrations and the percentage COD removals at steady state were 262 mg/L and 
87% for mesophilic UASB reactor and 329 mg!L and 83% for thermophilic UASB 
reactor, respectively. Based on statistical analysis (ANOV A; P<0.05), the COD 
removal at HRT of four days was significantly decreased if it was compared with the 
COD removal at HRT of five days for both UASB reactors. 
On day II 0, the mesophilic UASB reactor failed due to malfunctioning of the 
thermostat. The temperature increased to 60°C in one day and some sludge was 
washed out. From day Ill to day 118, the mesophilic UASB reactor was operated at 
ambient temperature (24±2°C) while it was being repaired. The COD concentration 
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increased sharply from 260 to 1254 mg!L. The percentage removal in the reactor 
during the upset period was not included in data analysis. After 30 days, the reactor 
stabilized with COD effluent of 353 mg!L and the COD removal efficiency reached 
81%. 
Lei tao et al. (2006) reviewed the effect of temperature shock on the anaerobic reactor 
performance. The anaerobic reactor operated under steady state conditions when it 
exposed to a sudden temperature change, the process could become unbalanced due to 
the different response of the various metabolic groups of microorganism. 
A temperature shock might cause an immediate pH drop in the anaerobic reactor. 
Then, it would stabilize at pH that was slightly lower than the previous steady state 
pH. This phenomenon was due to an increase of the VF A. The effluent COD 
increased due to the increase of effluent VFA and suspended solids concentrations 
(Leitao et al., 2006). 
From day 146 to day 179, the UASB reactors were operated at HRT of three days 
with influent COD concentration of 1773-1977 mg!L. The COD removal efficiency 
of the mesophilic UASB dropped roughly in seven days from 85 to 72%, although it 
increased again in the next six days. It seems the reactor was still sensitive to organic 
loading due to its previous failure (temperature shock). In thermophilic UASB 
reactor, the COD removal efficiency decreased slightly in 16 days from 84 to 76%. 
The COD removal efficiencies varied from 72 to 82% and 74 to 85% for mesophilic 
and thermophilic UASB reactors, respectively, while the effluent COD concentrations 
ranged from 339 to 547 mg!L and 282 to 489 mg!L for mesophilic and thermophilic 
UASB reactors, respectively. The average COD removal efficiencies at steady state 
conditions were 80% and 75% for mesophilic and thermophilic UASB reactors, 
respectively. The average effluent COD concentration in mesophilic UASB reactor 
was 369 mg!L while in thermophilic UASB reactor was 464 mg!L. The mesophilic 
and thermophilic UASB reactors showed a significantly lower COD 
removal (ANOVA; P<0.05) as the OLR increased due to HRT decrease from 
four to three days. The OLR increased from 0.59 to 0.66 g CODIL·day. Furthermore, 
the COD removal at the mesophilic temperature at HRT of three days was 
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significantly higher from that at the thermophilic temperature (ANOVA; P<O.OS). 
The detail of one-way ANOV A analysis is shown in APPENDIX B: Table B.l. 
For the last 20 days, the UASB reactors were operated at HRT of two days. The 
average OLR was 0.91 g CODIL·day and the influent COD ranged from 
1853 to 2073 mg/L. The COD removal decreased rapidly in both UASB reactors in 
two days because of COD shock loading, although, in the next two days the COD 
removal increased slightly in mesophilic UASB reactor from 70 to 71%, while in 
thermophilic UASB reactor the COD removal increased slightly in eight days from 
60 to 65%. The COD removal efficiencies ranged from 70 to 76% and 60 to 69% for 
mesophilic and thermophilic UASB reactors, respectively. The effluent COD 
concentrations ranged from 424 to 553 mg!L and 549 to 726 mg!L for mesophilic and 
thermophilic UASB reactors, respectively. The average effluent COD concentrations 
and the percentage COD removals at steady state were 478 mg!L and 74% for 
mesophilic UASB reactor and 582 mg!L and 68% for thermophilic UASB reactor, 
respectively. Based on statistical analysis (ANOV A; P<O.OS), COD removal at HRT 
of two days was significantly decreased compared to COD removal at HRT of three 
days in both UASB reactors. Moreover, the COD removal at the mesophilic 
temperature at HRT of two days was significantly higher from that at the thermophilic 
temperature (ANOV A; P<O.OS). 
The performances of the UASB reactors were also evaluated based on BODs. From 
day I to day 13, the reactor was fed with influent BODs of 299-311 mg/L at HRT of 
five days. The influent and effluent BODs concentrations during this study in UASB 
reactors are shown in Figure 4.17. The BODs removal efficiencies ranged from 
88 to 93% and 87 to 90% for mesophilic and thermophilic UASB reactors, 
respectively. The effluent BODs concentrations were from 20 to 36 mg/L and 
31 to 39 mg!L for mesophilic and thermophilic UASB reactors, respectively. The 
average BODs removal efficiency and average effluent BODs concentration in 
mesophilic UASB reactor at steady state condition was 91% and 27 mg!L, 
respectively, while the average BODs removal of 88% and average effluent BODs 
57 
concentration of 35 mg/L were achieved in thermophilic UASB reactor. The BODs 
removal in UASB reactors during this study is shown in Figure 4.18. 
The BODs/COD ratio of the pharmaceutical wastewater varied from 0.62 to 0.72. 
Even though the BODs and COD concentrations of the wastewater were fluctuated 
a lot but the BODs/COD ratio was relatively constant. The average BODs removal 
and BODs/COD ratio during this study in UASB reactors are shown in Figure 4.19. 
At HR T of five days, the BODs/COD ratio of the pharmaceutical wastewater that was 
fed to the UASB reactors was 0.62. After being treated by the UASB reactors, the 
BODs/COD ratios were 0.45 and 0.37 for mesophilic and thermophilic temperatures, 
respectively. The BODs/COD ratio in thermophilic UASB reactor was lower than in 
mesophilic UASB reactor. On the other hand, the performance of thermophilic 
UASB reactor was worse than the mesophilic reactor. From the observation, the 
degradation of organic matter in thermophilic UASB reactor was more dominantly 
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After 13 days, the HRT was decreased from five to three days. The BODs 
concentration ranged from 305 to 386 mg/L. The effluent concentrations were from 
14 to 49 mg/L and 24 to 53 mg/L for mesophilic and thermophilic UASB reactors, 
respectively, while the BODs removal efficiencies ranged from 84 to 96% and 
83 to 94% for mesophilic and thermophilic UASB reactors, respectively. 
At steady state condition, the average effluent BODs concentration and average BODs 
removal were 28 mg/L and 92% respectively, in mesophilic UASB reactor and 
34 mg/L and 90% respectively, in thermophilic UASB reactor. The influent 
BODs/COD ratio was 0.68 while the BODs/COD ratios of the mesophilic and 
thermophilic UASB reactors were 0.43 and 0.40, respectively. 
From day 76, the UASB reactors were fed with high strength wastewater with BODs 
concentration of 1198-1600 mg/L at HRTs of five, four, three and two days. 
The BODs/COD ratio of high strength pharmaceutical wastewater ranged from 
0.68 to 0.72. From day 76 to day 93, the UASB reactors were operated at HRT of 
five days with BODs concentration of 1427-1600 mg/L. The BODs removal 
efficiencies varied from 95 to 97% and 89 to 95% for mesophilic and thermophilic 
UASB reactors, respectively, while the effluent BODs concentrations ranged from 
42 to 79 mg/L and 77 to 163 mg/L for mesophilic and thermophilic UASB reactors, 
respectively. The average BODs removal efficiencies at steady state conditions were 
96% and 91% for mesophilic and thermophilic UASB reactors, respectively. The 
average effluent BODs concentration in mesophilic UASB reactor was 67 mg/L while 
it was 134 mg/L in thermophilic UASB reactor. The BODs/COD ratio of 
pharmaceutical wastewater was 0.72 while the BODs/COD ratios of the mesophilic 
and thermophilic UASB reactors were 0.43 and 0.63, respectively. 
From day 94 to day 145, the UASB reactors were operated at HRT of four days. 
The influent BODs ranged from 1388 to 1540 mg/L and effluent BODs ranged from 
107 to 144 mg/L and 171 to 228 mg/L for mesophilic and thermophilic UASB 
reactors, respectively. The BODs removal efficiencies ranged from 90 to 93% and 
84 to 88% for mesophilic and thermophilic UASB reactors, respectively. The average 
effluent BODs concentrations and percentage BODs removals at steady state were 
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124 mg!L and 92% for mesophilic UASB reactor and 197 mg!L and 86% for 
thermophilic UASB reactor, respectively. The BODs/COD ratio of influent was 0.72 
while the BODs/COD ratios of the mesophilic and thermophilic UASB reactors were 
0.47 and 0.60, respectively. During the mesophilic UASB reactor breakdown period, 
the BODs removal efficiency dropped from 92 to 73% while the BODs concentration 
was 382 mg!L. After about a month, the mesophilic UASB stabilized at the BODs 
removal of 92% and BODs effluent concentration of 117 mg!L. Reactor performance 
during breakdown was not included in data analysis. 
From day 146 to day 179, the UASB reactors were operated at HRT of three days 
with influent BODs of 1212-1483 mg!L, while for the last 20 days, the UASB reactors 
were operated at HRT of two days with influent BODs of 1198-1280 mg/L. The 
BODs removal efficiencies in mesophilic UASB reactor varied from 86 to 88% and 
76 to 85% for HRTs of three and two days, respectively, while the effluent 
concentrations ranged from 169 to 201 mg!L and 185 to 290 mg!L for HRTs of 
three and two days, respectively. 
The BODs/COD ratios in mesophilic UASB reactor decreased from 0.71 to 0.48 and 
0.68 to 0.46 for HRTs of three and two days, respectively. The BODs removal 
efficiencies in thermophilic UASB reactor ranged from 77 to 86% and 74 to 78% for 
HRTs of three and two days, respectively. The BODs effluent concentrations ranged 
from 210 to 287 mg!L and 287 to 314 mg!L for HRTs of three and two days, 
respectively. The BODs/COD ratios in thermophilic UASB reactor were 0.57 and 
0.51 for HR Ts of three and two days, respectively. 
The average BODs removal efficiencies at steady state conditions were 87% and 80% 
for mesophilic and thermophilic UASB reactors at HRT of three days, respectively 
and at HRT of two days were 82% and 76% for mesophilic and thermophilic UASB 
reactors, respectively. The average effluent BODs concentration of 175 mg!L was 
reached in mesophilic UASB reactor at steady state while the average effluent BODs 
concentration of 264 mg!L was achieved in thermophilic UASB reactor at HRT of 
three days. At HRT of two days, the average effluent BODs concentrations of 
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219 mg/L and 299 mg/L were reached in mesophilic and thermophilic UASB reactors 
respectively at steady state condition. 
4.2.2 COD and BOD5 in Mesophilic and Thermophilic HUASB Reactors 
The HUASB reactors were put in operation 62 days after the UASB reactors. For the 
first 12 days, the HUASB reactors were fed with low strength wastewater at HRT of 
three days. The reactors were fed with influent COD concentration of 503-519 mg/L 
with OLR of0.16-0.18 g CODIL·day. The COD concentration in HUASB reactors is 
shown in Figure 4.20 and the HUASB reactors performance in this study is shown in 
Figure 4.21. The COD removal efficiency ranged from 84 to 92% and 
46 to 69% for mesophilic and thermophilic HUASB reactors, respectively. The 
average COD removal efficiencies at steady state conditions were 88% and 66% for 
mesophilic and thermophilic HUASB reactors, respectively. Statistical analysis 
(ANOV A; P<0.05) showed that there was significant difference in the COD removal 
of the mesophilic and thermophilic HUASB reactors at HRT of three days. 
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Figure 4.20 Influent and effluent COD concentrations in HUASB reactors 
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Figure 4.21 OLR and COD removal in HUASB reactors 
After 12 days, the reactors were fed with high strength wastewater at HRTs of five, 
four, three and two days. The HUASB reactors were fed with influent COD 
concentration of 1170-2217 mg/L with OLR ranged from 0.39 to 0.94 g COD/L·day. 
From day 76 to day 93, the HUASB reactors were operated at HRT of five days and 
the average OLR was 0.43 g COD/L-day at which the COD removals ranged from 
93 to 95% and 85 to 90% for mesophilic and thermophilic HUASB reactors, 
respectively. The HUASB reactors were operated with influent COD concentration of 
1970-2217 mg!L. The removal efficiency of the mesophilic HUASB increased 
slightly when the HRT of reactor was changed to two days. However, the efficiency 
of the thermophilic HUASB reactor increased sharply from 68 to 88% in two days. 
Furthermore, the effluent COD concentrations increased sharply in both HUASB 
reactors due to the increase in influent concentration. The mesophilic HUASB reactor 
reached steady state with average COD removal of 94% while the average COD 
removal of the thermophilic HUASB reactor was 87%. The average effluent COD 
concentrations were 133 mg!L and 281 mg/L for mesophilic and thermophilic 
HUASB reactors, respectively. In addition, the mesophilic and thermophilic HUASB 
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reactors showed a significantly increase in COD removal (ANOV A; P<0.05) as the 
HRT was increased from three to five days with the feed of high strength 
pharmaceutical wastewater. Furthermore, at each HRT, the COD removal was 
significantly greater in the mesophilic temperature than in the thermophilic 
temperature (ANOV A; P<0.05). The detail of one-way ANOV A analysis is shown in 
APPENDIX 8: Table 8.1. 
From day 94 to day 145, the HUAS8 reactors were operated at HRT of four days and 
the average influent COD concentration of 1989 mg/L. The OLR ranged from 
0.46 to 0.52 g CODIL·day. The COD removal efficiency of the mesophilic HUAS8 
dropped slightly to reach steady state conditions within three day, whereas the COD 
removal dropped sharply from 85 to 72% in thermophilic HUAS8 reactor. The 
effluent COD concentrations ranged from 177 to 247 mg!L and 304 to 556 mg!L for 
mesophilic and thermophilic HUAS8 reactors, respectively. The HUAS8 reactor 
reached steady state after nine days and the average COD removal was 82% while in 
mesophilic HUAS8 reactor, the average COD removal was 90%. The average 
effluent COD concentration in mesophilic HUAS8 reactor was 208 mg!L while in 
thermophilic UAS8 reactor was 366 mg/L. The mesophilic HUAS8 reactor showed 
a significantly lower COD removal (ANOVA; P<0.05) as the HRT was decreased 
from five to four days. However, the thermophilic HUAS8 reactor showed no 
significant difference in COD removal (ANOV A; P<0.05). Furthermore, the COD 
removal at mesophilic temperature was significantly higher from that at thermophilic 
temperature (ANOV A; P<0.05). The detail of one-way ANOV A analysis is shown in 
APPENDIX 8: Table 8.1. 
From day 146 to day 179, the HUAS8 reactors were operated at HRT of three days 
with influent COD concentration of 1773-1977 mg!L. The average OLR increased 
from 0.50 to 0.62 g CODIL·day. The COD removal decreased rapidly in thermophilic 
HUAS8 reactors in four days while in mesophilic HUAS8 reactor, the COD removal 
decreased faintly. The COD removal increased slightly after eight days. The result 
showed that the thermophilic HUAS8 reactor was more unstable worked with the 
changing of OLR, unlike the mesophilic reactor that was stable. The effluent COD 
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ranged from 234 to 304 mg/L and 305 to 591 mg/L for mesophilic and thermophilic 
HUASB reactors, respectively. The COD removal efficiencies ranged from 
84 to 88% and 70 to 84% for mesophilic and thermophilic HUASB reactors, 
respectively. The average effluent COD concentration and percentage COD removal 
at steady state were 270 mg/L and 86% for mesophilic HUASB reactor and 382 mg/L 
and 79% for thermophilic HUASB reactor, respectively. Based on statistical analysis 
(ANOV A; P<0.05), the COD removal at HRT of three days was significantly 
decreased if it was compared with COD removal at HRT of four days in mesophilic 
HUASB reactor. While in thermophilic HUASB reactor, there was no significant 
difference between the COD removal at HRT of four days with HRT of three days. 
From day 180 to day 199, the HUASB reactors were operated at HRT of two days 
with influent COD concentration of 1770-1877 mg!L. The OLR ranged from 
0.89 to 0.94 g COD/L-day. The COD removal efficiency of the thermophilic HUASB 
dropped roughly in a day from 79 to 71%, after which it increased slightly. It might 
be due to the organic shock loading that resulted from the increased wastewater flow 
rate. The average OLR increased from 0.62 to 0.91 g CODIL·day. In mesophilic 
HUASB reactor; however, the COD removal efficiency decreased only marginally 
from 86 to 85%. The COD removal efficiencies varied from 80 to 85% and 
71 to 76% for mesophilic and thermophilic HUASB reactors, respectively, while the 
effluent COD concentrations ranged from 285 to 371 mg/L and 432 to 545 mg/L for 
mesophilic and thermophilic HUASB reactors, respectively. The average COD 
removal efficiencies at steady state conditions were 83% and 74% for mesophilic and 
thermophilic HUASB reactors, respectively. The average effluent COD concentration 
in mesophilic UASB reactor was 319 mg!L while in thermophilic HUASB reactor 
was 473 mg/L. The mesophilic HUASB reactor showed no significant difference in 
the COD removal (ANOV A; P<0.05) as the HRT was decreased from three to two 
days while the thermophilic HUASB reactor showed a significantly lower COD 
removal. Furthermore, the COD removal at mesophilic temperature at HRT of 
two days was significantly higher from that at thermophilic temperature 
(ANOV A; P<0.05). The detail of one-way ANOV A analysis is shown in 
APPENDIX B: Table B.l. 
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Nandy and Kaul (200 I) observed that the decrease in conversion efficiency with 
reduction in HRT is greater at higher substrate concentration. It indicated that the 
system became more organically stressed at higher organic loading. Variation in 
HRT at constant organic substrate loading by varying feed substrate concentration 
indicates that performance efficiency varies linearly; increasing with increase in HRT. 
By optimizing the substrate loading rate, the system can be operated at the loading 
either by increasing influent substrate concentration with high HRT or operating with 
low HRT and low influent substrate concentration. Nandy and Kaul (2001) showed 
that HRT between 5.0 and 2.5 days could be identified as critical, depending on feed 
substrate concentration. 
The performances of the HUASB reactors were also evaluated in terms of BODs 
removal from day 62 after the UASB reactors were operated. For the first 12 days, 
the reactors were fed with influent BODs of 325-383 mg!L at HRT of three days. The 
BODs concentration during this study in HUASB reactors is shown in Figure 4.22 and 
the BODs removal in HUASB reactors during this study is shown in Figure 4.23. The 
BODs removal efficiency in mesophilic HUASB reactor ranged from 90 to 95% while 
the BODs removal in thermophilic HUASB reactor ranged from 70 to 80%. The 
effluent BODs concentrations were from 20 to 36 mg/L and 31 to 39 mg/L for 
mesophilic and thermophilic HUASB reactors, respectively. The average BODs 
removal efficiency and average effluent BODs concentration in mesophilic HUASB 
reactor at steady state conditions were 93% and 27 mg!L, respectively, while the 
average COD removal of 83% and average effluent COD concentration of 83 mg/L 
were achieved in thermophilic HUASB reactor. The BODs/COD ratio in the 
wastewater ranged from 0.68 to 0.72 during the operation of the HUASB reactors. 
The average BODs removal and BODs/COD ratio in HUASB reactors are shown in 
Figure 4.24. At HRT of three days, the BODs/COD ratio of low strength 
pharmaceutical wastewater was 0.68. After treatment by the HUASB reactors, 
BODs/COD ratios were 0.45 and 0.37 for mesophilic and thermophilic temperatures, 
respectively. 
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Figure 4.22 Influent and effluent BODs concentrations in HUASB reactors 
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Figure 4.24 Average BODs and COD removals and BODs/COD ratio in HUASB 
reactors at steady state condition 
After 13 days, the HRT was increased from three to five days to avoid shock organic 
loading due to the increased pharmaceutical wastewater COD and BODs 
concentrations. The average effluent BODs concentration increased from 
501 to 1938 mg/L. The BODs concentration ranged from 1427 to 1600 mg/L. The 
effluent BODs concentrations were from 40 to 71 mg/L and 138 to 171 mg/L for 
mesophilic and thermophilic HUASB reactors, respectively, while the BODs removal 
efficiencies ranged from 95 to 97% and 89 to 91% for mesophilic and thermophilic 
HUASB reactors, respectively. At steady state conditions, the average effluent BODs 
concentration and average BODs removal were 51 mg/L and 97% in mesophilic 
HUASB reactor, respectively, whereas in thermophilic HUASB reactor were 
151 mg/L and 90%, respectively. The BODs/COD ratio of pharmaceutical 
wastewater at HRT of five days was 0.72 while the BODs/COD ratio of the 
mesophilic and thermophilic HUASB reactors were 0.39 and 0.54, respectively. 
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From day 94 to day 145, the HUASB reactors were operated at HRT of four days with 
influent BODs concentration of 1388-1540 mg/L. The BODs removal efficiencies 
varied from 92 to 95% and 82 to 91% for mesophilic and thermophilic HUASB 
reactors, respectively, while the effluent BODs concentrations ranged from 
81 to 120 mg!L and 123 to 267 mg/L for mesophilic and thermophilic HUASB 
reactors, respectively. The average BODs removal efficiencies at steady state 
conditions were 93% and 89% for mesophilic and thermophilic HUASB reactors, 
respectively. The average effluent BODs concentration in mesophilic HUASB reactor 
was 96 mg!L while in thermophilic HUASB reactor was 156 mg/L. The BODs/COD 
ratio of pharmaceutical wastewater at HRT of four days was 0. 72 while the 
BODs/COD ratios of the mesophilic and thermophilic HUASB reactors were 0.46 and 
0.43, respectively. 
From day 146 to day 179, the HUASB reactors were operated at HRT of three days. 
The influent BODs ranged from 1212 to 1483 mg!L and effluent BODs ranged from 
97 to 134 mg!L and 132 to 200 mg!L for mesophilic and thermophilic HUASB 
reactors, respectively. The BODs removal efficiencies ranged from 89 to 93% and 
86 to 91% for mesophilic and thermophilic HUASB reactors, respectively. The 
average effluent BODs concentrations and BODs removals at steady state were 
115 mg!L and 91% for mesophilic HUASB reactor and !50 mg!L and 88% for 
thermophilic HUASB reactor, respectively. The BODs/COD ratio of influent was 
0.71 while the BODs/COD ratios of the mesophilic and thermophilic HUASB reactors 
were 0.43 and 0.39, respectively. 
For the last 20 days, the HUASB reactors were operated at HRT of two days with 
influent BODs of 1198-1280 mg!L. The BODs removal efficiencies in mesophilic 
and thermophilic HUASB reactors at HRT of two days varied from 87 to 92% and 
83 to 84%, respectively, while the effluent BODs concentrations ranged from 
I 02 to !56 mg!L and 194 to 276 mg/L for mesophilic and thermophilic HUASB 
reactors, respectively. The BODs/COD ratio in mesophilic HUASB reactor decreased 
from 0.68 to 0.38 while in thermophilic HUASB reactor decreased from 0.68 to 0.46. 
The average BODs removal efficiencies at steady state conditions were 90% and 83% 
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for mesophilic and thermophilic HUASB reactors at HRT of two days, respectively. 
The average effluent BODs concentration of 122 mg!L was reached in mesophilic 
HUASB reactor at steady state while the average effluent BODs concentration of 
218 mg/L was achieved in thermophilic HUASB reactor. 
4.2.3 Summary ofUASB and HUASB Reactors Performance 
In Phase II study, the UASB and HUASB reactors were fed with low strength and 
high strength influent at HRTs of five, four, three and two days under mesophilic 
(35±2°C) and thermophilic (55±2°C) conditions. The performance of each reactor 
was evaluated in terms of COD and BODs removals. Table 4.1 and Table 4.2 show 
the average COD and BODs concentrations obtained from the UASB and HUASB 
reactors at steady state conditions. The objective of this study was to evaluate the 
performance of mesophilic and thermophilic UASB and HUASB reactors in treating 
non-penicillin pharmaceutical wastewater. The reactors were seeded with sludge 
from an aerobic domestic sewage treatment plant. The results show the HUASB 
reactors to be significantly more efficient in COD removal than the UASB reactors. 
The pharmaceutical wastewater was very fluctuative in COD and BODs 
concentrations. The reactors were fed with low strength influent 
(COD 458-526 mg!L) and high strength influent (COD 1770-2217 mg!L). The 
reactors showed higher COD removal in treating high strength wastewater. 
This study was also to evaluate the effect of HRT and temperature on the performance 
of UASB and HUASB reactors. The reactors were operated under mesophilic 
(35±2°C) and thermophilic (55±2°C) temperatures and HRTs of five, four, three and 
two days. The results show that the reactor performance was significantly affected by 
type of reactors, HRT and temperature. Both mesophilic UASB and HUASB reactors 
showed higher COD and BODs removals in treating pharmaceutical wastewater. 
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Table 4.1 Average influent and effluent COD concentrations, OLR and COD 
removal in UASB and HUASB reactors 
HRT Influent COD OLR Mesophilic UASB Thermophilic UASB 
(days) (mg/L) (g COD/L·d) Eff. COD COD Rem. Eff.COD COD Rem. (mg!L) (%) (mg/L) (%) 
Low strength influent 
5 487 0.10 60 88 95 80 
3 505 0.17 65 87 83 84 
High strength influent 
5 2127 0.43 158 93 213 90 
4 1989 0.50 262 87 329 83 
3 1875 0.62 369 80 464 75 
2 1820 0.91 478 74 582 68 
HRT Influent COD OLR Mesophilic HUASB Thermophilic HUASB 
(days) (mg!L) (g CODIL·d) Eff. COD COD Rem. Eff. COD COD Rem. (mg/L) (%) (mg/L) (%) 
Low strength influent 
3 505 0.17 61 88 172 66 
High strength influent 
5 2127 0.43 133 94 281 87 
4 1989 0.50 208 90 366 82 
3 1875 0.62 270 86 382 79 
2 1820 0.91 319 83 473 74 
Table 4.2 Average influent and effluent BODs concentrations and BODs removal in 
UASB and HUASB reactors 
HRT Influent BODs Mesophilic UASB Thermophilic UASB 
(days) (mg!L) Eff. BODs BODs Rem. Eff. BOD, BOD, Rem. (mg/L) (%) (mg/L) (%) 
Low strength influent 
5 305 27 91 35 88 
3 345 28 92 34 90 
High strength influent 
5 1532 67 96 134 91 
4 1441 124 92 197 86 
3 1339 175 87 264 80 
2 1245 219 82 299 76 
HRT Influent BODs Mesophilic HUASB Thermophilic HUASB 
(days) (mg!L) Eff. BOD, BOD, Rem. Eff. BOD, BOD, Rem.· (mg/L) (%) (mg/L) (%) 
Low strength influent 
3 345 27 93 83 77 
High strength influent 
5 1532 51 97 151 90 
4 1441 96 93 156 89 
3 1339 115 91 150 88 
2 1245 122 90 218 83 
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The highest average COD and BODs removals were achieved by the mesophilic 
HUASB reactor treating high strength pharmaceutical wastewater at HRT of five days 
(average OLR 0.43 g COD/L·day); average COD removal was 90%, average effluent 
COD was 133 mg!L, average BODs removal was 97% and average effluent BODs 
was 51 mg!L. The COD and BODs removals decreased when the HRT was 
decreased. The lowest average COD and BODs removals were achieved by the 
thermophilic UASB reactor at HRT of two days. The average COD and BODs 
removals were 68% and 76%, respectively, whereas the average COD and BODs 
concentrations were 582 mg!L and 299 mg/L, respectively. 
From the two-way ANOVA result, it found that there was a significant effect of 
reactor configuration, HRT and temperature, so it implied that the mean of COD 
removal varied between HRTs of five, four, three and two days and temperature of 
mesophilic and thermophilic. In addition, there was statistical indication of 
interaction between HRT and type of reactor, thus the effect of HRT on the COD 
removal varied significantly with the variation of reactor. The COD removal differed 
due to the effect between HRT with temperature and reactor with temperature. The 
two-way ANOV A result showed the COD removal varied with the effect of three 
variable operation conditions. The detail of two-way ANOV A analysis is shown in 
APPENDIX B: Table B.2. 
4.2.4 Nutrients in Mesophilic and Thermophilic UASB Reactors 
Figure 4.25 to Figure 4.32 show the influent and effluent nutrient concentrations 
(NH3-N, N03-N, TKN and TP) in UASB reactors. In the first 13 days, the UASB 
reactors were operated at HRT of five days and the influent NH3-N and N03-N 
concentrations ranged from 3.0 to 3.7 mg!L and 0.6 to 0.9 mg!L, respectively. 
The effluent NH3-N increased in both UASB reactors during this study, whereas the 
N03-N was not significantly difference between the influent and effluent of the 
UASB reactors. The effluent NH3-N and N03-N concentrations in mesophilic UASB 
reactor ranged from 11.5 to 13.0 mg!L and 0.4 to 0. 7 mg!L, respectively, while in 
thermophilic reactor they ranged from 18.5 to 13.0 mg!L and 0.1 to 0.4 mg!L, 
respectively. 
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Figure 4.25 Influent and effluent NH3-N concentrations in UASB reactors 
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Figure 4.26 Average influent and effluent NH3-N concentrations at each variation of 
HRT in UASB reactors 
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Figure 4.27 Influent and effluent N03-N concentrations in UASB reactors 
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Figure 4.28 Average influent and effluent N03-N concentrations at each variation of 
HRT in UASB reactors 
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Figure 4.29 Influent and effluent TKN concentrations in UASB reactors 
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Figure 4.30 Average influent and effluent TKN concentrations at each variation of 
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Figure 4.31 Influent and effluent TP concentrations in UASB reactors 
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Figure 4.32 Average TP concentration at each variation ofHRT in UASB reactors 
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In low strength pharmaceutical wastewater (COD 458-499 mg!L), the average TKN 
and TP concentrations of pharmaceutical wastewater were 36.9 mg/L and 6.6 mg/L, 
respectively at HRT of five days. The COD:TKN:TP ratio was 67:5: I. The average 
effluent TKN concentrations were 33.3 mg!L and 34.6 mg/L for mesophilic and 
thermophilic UASB reactors, respectively. Moreover, the average effluent TP 
concentrations were 17.3 mg/L and 19.9 mg!L. The average TKN and TP 
concentrations are shown m Figure 4.30 and Figure 4.32, respectively. 
The COD:TKN:TP ratios decreased from 67:5:1 to 3:2:1 and 4:2:1 for mesophilic and 
thermophilic UASB reactors, respectively. 
At HRT of three days, the average effluent NH3-N of the mesophilic UASB reactor 
was higher than the thermophilic UASB reactor whereas the average effluent N03-N 
of the mesophilic UASB reactor was lower than the thermophilic UASB reactor. The 
average NH3-N concentrations increased from 4.6 to 8. 7 mg!L and 4.6 to 7.2 mg/L for 
mesophilic and thermophilic UASB reactors, respectively. The average N03-N 
concentrations were relatively constant from 0.4 to 0.5 mg/L and 0.5 to 0.6 mg/L for 
mesophilic and thermophilic UASB reactors, respectively. The influent and effluent 
NH3-N and N03-N concentrations in UASB reactors during this study are shown in 
Figure 4.25 to Figure 4.28, respectively. From day 14 to day 75, the UASB reactors 
were fed by low strength pharmaceutical wastewater (COD 483-526 mg!L) and TP 
concentrations of pharmaceutical wastewater varied from 5.5 to 8.5 mg/L. The 
effluent TP concentrations in mesophilic and thermophilic UASB reactors ranged 
from 14.7 to 20.6 mg!L and 14.1 to 23.9 mg!L, respectively. The influent and effluent 
TP concentrations in UASB reactors during this study are shown in Figure 4.31. The 
average TKN concentration of pharmaceutical wastewater was 36.3 mg!L, while the 
average effluent TKN concentrations were 33.1 mg/L and 34 mg/L for mesophilic and 
thermophilic UASB reactors, respectively. The COD:TKN:TP ratios decreased from 
79:6: I to 3:2: I and 5:2: I for mesophilic and thermophilic UASB reactors, 
respectively. 
From day 76, the UASB reactors were fed with high strength wastewater 
(COD 1770-2217 mg/L) at HRTs of five, four, three and two days. At HRT of 
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five days, the average influent NH3-N and NOrN concentrations were 14.7 mg/L and 
0.6 mg/L, respectively. The NH3-N concentration increased in mesophilic UASB 
reactor (from 14.7 to 19.2 mg!L) whereas in thermophilic UASB reactor, it decreased 
(from 14.7 to 12.7 mg!L). The N03-N concentrations slightly decreased in both 
UASB reactors. The average effluent N03-N concentrations in mesophilic and 
thermophilic UASB reactor were 0.5 mg/L and 0.4 mg!L, respectively. In high 
strength pharmaceutical wastewater (COD 1970-2217 mg!L) when the UASB reactors 
were operated at HRT of five days, the average TKN and TP concentrations of 
pharmaceutical wastewater were 54.8 mg/L and 13.3 mg/L, respectively. The 
COD:TKN:TP ratio of pharmaceutical wastewater was 163:4:1. The average effluent 
TKN concentrations were 49.7 mg/L and 51.2 mg/L for mesophilic and thermophilic 
UASB reactors, respectively. Moreover, the average effluent TP concentrations were 
18.2 mg/L and 19.3 mg/L for mesophilic and thermophilic UASB reactors, 
respectively. The COD:TKN:TP ratios decreased from 163:4:1 to 10:3:1 and 13:2:1 
for mesophilic and thermophilic UASB reactors, respectively. 
From day 94 to day 145, the UASB reactors were operated at HRT of four days. The 
average effluent NH3-N of the mesophilic UASB reactor was higher than that of the 
thermophilic UASB reactor whereas the average effluent N03-N of the mesophilic 
UASB reactor was lower than that of the thermophilic reactor. The average NH3-N 
concentrations increased from 14.9 to 15.1 mg!L and 14.9 to 13.0 mg/L for 
mesophilic and thermophilic UASB reactors, respectively. The average N03-N 
concentrations were relatively constant from 0.3 to 0.4 mg!L and 0.3 to 0.5 mg/L for 
mesophilic and thermophilic UASB reactors, respectively. At HRT of four days, the 
UASB reactors were fed by high strength pharmaceutical wastewater 
(COD 1853-2073 mg!L) and average TP concentrations of pharmaceutical wastewater 
was 11.3 mg/L. The average effluent TP concentration in mesophilic and 
thermophilic UASB reactors were 18.1 mg/L and 18.5 mg!L, respectively. The 
average TKN concentration of pharmaceutical wastewater was 56.7 mg/L, while the 
average effluent TKN concentrations were 52.2 mg/L and 56.7 mg/L for mesophilic 
and thermophilic UASB reactors, respectively. The COD:TKN:TP ratios decreased 
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from 180:5:1 to 19:3:1 and 18:3:1 for mesophilic and thermophilic UASB reactors, 
respectively. 
On day II 0, the mesophilic UASB reactor failed due to malfunctioning of the 
thermostat. The temperature increased to 60°C. From day Ill to day 118, the 
mesophilic UASB reactor was operated at ambient temperature (24±2°C) while it was 
being repaired. The effluent NHrN and N03-N concentrations ranged from 
12.7 to 14.7 mg/L and 0.2 to 0.3 mg/L, respectively. The effluent NH3-N 
concentrations were lower than the effluent NH3-N concentrations before the 
mesophilic UASB reactor failed while the effluent N03-N concentrations relatively 
did not change, whereas the effluent TP concentrations sharply increased. The 
effluent TP concentration ranged from 22.4 to 32.5 mg/L. The results for the reactor 
breakdown period were not included for data analysis. The TKN concentration 
increased from 57.7 mg/L (influent) to 59.6 mg!L (effluent). After 30 days, the 
reactor stabilized with effluent TP of20.5 mg/L 
From day 146 to day 179, the UASB reactors were operated at HRT of three days, 
while for the last 20 days, the UASB reactors were operated at HRT of two days. The 
average influent NH3-N concentrations were 12.1 mg/L and 11.3 mg/L at HRTs of 
three and two days, respectively. The average effluent NH3-N concentration in 
mesophilic UASB reactor decreased at the lower HRT, while in thermophilic UASB 
reactors it remained constant when the HR T was reduced. The average effluent 
NH3-N concentrations in mesophilic UASB reactor were 15.4 mg/L and 14.9 mg/L at 
HRTs of three and two days, respectively whereas in thermophilic UASB reactors, it 
was 13.7 mg/L at both HRTs of three and two days. The average influent N03-N 
concentrations were 0.4 mg/L and 0.5 mg/L at HRTs of three and two days, 
respectively. The average effluent N03-N concentrations in both UASB reactors were 
relatively constant when the HRT was reduced. The average effluent NOrN 
concentrations in mesophilic UASB reactor were 0.2 mg/L and 0.3 mg/L at HRTs of 
three and two days, respectively whereas in thermophilic UASB reactors N03-N 
concentrations were 0.4 mg/L and 0.3 mg!L at HRTs of three and two days, 
respectively. 
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At HRT of three days the pharmaceutical wastewater COD of 1875 mg/L was fed in 
UASB reactors, whereas COD of 1820 mg!L was fed to the UASB reactor at HRT of 
two days. The influent COD:TKN:TP ratio was 158:4: I for both HRTs of three and 
two days. The average TKN concentrations of pharmaceutical wastewater were 
51.5 mg/L and 49.7 mg/L, whereas the average TP concentrations were 11.7 mg/L 
and 11.6 mg/L for HRTs of three and two days, respectively. The effluent 
COD:TKN:TP ratio at HRT of three days were lower than the effluent COD:TKN:TP 
ratio at HRT of two days in both UASB reactors. This is mainly attributed to the 
increase in effluent COD as the main factor. The effluent COD:TKN:TP ratios were 
24:3:1 and 34:4:1 for HRTs of three and two days in mesophilic reactor, respectively 
whereas in thermophilic reactor, the effluent COD:TKN:TP ratios were 25:3:1 and 
34:3: I for HRTs of three and two days, respectively. In mesophilic UASB reactor, 
the average effluent TKN concentration increased from 45.7 to 47.7 mg/L when the 
HRT was decreased from three to two days while in thermophilic UASB reactor, the 
average effluent TKN concentration slightly decreased from 48.6 to 48.0 mg/L. 
Moreover, the average effluent TP concentration in mesophilic UASB reactor 
decreased from 15.0 to 13.4 mg/L while in thermophilic UASB reactor, the average 
effluent TP concentration slightly increased from 17.7 to 17.9 mg!L when the HRT 
was decreased from three to two days. 
4.2.5 Nutrients in Mesophilic and Thermophilic HUASB Reactors 
Figure 4.33 to Figure 4.40 show the influent and effluent nutrient concentrations 
(NH3-N, N03-N, TKN and TP) in HUASB reactors. The HUASB reactors started 
operation 62 days after the UASB reactors. For the first 12 days, the HUASB reactors 
were fed with low strength wastewater at HRT of three days. The influent NH3-N and 
N03-N concentrations ranged from 4.6 to 5.1 mg/L and 0.6 to 0.5 mg/L, respectively. 
The NH3-N concentrations sharply increased in both HUASB reactors during this 
study whereas the N03-N concentrations did not significantly change between the 
influent and effluent of HUASB reactors. The effluent NH3-N and N03-N 
concentrations in mesophilic HUASB reactor varied from 18.4 to 19.4 mg/L 
and 0.1 to 0.2 mg!L, respectively, while in thermophilic reactor varied from 
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13.4 to 14.1 mg/L and 0.2 to 0.3 mg/L, respectively at HRT of three days. The 
influent and effluent NH3-N and N03-N concentrations in UASB reactors during this 
study are shown in Figure 4.33 and Figure 4.35, respectively. In low strength 
pharmaceutical wastewater (COD 503-519 mg!L), the average TKN and TP 
concentrations of pharmaceutical wastewater were 37.5 mg/L and 6.2 mg/L, 
respectively. The COD:TKN:TP ratio was 79:6: I. The average effluent TKN 
concentrations were 31.8 mg/L and 34.1 mg/L for mesophilic and thermophilic 
HUASB reactors, respectively. Moreover, the average effluent TP concentrations 
were 26.8 mg/L and 27.2 mg/L for mesophilic and thermophilic HUASB reactors, 
respectively. The average influent and effluent TKN and TP concentrations in 
HUASB reactors are shown in Figure 4.38 and Figure 4.40, respectively. The 
COD:TKN:TP ratios decreased from 67:5: I to 3: I: I and II: I: I for mesophilic and 
thermophilic HUASB reactors, respectively. 
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Figure 4.34 Average influent and effluent NH3-N concentrations at each variation of 
HRT in HUASB reactors 
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Figure 4.36 Average influent and effluent N03-N concentrations at each variation of 
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Figure 4.40 Average influent and effluent TP concentrations at each variation ofHRT 
in HUASB reactors 
From day 76, high strength wastewater was fed to the HUASB reactors 
(COD 1770-2217 mg!L) at HRTs of five, four, three and two days. From day 76 to 
day 93, the HUASB reactors were operated at HRT of five days, while from day 94 to 
day 145, the HUASB reactors were operated at HRT of four days. The average 
influent NH3-N concentrations were 14.7 mg!L and 14.9 mg/L at HRT of 
five and four days, respectively. The average effluent NH3-N concentrations 
increased in both HUASB reactors when the HRT was reduced. The average effluent 
NH3-N concentrations in mesophilic HUASB reactor were 15.3 mg/L and 
18.0 mg/L at HRTs of five and four days, respectively whereas in thermophilic 
HUASB reactors, they were 14.7 mg!L and 15.3 mg!L at HRTs of three and two days, 
respectively. The average influent N03-N concentrations were 0.6 mg/L and 
0.5 mg/L at HRTs of three and two days, respectively. The average effluent N03-N 
concentrations in both HUASB reactors were relatively constant when the HRT was 
reduced. The average effluent N03-N concentrations in mesophilic HUASB reactor 
were 0.3 mg/L and 0.4 mg!L at HRTs of three and two days, respectively, whereas in 
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thermophilic HUASB reactors, they were 0.2 mg/L and 0.5 mg/L at HRTs of 
three and two days, respectively. 
At HRTs offive and four days, the COD concentrations of pharmaceutical wastewater 
fed to the HUASB reactors were 2127 mg/L and 1989 mg/L, respectively. 
The influent COD:TKN:TP ratios were 163:4: I and 180:5: I for HRTs of 
five and four days, respectively. The average TKN concentrations of pharmaceutical 
wastewater were 54.8 mg!L and 56.7 mg/L, whereas the average TP concentrations 
were 13.3 mg!L and 11.3 mg!L for HRTs of five and four days, respectively. 
The effluent COD:TKN:TP ratios at HRT of five days were lower than the effluent 
COD:TKN:TP ratio at HRT of four days in both HUASB reactors. These results are 
attributed to the increase in effluent COD as the main factor. The effluent 
COD:TKN:TP ratios were 5:2:1 and 10:4:1 for HRTs of five and four days in 
mesophilic HUASB reactor, respectively whereas in HUASB thermophilic 
reactor, the effluent COD:TKN:TP ratios were 8: I: I and 13:2: I for HRTs of 
five and four days, respectively. In mesophilic HUASB reactor, the average effluent 
TKN concentrations increased from 46.5 to 51.3 mg/L when the HRT was decreased 
from five to four days while in thermophilic HUASB reactor, the average effluent 
TKN concentrations increased from 49.5 to 53.8 mg/L. Moreover, the 
average effluent TP concentrations in mesophilic HUASB reactor decreased from 
29.3 to 23.2 mg/L while in thermophilic HUASB reactor, the average effluent TP 
concentrations decreased from 32.2 to 26.7 mg!L when the HRT was decreased from 
five to four days. 
From day 146 to day 179, the HUASB reactors were operated at HRT of three days 
and fed by the pharmaceutical wastewater COD of 1875 mg/L, while for the last 
20 days, the UASB reactors were operated at HRT of two days and supplied by the 
pharmaceutical wastewater with COD of 1820 mg/L. At HRT of three days, the 
average TKN and TP concentrations of pharmaceutical wastewater were 51.5 mg/L 
and II. 7 mg/L, respectively, whereas at HRT of two days, the average TKN and TP 
concentrations were 49.7 mg/L and 11.6 mg/L, respectively. In mesophilic HUASB 
reactor, the average effluent TKN concentrations were about the same 
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(46.8 mg/L and 46.9 mg!L) when the HRT was decreased from three to two days 
while in thermophilic HUASB reactor, the average TKN concentration slightly 
decreased from 47.8 mg!L to 47.2 mg!L. Moreover, the average effluent TP 
concentration in mesophilic HUASB reactor increased from 23.1 to 23.9 mg!L, while 
in thermophilic HUASB reactor, the average effluent TP concentration decreased 
from 27.4 to 26.4 mg!L when the HRT was decreased from 
three to two days. The influent COD:TKN:TP ratios were 158:4: I for both HRTs of 
three and two days. The effluent COD:TKN:TP ratios at HRT of two days were 
higher than the effluent COD:TK.N:TP ratios at HRT of three days in both HUASB 
reactors. The effluent COD:TK.N:TP ratios were 12:2:1 and 15:2:1 for HRTs of 
three and two days in mesophilic HUASB reactor, respectively whereas in 
thermophilic HUASB reactor, the effluent COD:TKN:TP ratios were 14:2:1 and 
17:2:1 for HRTs of three and two days, respectively. 
The average influent NH3-N concentrations were 12.1 mg/L and 11.3 mg/L at HRTs 
of three and two days, respectively. In mesophilic HUASB reactor, the average 
effluent NH3-N concentrations decreased and in thermophilic HUASB reactor 
was constant, when the HRT was reduced. The average effluent NH3-N 
concentrations in mesophilic HUASB reactor were 17.4 mg!L and 16.6 mg!L at HRTs 
of three and two days, respectively whereas in thermophilic HUASB reactors were 
13.9 mg!L and 14.0 mg!L at HRTs of three and two days, respectively. The 
average influent N03-N concentrations were 0.4 mg!L and 0.5 mg!L at HRTs of 
three and two days, respectively. The average effluent N03-N concentrations in both 
HUASB reactors were relatively constant when the HRT was reduced. The average 
effluent N03-N concentrations in mesophilic HUASB reactor were 0.2 mg!L and 
0.3 mg!L at HRTs of three and two days, respectively whereas in thermophilic 
HUASB reactors were 0.3 mg!L and 0.2 mg/L at HRTs of three and two days, 
respectively. 
4.2.6 Summary of Nutrient Parameters in UASB and HUASB Reactors 
Table 4.1 to Table 4.6 show the average nutrient concentrations (NH3-N, NOrN, 
TKN and TP) in UASB and HUASB reactors at steady state conditions. The 
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concentration of NH3-N and total phosphorous increased during this study, whereas 
the concentration of N03-N was constant and concentration of TKN slightly reduced. 
Jenicek et al. (1996) also reported negligible nitrogen removal using a UASB reactor 
treating biosynthetic pharmaceutical wastewater. 
Table 4.3 Average influent and effluent NH3-N concentrations in UASB and 
HUASB reactors 
HRT Influent NH3-N 
Effluent NH3-N (mg/L) 
(days) (mg!L) Mesophilic Thermophilic Mesophilic Thermophilic 
UASB UASB HUASB HUASB 
Low strength influent 
5 3.3 12.5 11.6 N/A N/A 
3 4.6 8.7 7.2 18.9 13.8 
High strength influent 
5 14.7 19.2 12.7 15.3 14.7 
4 14.9 15.1 13.0 18.0 15.3 
3 12.1 15.4 13.7 17.4 13.9 
2 11.3 14.9 13.7 16.6 14.0 
Table 4.4 Average influent and effluent N03-N concentrations in UASB and 
HUASB reactors 
HRT Influent N03-N 
Effluent N01-N (mg/L) 
(days) (mg!L) Mesophilic Thermophilic Mesophilic Thermophilic 
UASB UASB HUASB HUASB 
Low strength influent 
5 0.7 0.6 0.3 N/A N/A 
3 0.5 0.4 0.6 0.2 0.3 
High strength influent 
5 0.6 0.5 0.4 0.3 0.2 
4 0.5 0.3 0.4 0.4 0.5 
3 0.4 0.2 0.4 0.2 0.3 
2 0.5 0.3 0.3 0.3 0.2 
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The effluent from the UASB reactor contained higher orthophosphates and nitrogen 
levels. Under anaerobic conditions, phosphorous accumulating organisms (PAOs) 
will assimilate fermentation products into storage products within the cells with 
concomitant release of phosphorous from stored polyphosphates. The nitrogen 
demand for growth of anaerobic bacteria is almost negligible and if no 
accumulation of organic matter in the bioreactor occurs, the balance between total 
nitrogen flow in and out of the reactor should be constant (Metcalf & Eddy, 2003; 
Parawira et al., 2005). The effluent NH3-N concentration increased and the effluent 
N03-N concentration was constant because nitrification did not occur in UASB and 
HUASB reactors. 
4.3 VFA, alkalinity and pH in UASB and HUASB Reactors 
The anaerobic reactors generally are affected by the changing of environmental and/or 
operating conditions. The typical responses in the anaerobic reactor include 
a decrease in performance, VFA accumulation, pH and alkalinity drop, change of 
biogas production and composition and sludge washout. The VF Nalkalinity ratio 
should be lower than 0.3 (Lei tao et al., 2006). 
During this study, the pH of pharmaceutical wastewater ranged from 4. 76 to 6.04. 
The influent alkalinity was maintained at 1500 to 2000 mg CaC03/L. The pH of 
pharmaceutical wastewater after adjustment with sodium bicarbonate was 
approximately 7.48. The influent and effluent pH and alkalinity in UASB and 
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Figure 4.41 Influent and effluent pH and alkalinity in UASB reactors 
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Figure 4.42 Influent and effluent pH and alkalinity in HUASB reactors 
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In the first 75 days, the UASB reactors were fed with low strength influent 
(COD 458-526 mg!L) at HRTs of five and three days. The influent pH of the UASB 
reactors ranged from 7.26 to 7.84 and 7.28 to 7.91, whereas, the influent alkalinity 
ranged from 1603 to 1787 mg CaC031L and 1609 to 1813 mg CaC03/L for HRT of 
five and three days, respectively. The average effluent pH slightly decreased when 
the HRT was decreased from five to three days. The average effluent pH decreased 
from 7.81 to 7.78 and 8.25 to 7.98 for mesophilic and thermophilic UASB reactors, 
respectively. The effluent alkalinity at HRT of five days ranged from 
1644 to 1866 mg CaC03!L and 1848 to 1861 mg CaC03!L, whereas at HRT of 
three days, the effluent alkalinity ranged from 1646 to 1875 mg CaC031L and 
1696 to 1909 mg CaC031L for mesophilic and thermophilic UASB reactors, 
respectively. 
The HUASB reactors were put in operation 62 days after the UASB reactors. For the 
first 12 days, the HUASB reactors were fed with low strength wastewater at HRT of 
three days. The average effluent pH were 7.95 and 8.05, whereas the effluent 
alkalinity ranged from 1865 to 1964 mg CaC03!L and 1833 to 1973 mg CaC03!L for 
mesophilic and thermophilic HUASB reactors, respectively. 
The VFA was measured from day 65 and the average influent and effluent VFA 
concentration m UASB and HUASB reactors during this study is shown in 
Figure 4.43. At HRT of three days, the average influent VFA was 
16.2 mg acetic acid!L. The average effluent VFA in mesophilic reactors was lower 
than the average effluent VF A in thermophilic reactors. The average effluent VF A in 
mesophilic and thermophilic UASB reactors were 23.5 mg acetic acid/L and 
36.5 mg acetic acid!L, respectively, whereas the average effluent VFA were 
29.0 mg acetic acid/L and 55.3 mg acetic acid!L for mesophilic and thermophilic 
HUASB reactors, respectively. 
High strength influent 
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Figure 4.43 Average influent and effluent VFA concentrations in UASB and HUASB 
reactors 
From day 76 to day 199, the UASB and HUASB reactors were fed with high strength 
wastewater (COD 1770-2217 mg!L) at HRTs of five, four, three and two days. The 
influent pH and alkalinity in UASB reactors ranged from 7.11 to 7.70 mg CaC03/L 
and 1547 to 1743 mg CaC03/L, respectively. On day 110, the mesophilic UASB 
reactor failed due to malfunctioning of the thermostat. The effluent VFA sharply 
increased from 35 to 293 mg acetic acid/L, whereas the effluent pH sharply decreased 
from 7.16 to 5.81. The pH and alkalinity in the reactor during the upset period was 
not included in data analysis. After 30 days, the reactor stabilized with pH of 7.28 
and alkalinity of 1643 mg CaC03/L. 
The average effluent pH decreased when the HRT were decreased. The average 
effluent pH in mesophilic UASB reactor was lower than the average effluent pH in 
thermophilic UASB reactor. The average effluent pH in mesophilic UASB reactor 
were 7.18, 7.26, 6.89 and 6.55, whereas in thermophilic UASB reactor, the average 
effluent pH were 7.50, 7.29, 7.16 and 6.92 at HRTs of five, four, three and two days, 
respectively. The average effluent alkalinity also decreased when the HRT were 
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decreased in both of UASB reactors. The average effluent alkalinity in mesophilic 
UASB reactor were 1600, 1621, 1582 and 1537 mg CaC03/L, whereas in 
thermophilic UASB reactor, the average effluent alkalinity were 1680, 1613, 1570 
and 1562 mg CaC03/L at HRTs of five, four, three and two days, respectively. The 
average effluent alkalinity in mesophilic UASB reactor was higher than the average 
effluent alkalinity in thermophilic UASB reactor at HRTs of four and three days. It 
seems the reactor was still sensitive due to its previous failure (temperature shock). 
The average effluent pH in mesophilic HUASB reactor was lower than the average 
effluent pH in thermophilic HUASB reactor. The average effluent pH in mesophilic 
HUASB reactor were 7.25, 6.99, 6.63 and 6.36, whereas in thermophilic HUASB 
reactor, the average effluent pH were 7.42, 7.12, 6.86 and 6.86 at HRTs of five, four, 
three and two days, respectively. The average effluent alkalinity also decreased when 
the HRT were decreased in both of HUASB reaCtors. The average effluent alkalinity 
in mesophilic HUASB reactor were 1663, 1621, 1587 and 1595 mg CaC03/L, 
whereas in thermophilic HUASB reactor, the average effluent alkalinity were 1668, 
1597, 1592 and 1624 mg CaC03/L at HRTs of five, four, three and two days, 
respectively. 
The YFA of high strength influent ranged from 15.7 to 25.3 mg acetic acid!L. 
At HRT of five days, the average effluent YFA in mesophilic reactors were lower 
than the average effluent VFA in thermophilic reactors at both UASB and HUASB 
reactors. The average VFA in mesophilic and thermophilic UASB reactors were 
28.0 mg acetic acid/L and 39.2 mg acetic acid!L, respectively, whereas the average 
YFA were 22.5 mg acetic acid!L and 44.7 mg acetic acid!L for mesophilic and 
thermophilic HUASB reactors, respectively. The average effluent VFA increased in 
all reactors when the HRT were decreased, except in mesophilic UASB reactor after it 
failure. The average effluent YFA increased from 49.3 to 60.2 mg acetic acid!L, 
26.5 to 33.3 mg acetic acid!L and 53.8 to 62.8 mg acetic acid!L for thermophilic 
UASB reactor, the mesophilic and thermophilic HUASB reactors, respectively, when 
the HRT was decreased from four to three days. Whereas, the average effluent YFA 
decreased from 44.7 to 44.1 mg acetic acid!L in mesophilic UASB reactor. For the 
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last 20 days, the reactors were operated at HRT of two days. The average effluent 
VF A were 51.0, 69.3, 39.2, 66.3 mg acetic acid/L for mesophilic and thermophilic 
UASB reactors and mesophilic and thermophilic HUASB reactors, respectively. 
In their review, Leitao et al. (2006) reported that methanogenic activity optimally 
proceed in the pH range of 6.3-7 .8. They also reported that the effect of a drastic pH 
changed in the influent depended on the alkalinity availability in the anaerobic 
reactor. This behavior occurred because the buffer capacity of the anaerobic reactor 
sufficed to maintain the pH in the anaerobic reactor in the optimal range. The 
recovery in the anaerobic process depends on the level and duration of the imposed 
changed, in addition to the concentration of VFA during the event. The VFA 
concentrations in the effluent of all reactors were low and the total alkalinity was 
relatively high. Accordingly, the VF A/bicarbonate alkalinity ratio was always less 
than 0.3. 
4.4 Kinetic Evaluation 
Kinetic evaluation is important m the design, development and operation of 
UASB and HUASB reactors (Bhunia and Ghangrekar, 2008; Buyukkamaci and 
Filibeli, 2002). The determination of kinetics constants of the reactors was performed 
by applying three kinetic models to data obtained from the experiments. Based on the 
biochemistry and microbiology in the anaerobic process, kinetic evaluation deals with 
operational and environmental factors. Bacterial growth kinetics was based on two 
fundamental relationships, i.e., growth rate and substrate utilization rate. Various 
kinetic models reported for biological treatment (including for anaerobic treatment) 
predominantly based on Monod's equation or its modifications. Different researchers 
have determined the values of kinetic coefficients by means of regression analysis of 
experimental data that were generated from lab scale and/or pilot scale studies. Based 
on previous studies, most kinetic models were non-linear in nature. Therefore, a non-
linear regression technique would be more suitable for evaluation of kinetic constants 
embedded in the models. However, linear regression can also able to yield a set of 
good estimates, if the non-linear model could be transformed into proper linear form. 
Three kinetic models i.e. Monod, modified Slover-Kincannon and Grau second-order 
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were applied in this study and the reactor performance data under steady-state 
condition for kinetic models analysis are shown in Table 4. 7. Monod and modified 
Slover-Kincannon kinetic models were evaluated for high strength wastewater, 
whereas Grau second-order kinetic model was evaluated for low strength and high 
strength wastewater. Due to low R 2 values, the low strength wastewater data was not 
used in Monod and Staver-Kincannon kinetic models. 
The sludge volume and sludge concentration in UASB and HUASB reactors during 
this study are shown in Figure 4.44 and Figure 4.45, respectively. In the first 
75 days, the UASB reactors were fed with low strength influent at HRTs of 
five and three days. At HRT of five days, the average sludge volumes were 2.42 L 
and 2.39 L, whereas the average sludge concentrations were 13558 mg VSSIL and 
12245 mg VSSIL for mesophilic and thermophilic UASB reactors, respectively. At 
HRT of three days, the average sludge concentrations were 13922 mg VSSIL and 
12914 mg VSSIL and the sludge volumes increased from 2.42 to 2.43 L and 
2.39 to 2.40 L for mesophilic and thermophilic UASB reactors, respectively. The 
HUASB reactors were put in operation 62 days after the UASB reactors. For 
mesophilic and thermophilic HUASB reactors, the average sludge volumes were 
2.36 Land 2.29 L, whereas the average sludge concentrations were 14124 mg VSSIL 
and 13098 mg VSSIL, respectively. 
From day 76 to day 199, the UASB and HUASB reactors were fed with high strength 
wastewater at HRTs of five, four, three and two days. For mesophilic and 
thermophilic UASB reactors at HRT of five days, the average sludge volumes were 
2.43 L and 2.40 L, whereas the average sludge concentrations were 14438 mg VSS!L 
and 13668 mg VSSIL, respectively, whereas for mesophilic and thermophilic HUASB 
reactors, the sludge volumes and concentrations were 2.37 L and 2.31 L and 
14736 mg VSSIL and 13428 mg VSSIL, respectively. On day 110, the mesophilic 
UASB reactor failed due to malfunctioning of the thermostat. The sludge volume and 
sludge concentration decreased from 2.43 to 2.39 L and 14959 to 12927 mg VSS/L, 
respectively, due to sludge washout. The sludge data in the reactor during the upset 
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period was not included in data analysis. After 30 days, the reactor stabilized with 
sludge volume of 2.37 Land sludge concentration of 13551 mg VSSIL. 
Table 4.7 Reactor performance parameters under steady-state condition 
HRT Influent COD Effluent COD Sludge bed X Xe Influent flow SRT 
(day) (mg!L) (mg!L) volume (L) (mg/L) (mg!L) rate (Liday) (day) 
Mesophilic UASB 
5* 487 60 2.42 13558 15 1.00 2218 
3* 505 65 2.42 13922 10 1.67 1971 
5 2127 158 2.43 14438 16 1.00 2248 
4 !989 262 2.41 14424 17 1.25 1597 
3 1875 369 2.37 15452 21 1.67 1057 
2 1820 478 2.39 16545 26 2.50 614 
Thermophilic UASB 
5* 487 95 2.39 12245 12 1.00 2391 
3* 505 83 2.39 12914 13 1.67 1449 
5 2127 213 2.40 13668 19 1.00 1759 
4 1989 329 2.42 14216 30 1.25 913 
3 1875 464 2.43 15652 24 1.67 936 
2 1820 582 2.43 16701 27 2.50 596 
Mesophilic HUASB 
3* 505 61 2.36 14124 12 1.67 1647 
5 2127 133 2.36 14736 14 1.00 2534 
4 1989 208 2.38 15248 15 1.25 1952 
3 1875 270 2.39 16530 19 1.67 1261 
2 1820 319 2.40 17412 21 2.50 793 
Thermophilic HUASB 
3* 505 172 2.29 13098 15 1.67 1205 
5 2127 281 2.30 13428 18 1.00 1816 
4 1989 366 2.32 14263 21 1.25 1304 
3 1875 382 2.33 15643 21 1.67 1062 
2 1820 504 2.33 16493 24 2.50 638 
(* low strength wastewater data for Grau second-order kinetic model) 
(X is the biomass concentration in the sludge bed; X, is the biomass concentration of effluent 
wastewater) 
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Figure 4.45 Sludge volume and sludge concentration in HUASB reactors 
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At HRT of four days, the sludge volumes were increased in all reactors, except in 
mesophilic UASB reactor. The sludge volume increased from 2.42 to 2.43 L, 
2.37 to 2.39 L and 2.31 to 2.33 L for thermophilic UASB, mesophilic and 
thermophilic HUASB reactors, respectively. The average sludge concentration in 
thermophilic UASB reactor was 14216 mg VSS!L, whereas in the mesophilic and 
thermophilic HUASB reactors it was 15248 mg VSS/L and 14263 mg VSSIL 
respectively. The average sludge volumes and sludge concentrations in mesophilic 
UASB reactors were 2.41 Land 14424 mg VSSIL, respectively. 
From day 146 to day 199, the reactors were operated at HRTs of three and two days. 
In mesophilic UASB reactor, the sludge volume increased from 2.37 to 2.39 L, 
whereas it was constant in thermophilic UASB reactor. The average 
sludge concentrations increased from 15452 to 16545 mg VSSIL and 
15652 to 16701 mg VSS/L for mesophilic and thermophilic UASB reactors, 
respectively. In mesophilic HUASB reactor, the sludge volume also increased from 
2.39 to 2.40 L, whereas it was constant in thermophilic HUASB reactor. The 
average sludge concentrations increased from 16530 to 17412 mg VSSIL and 
15643 to 16493 mg VSSIL for mesophilic and thermophilic HUASB reactors, 
respectively. 
4.4.1 Application ofMonod Kinetic Model 
For the UASB and HUASB reactors without biomass recycle, the rate of change of 
biomass and substrate in the system can be expressed respectively as Eqs. 4.1 and 4.2: 
dX Q Q 
-=-·X --·X +Jl·X-K ·X dt V 0 V e d 
b b 
(Wiesmann et al., 2007) 
dS Q Q Jl·X 
-=-·S --·S ---
dt V 0 V e Y b b 
(Wiesmann et al., 2007) 
(4.1) 
(4.2) 
where, Q is the flow rate of influent wastewater in Llday; Vb is the volume of sludge 
bed in L; Xo is the biomass concentration of influent wastewater in mg!L; Xe is the 
biomass concentration of effluent wastewater in mg!L; X is the biomass concentration 
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m the sludge bed in mg!L; Jl is the specific growth rate in per day; K" is the 
endogenous decay coefficient in per day; Y is the cell yield coefficient in 
mg VSS/mg COD; So is the influent substrate concentration in mg!L; and S, is the 
effluent substrate concentration in mg/L. 
The ratio of total biomass in the reactor to biomass wasting rate is called SRT or 
referred as mean cell residence time ( B,). The B, is calculated using Eq. 4.3. 
e = vb .x 
' Q·X, 
(Metcalf & Eddy, 2003) 
Eq. 4.4 shows the specific growth rate (JL) 
f.lm • S, 
f.!.= 
K, +S, 
(Wiesmann et a!., 2007) 
(4.3) 
(4.4) 
If it is presumed that biomass concentration of influent wastewater, X 0 , is negligible 
and at steady state conditions, dX = 0 and dS = 0, then: 
dt dt 
x = Q. Y. e, . (s. - s,) 
Vb ·(l+K, ·BJ 
(Bhunia and Ghangrekar, 2008) 
S = K, ·(l+K, ·BJ 
' B .f ·· - K }-1 c \flm d 
(Bhunia and Ghangrekar, 2008) 
(4.5) 
(4.6) 
Eqs. 4.5 and 4.6 are nonlinear in nature, hence it is indispensable to transform them to 
linearized forms. Two different linearized equations can be framed to obtain Y and Kd 
values, which are 
Q·(S. -s.} =_!___I +_!__K, 
vb. x y e, y (4.7) 
(Bhunia and Ghangrekar, 2008) 
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(4.8) 
(Bhunia and Ghangrekar, 2008) 
To obtain the estimates of f.i.m and K,, linear regression is applied on the linearized 
equation derived from substituting Eq. 4.6 into Eq. 4.2. 
V ·S ·X Y Y·K 
• ' -·S +--··· 
Q·(So -S,) J.l.m e J.l.m (4.9) 
(Bhunia and Ghangrekar, 2008) 
The other linear form of linearized equation reported in the literature for estimation of 
f.i.m and K, are as follow 
X· v. I K, I 
---,--"-----.- - -.-+-
Q·(So -S.) Y- J.l.m S, J.l.m ( 4.1 0) 
(Bhunia and Ghangrekar, 2008) 
Q·(So-S.)·Y = -K Q·(So-S.)·Y 
V · X J.l.m ' X· V · S h h e 
( 4.11) 
(Bhunia and Ghangrekar, 2008) 
In order to determine the Monod kinetic model coefficients ( Y, Kd, f.i.m and K,), the 
data (high strength influent) shown in Table 4. 7 were plotted in Figure 4.46 and 
Figure 4.47. The values of Y and Kd were determined based on the linearized 
equation (Eq. 4. 7). The values of Y and Kd were calculated from the intercept and 
slope of the linearized graphs (Figure 4.46). The values of f.i.m and K, were determined 
based on the linearized equation (Eq. 4.9). The values of f.i.m and K, were calculated 
from the intercept and slope of the linearized graphs and were shown in Figure 4.4 7. 
Table 4.8 shows the Monod kinetic model coefficients obtain in this study for the 
reactors. High R2 values (R2>0.9) were obtained for Y and Kd determinations for all 
reactors and f.i.m and K, determinations for UASB reactors. However, the R2 values 
were lower for f.i.m and K, determinations (0. 7023 and 0.6797) for HUASB reactors. 
~ 
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Figure 4.46 Determination ofMonod kinetic model coefficients, Y and Kd values 
9000 
Mesophilic UASB 






~ y = IUOix + 1580.2 








0 100 200 
+Mesophilic UASB .1.. Themophilic UASB 
300 400 
s, 
o Mesophilic HUASB 
Mesophilic HUASB 
y = 7.4131x + 1588.3 
R2 = 0.7023 
Thermophilic HUASB 
y = 4.3897x + 3891.9 
R 2 = 0.6797 
500 600 700 
;t.::Thcnrophilic HUASB 
Figure 4.4 7 Determination of Monod kinetic model coefficients, f.lm and Ks values 
101 




R' Reactor y {per day) (per day) (mg!L) 
Mesophilic UASB 0.042 0.00193 0.9969 0.00467 187.3 0.9199 
Thermophilic UASB 0.060 0.00284 0.9287 0.00534 139.8 0.9179 
Mesophilic HUASB 0.027 0.00110 0.9757 0.00371 220.6 0.7023 
Thermophilic HUASB 0.036 0.00153 0.9760 0.00825 886.6 0.6797 
(Yin mg VSS/mg COD) 
4.4.2 Application of Modified Staver-Kincannon Kinetic Model 
Slover-Kincannon is one of the most widely used mathematical model for 
determining the kinetic constant in biofilm reactors. The Stover-Kincannon model 
considers the organic substance removal rate as a function of organic loading rate at 
steady state as in Eq. 4.12 
(4.12) 
(Buyukkamaci and Filibeli, 2002; Kapdan, 2005) 
Equations of the modified Stover-Kincannon model are follows: 
(4.13) 
(Buyukkamaci and Filibeli, 2002; Kapdan, 2005) 
where, K8 saturation value constant (modified Slover-Kincannon) in g/L·day; Umax 
maximum substrate removal rate (modified Stover-Kincannon), in g/L·day 
Eq. 4.14 obtained from linearization of Eqs. 4.12 and 4.13 as follows: 
v KB v I 
--,---, = --. --+ --Q·(S. -SJ U~, Q·S. U.,., (4.14) 
(Buyukkamaci and Filibeli, 2002; Kapdan, 2005) 
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In order to determine the modified Staver-Kincannon kinetic model coefficients 
(K8 and Umax), the data (high strength influent) shown in Table 4. 7 were plotted in 
Figure 4.48. The values of K8 and Umax were determined based on the linearized 
equation (Eq. 4.14). The values of K8 and Umax were calculated from the intercept and 
slope of the linearized graphs. Table 4.9 shows the modified Slover-Kincannon 
kinetic model coefficients obtain in this study for the reactors. High R2 values 
(R2>0.9) were obtained for K8 and Umax determinations for all reactors. 
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Figure 4.48 Determination of modified Slover-Kincannon kinetic model coefficients, 
Kn and Umax values 
Table 4.9 Modified Stover-Kincannon kinetic model coefficients 
Reactor Ke (g/L·day) Uma< (g/L·day) R' 
Mesophilic UASB 1.376 1.637 0.9912 
Thermophilic UASB 0.993 1.2489 0.984 
Mesophilic HUASB 2.849 3.024 0.995 
Thermophilic HUASB 2.046 2.113 0.9952 
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4.4.3 Application Grau Second-order Multi-component Substrate Removal 
Kinetic Model 
The general equation of a second order kinetic model used for predicting the 
behaviour of reactors for estimating kinetic coefficients is given in Eq. 4.15. 
dS = K . X . ( Se )' dt ,, s 
0 
( 4.15) 
(Metcalf & Eddy, 2003) 
If Eq. 4.15 is integrated (S = S, to S,; and t = 0 to BH), the linearized Eq. 4.16 will be 
obtained: 
e S, H +--"--
K,2 ·X 
(Bhunia and Ghangrekar, 2008) 
(4.16) 
If the second part of the right hand side in Eq. 4.16 is a constant "a", Eq. 4.17 will be 
obtained 
_s-"-'-· e_,H'- b e 
..., =a+ . H 
s. -s, 
(4.17) 
(Bhunia and Ghangrekar, 2008) 
where, the substrate removal kinetic constant a = S' and the coefficient b in 
K, 2 ·X 
Eq. 4.17 is close to one and generally reflects the impracticality of attaining a zero 
value of COD. The substrate removal efficiency . d s.-s, d. IS expresse as an IS 
S, 





(Bhunia and Ghangrekar, 2008) 
( 4.18) 
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In order to determine the kinetic coefficients (a, b and ks2) applying Eq. 4.18, a graph 
can be plotted with BH versus BH The values a and b are calculated from the 
E 
intercept and slope of the straight line. 
In order to determine the kinetic coefficients (a, b), the data set shown Table 4.7 was 
plotted in Figure 4.49. The values of a and b were calculated from the intercept and 
slope of the linearized graph. Table 4.10 shows the values of kinetic parameter obtain 
in this study for the reactors. High R2 values (R2>0.9) were obtained for a and b 
determinations for all reactors. 
• Mesophilic UASB a Thenrophilic UASB • Mesophilic HUASB x Therm:)philic HUASB 
Figure 4.49 Determination of Grau second-order kinetic model coefficients 
Table 4.10 Grau second-order kinetic model coefficients 
Reactor a (per day) b R' 
Mesophilic UASB 0.7512 0.9588 0.9865 
Thermophilic UASB 0.8417 0.9997 0.9595 
Mesophilic HUASB 0.5255 0.9715 0.9974 
Thermophilic HUASB 1.0381 0.9703 0.908 
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4.4.4 Evaluation of the Kinetic Models 
Table 4.11, Table 4.12 and Table 4.13 show the comparisons of Monod, modified 
Staver-Kincannon and Grau second-order kinetic model coefficients, respectively. 
The Monod model is widely used for UASB reactors and other industrial biological 
reactors. The Monod kinetic model has been applied to anaerobic treatment of 
various type of wastewater, including synthetic wastewater (Bhunia and Ghangrekar, 
2008), simulated textile wastewater (Isik and Sponza, 2005), municipal wastewater 
(Singh and Viraraghavan, 2002) and POME wastewater (Zinatizadeh et al., 2006). 
The modified Staver-Kincannon kinetic model has been applied to mesophilic and 
thermophilic AF for synthetic starch wastewater (Ahn and Forster, 2000), mesophilic 
HUASB for synthetic molasses wastewater (Buyukkamaci and Filibeli, 2002), 
mesophilic UASB for textile wastewater (Isik and Sponza, 2005) and 
mesophilic UAFB for formaldehyde and textile wastewater (Priya et al., 2009; 
Sandhya and Swaminathan, 2006). The maximum COD removal rate (Umax) and 
saturation value constant (K8) in this study were lower than modified 
Staver-Kincannon kinetic model coefficients that were obtained by Ahn and Foster 
(2000), Buyukkamaci and Filibeli (2002), Isik and Sponza (2005) and Sandhya and 
Swaminathan (2006). However, the values of Uma.< and K8 in this study were similar 
with kinetic model coefficients that were obtained by Priya et al. (2009). 
The Grau second-order kinetic model has been applied successfully to anaerobic 
treatment of various type of wastewater, including synthetic wastewater (Bhunia and 
Ghangrekar, 2008), poultry slaughterhouse wastewater (Debik and Coskun, 2009), 
simulated textile wastewater (Isik and Sponza, 2005), synthetic para-nitrophenol 
wastewater (Kuscu and Sponza, 2009) and simulated synthetic coal 
(Ramakrishnan and Gupta, 2008). The values of a in this study were similar with the 
values of a that were obtained by Bhunia and Ghangrekar (2008) and Isik and Sponza 
(2005). 
Table 4.11 Comparison of Monod kinetic model coefficients 
Wastewater Type of reactors Influent COD HRT 
Monod y 
Pharmaceutical Mesophilic UASB 1820-2127 mg/L 2-5 d 0.042 
Pharmaceutical Thermophilic UASB 1820-2127 mg/L 2-5 d 0.060 
Pharmaceutical Mesophilic HUASB 1820-2127 mg/L 2-5 d 0.027 
Pharmaceutical Thermophilic HUASB 1820-2127 mg/L 2-5 d 0.036 
Synthetic UASB 300-2000 4-8 h 0.083 
Simulated textile Mesophilic UASB 4214 mg/L 6-IOOh 0.125 
Municipal Mesophilic UASB 250-550 mg/L 3-48h 0.422 
POME Mesophilic UASFF 5260-34725 mg/L 1-6 d 0.174 


























(Bhunia and Ghangrekar, 2008) 
(Isik and Sponza, 2005) 
(Singh and Yiraraghavan, 2002) 
(Zinatizadeh et al., 2006) 
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Table 4.12 Comparison of modified Staver-Kincannon kinetic model coefficients 
Wastewater Type of reactors Influent COD HRT Kinetic parameters References 
Modified Slover-Kincannon u_ (g/L·d) Kn (g/L·d) 
Pharmaceutical Mesophilic UASB 1820-2127 mg/L 2-5 d 1.637 1.376 This study 
Pharmaceutical Thermophilic UASB 1820-2127 mg/L 2-5 d 1.2489 0.993 This study 
Pharmaceutical Mesophilic HUASB 1820-2127 mg!L 2-5 d 3.024 2.849 This study 
Pharmaceutical Thermophilic HUASB 1820-2127 mg!L 2-5 d 2.113 2.046 This study 
Synthetic starch Mesophilic AF 2000-4000 mg/L 24 h 49.8 50.6 (Ahn and Forster, 2000) 
Synthetic starch Thermophilic AF 2000-4000 mg!L 24 h 66.7 70.2 (Ahn and Forster, 2000) 
Synthetic molasses Mesophilic HUASB 1-10 g CODIL·d 0.5-2 d 83.3 186.23 (Buyukkamaci and Filibeli, 2002) 
Poultry slaughterhouse Static Anaerobic Sludge Bed 6880± 1400 mg!L 36-60 121.71 130.28 (Debik and Coskun, 2009) 
Reactor 
Poultry slaughterhouse Static Granular Bed Reactor 6880±1400 mg/L 36-60 164.48 177.21 (Debik and Coskun, 2009) 
Simulated textile Mesophilic UASB 4214 mg/L 6-100 h 8.211 7.501 (lsik and Sponza, 2005) 
Synthetic dye Upflow anaerobic packed bed 1-8 g/L·d N/S 12.9 37.9 (Kapdan, 2005) 
reactor 
Industrial pig farming Anaerobic bioreactor 3150 mg!L 0.6-10 d 80.9 91.582 (Kosinska and Miskiewicz, 2009) 
Synthetic para-nitrophenol AMBR 3000 mg/L 1-10.38 d 29.49 31.55 (Kuscu and Sponza, 2009) 
Formaldehyde Mesophilic UAFB I 0976-1 1840 mg/L 6-24 h 3.4 4.6 (Priya et al., 2009) 
Textile Mesophilic UAFB 1835-3828 mg!L 9.9-23.76 h 31.69 45.37 (Sandhya and Swaminathan, 2006) 
-0 
_, 
Table 4.13 Comparison of Grau second-order kinetic model coefficients 
Wastewater Type of reactors Influent COD 
Grau second-order 
Phannaceutical Mesophilic UASB 1820-2127 mg/L 
Phannaceutical Thennophilic UASB 1820-2127 mg/L 
Pharmaceutical Mesophilic HUASB 1820-2127 mg/L 
Phannaceutical Thermophilic HUASB 1820-2127 mg!L 
Synthetic UASB 300-2000 
Poultry slaughterhouse Static Anaerobic Sludge Bed Reactor 6880± 1400 mg!L 
Poultry slaughterhouse Static Granular Bed Reactor 6880± 1400 mg/L 
Simulated textile Mesophilic UASB 4214 mg/L 
Synthetic para-nitrophenol AMBR 3000 mg/L 
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Bhunia and Ghangrekar (2008) reported that the Grau second-order kinetic was found 
as the best class of fit for wide range of data set in UASB reactor. The value of a and 
b were 0.558 and 1.043, respectively, in UASB reactor that was treating synthetic 
wastewater in the range of 300-4000 mg COD/L. Isik and Sponza (2005) reported 
that Grau second-order and modified Staver-Kincannon kinetic models were found to 
be more suitable than Monod, Contois and first-order kinetic models in mesophilic 
UASB reactor. 
Figure 4.50 to Figure 4.53 show the comparisons of the measured and predicted COD 
concentration in UASB and HUASB reactors. In mesophilic and thermophilic UASB 
reactors, high R2 values (R2>0.9) were obtained in the comparisons of measured and 
predicted effluent COD for modified Slover-Kincannon and Grau second-order 
kinetic models. They indicated high correlations between the measured and predicted 
effluent COD data and the linear regression lines. However, the R2 values were 
lower for Monod kinetic model in mesophilic and thermophilic UASB reactors 
(0.8165 and 0.8065). In mesophilic UASB reactor, the measured and predicted 
effluent COD values were similar based on linear regression equations for 
modified Stover-Kincannon (y = 0.9923x + 3.4313) and Grau second-order 
(y = 0.9334x + 3.6452) kinetic models (Figure 4.50). However, the predicted effluent 
COD value was higher than the measured effluent COD value in Monod kinetic 
model (y = 1.2144x -55.085). 
In thermophilic UASB reactor, the measured and predicted effluent COD value were 
similar based on linear regression equation only for modified Slover-Kincannon 
(y = 0.9923x + 3.4313) kinetic model (Figure 4.51 ). The predicted effluent COD 
value was higher than the measured effluent value in Monod kinetic model 
(y = 1.2144x- 55.085) and the predicted effluent COD value was lower than the 
measured effluent COD value m Grau second-order kinetic model 
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Figure 4.51 Comparison of the measured and predicted effluent COD in thermophilic 
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Figure 4.53 Comparison of the measured and predicted effluent COD in thermophilic 
HUASB reactor 
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In mesophilic HUASB reactor, high R2 value (R2>0.9) was obtained in the 
comparison of measured and predicted effluent COD for Grau second-order kinetic 
model. It indicated high correlation between the measured and predicted effluent 
COD data and the linear regression line. However, the R2 values were lower for 
Monod and modified Staver-Kincannon kinetic model (0.792 and 0.8549). The 
measured and predicted effluent COD values were similar based on linear 
regression equations for modified Stover-Kincannon (y = 0.97llx + 8.0585) and 
Grau second-order (y = 0.9766x + 3.6126) kinetic models (Figure 4.52). However, 
the predicted effluent COD value was higher than the measured effluent COD value 
in Monod kinetic model (y = 1.177 x- 39.344). 
In thermophilic HUASB reactor, high R2 values (R2>0.9) were obtained in the 
comparisons of measured and predicted effluent COD for all kinetic models. They 
indicated high correlations between the measured and predicted effluent COD data 
and the linear regression lines. The measured and predicted effluent COD values 
were similar based on linear regression equations for Monod (y = 1.0518x- 13.413) 
and modified Staver-Kincannon (y = 0.97 x + 12.117) kinetic models (Figure 4.53). 
The predicted effluent COD value was higher than the measured effluent value in 
Grau second-order kinetic model (y = 1.3207 x- 67.433). 
CHAPTERS 
CONCLUSIONS AND RECOMMENDATIONS 
5.1 Conclusions 
The biological wastewater treatment study was performed to treat non-penicillin 
pharmaceutical wastewater. The study was conducted in two phases. The Phase I 
study observed the performance of semi-anaerobic and aerobic reactors in treating 
non-penicillin pharmaceutical wastewater. The Phase II was carried out on anaerobic 
treatment processes. Based on the performance observation of semi-anaerobic and 
aerobic reactors, the following conclusions can be drawn: 
a. Train I (SABR-ASP reactor) achieves higher COD removal in treating the 
high strength wastewater (COD 1953 mg!L); however, Train 2 (ASP reactor) 
achieves higher COD removal in treating the low strength wastewater 
(COD 635 mg!L). 
b. The aerobic biomass from a sewage treatment plant can be successfully used 
as seed biomass in aerobic and semi-anaerobic reactors in treating non-
penicillin pharmaceutical wastewater. 
The objective of this study was to evaluate the performance of mesophilic and 
thermophilic UASB and HUASB reactors in treating non-penicillin pharmaceutical 
wastewater. The reactors were seeded with sludge from an aerobic domestic sewage 
treatment plant. The pharmaceutical wastewater was very fluctuative in COD 
and BOD5 concentrations. The reactors were fed with low strength influent 
(COD 458-526 mg!L) and high strength influent (COD 1770-2217 mg!L). Based on 
the performance evaluation of mesophilic and thermophilic UASB and HUASB 
reactors, the following conclusions can be drawn: 
a. The HUASB reactors are significantly more efficient in COD removal than the 
UASB reactors. The UASB and HUASB reactors showed higher COD 
removals in treating the high strength wastewater. 
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b. The concentrations of NH3-N and total phosphorous increase, whereas the 
concentration of N03-N remains constant and concentration of TKN slightly 
reduces. 
This study evaluated the effect ofHRT and temperature on the performance ofUASB 
and HUASB reactors. The reactors were operated under mesophilic (35±2°C) and 
thermophilic (55±2°C) temperatures and HRTs of five, four, three and two days. 
Based on the evaluation of the operation condition effect in mesophilic and 
thermophilic UASB and HUASB reactors, the following conclusions can be drawn: 
a. The reactor performance is significantly affected by type of reactors, HRT and 
temperature. 
b. Mesophilic UASB and HUASB reactors achieve higher COD and BODs 
removals than both thermophilic reactors in treating pharmaceutical 
wastewater. 
c. The COD and BODs removals decrease when the HRT was decreased. 
d. The highest average COD and BODs removals are achieved by the mesophilic 
HUASB reactor treating high strength pharmaceutical wastewater at HRT of 
five days (average OLR 0.43 g CODIL·day); average COD removal is 90%, 
average effluent COD is 133 mg!L, average BODs removal is 97% and 
average effluent BODs is 51 mg!L. 
e. The lowest average COD and BODs removals are achieved by the 
thermophilic UASB reactor at HRT of two days. The average COD and BODs 
removals are 68% and 76%, respectively, whereas the average COD and 
BODs concentrations are 582 mg!L and 299 mg!L, respectively. 
Three kinetics models i.e. Monad, modified Staver-Kincannon and Grau second-order 
were applied in this study to determine the kinetics of pharmaceutical wastewater 
treatment using UASB and HUASB reactors. The results of kinetic model analysis 
indicate: 
a. Grau second-order fits well for estimates of kinetic coefficients in all reactors. 
High R2 values (R2>0.9) were obtained for a and b determinations for all 
reactors. 
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b. Among the three kinetic models, Grau second order model is observed to be 
the preeminent model for predicting the performance of UASB and HUASB 
reactors. In mesophilic and thermophilic UASB reactors, the values of a are 
0.8822 and 0.8471 per day and the values of b are and 0.9111 and 0.9997, 
respectively. In mesophilic and thermophilic HUASB reactors, the values of 
a are 0.5244 and 0.8767 per day and the values of bare and 0.9715 and 1.029, 
respectively. 
c. In Monod kinetic model, high R2 values (R2>0.9) are obtained for Y and Kd 
determinations for all reactors and f.lm and Ks determinations for UASB 
reactors. However, the R2 values are lower for f.lm and Ks determinations 
(0.7023 and 0.6797) for HUASB reactors. In mesophilic UASB reactor, the 
values of Y and Kd are 0.042 mg VSS/mg COD and 0.00193 per day, 
whereas in thermophilic UASB reactor, the values of Y and Kd are 
0.060 mg VSS/mg COD and 0.00284 per day, respectively. The values of 
f.lm and Ks are 0.00467 per day and 187.3 mg/L in mesophilic UASB 
reactor, while in thermophilic UASB reactor, the values of f.lm and Ks are 
0.00534 per day and 139.8 mg!L, respectively. In mesophilic HUASB reactor, 
the values of Y and Kd are 0.027 mg VSS/mg COD and 0.00110 per day, 
whereas in thermophilic HUASB reactor, the values of Y and Kd are 
0.036 mg VSS/mg COD and 0.00153 per day, respectively. The values of 
f.lm and Ks are 0.00371 per day and 220.6 mg!L in mesophilic HUASB reactor, 
whereas in thermophilic HUASB reactor, the values of f.lm and Ks are 
0.00825 per day and 886.6 mg/L, respectively. 
5.2 Recommendations 
This study has shown that both UASB and HUASB reactors have potential to be used 
as treatment alternatives for non-penicillin pharmaceutical wastewater. However, the 
UASB and HUASB reactors require post treatment in treating high strength 
pharmaceutical wastewater. Moreover, nutrient treatment is required because the 
nutrient removals were negligible during this study. Combined treatment for organics 
and nutrients removal, using anaerobic process and other biological process can be 
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used as an alternative for non-penicillin pharmaceutical wastewater treatment. 
Response of UASB and HUASB reactors to shock loads from non-penicillin 
pharmaceutical wastewater may be studied. Further study is required to study the 
effect of acclimatization period and method on the anaerobic reactor performance. 
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A.l COD data for the UASB and HUASB reactors 
Table A.l Influent and effluent COD concentrations, OLR, and COD removal data in the mesophilic and thermophilic UASB reactors 
Date Days Influent COD (mg/L) OLR Effluent COD M-UASB (mg!L) Rem. Effluent COD T-UASB (mg/L) Rem. SI S2 S3 Ave. (g CODIL/.d) SI S2 S3 Ave. % Sl S2 S3 Ave. % 
Low strength influent; HRT of five days 
30-Nov-07 I 487 504 





















Low strength influent; HRT of three days 
16-Dec-07 17 504 515 
18-Dec-07 19 503 502 











































































































































































64 87.18 291 296 295 
69 86.01 178 179 187 
71 85.70 168 160 156 
65 87.03 124 117 119 
48 89.84 84 76 80 
43 90.61 77 


















































































Table A.l (Continued) 
Date Days Influent COD (mg/L) 
S I S2 S3 Ave. 
Low strength influent; HRT of three days (continued) 
I 7-Jan-08 49 487 488 482 486 
21-Jan-08 53 526 520 532 526 
23-Jan-08 55 5 I I 498 493 50 I 

































High strength influent; HRT of five days 
14-Feb-08 77 2110 2160 
I 6-Feb-08 79 2200 2240 
81 2200 2140 
83 2150 2130 

































87 2080 1920 1910 1970 
89 2080 2170 2120 2123 























Effluent COD M-UASB (mg/L) Rem. Effluent COD T-UASB (mg!L) Rem. 

































































































































205 89.6 I 294 303 296 
234 89.00 252 254 252 










73 85.6 I 
66 86.88 
7 I 85.94 
I 15 94.63 
169 92.36 








Table A.l (Continued) 
Date Days Influent COD (mg!L) OLR Effluent COD M-UASB (mg!L) Rem. Effluent COD T-UASB (mg!L) Rem. 
Sl S2 S3 Ave. (g CODIL/.d) Sl S2 S3 Ave. % Sl S2 S3 Ave. % 
High strength influent; HRT of four days 
05-Mar-08 97 1980 2060 







103 2120 2100 
lOS 2010 2000 
107 1990 2070 
I 09 2030 1950 
117 2010 2020 
121 2050 2040 
02-Apr-08 125 1890 1950 
06-Apr-08 129 2030 2080 
10-Apr-08 133 1880 1910 
14-Apr-08 137 1980 1990 
18-Apr-08 141 1850 1840 
22-Apr-08 145 1990 2010 
High strength influent; HRT of three days 
27-Apr-08 I SO 1960 1990 
29-Apr-08 I 52 1970 1960 
0 1-May-08 I 54 1950 1930 
05-May-08 I 58 1830 1850 




















































































































































































































Table A.l (Continued) 
Date Da s Influent COD (mg/L) y Sf S2 S3 Ave. 
High strength influent; HRT of three days (continued) 
09-May-08 162 1810 1760 1750 1773 
11-May-08 164 1830 1860 1870 1853 
13-May-08 166 1900 1910 1870 1893 
I 5-May-08 168 1860 1890 1870 1873 
17-May-08 170 1830 1860 1910 1867 
20-May-08 173 1850 1890 1880 1873 
22-May-08 175 1820 1830 1830 1827 
24-May-08 177 1880 1850 1860 1863 
26-May-08 179 1870 1860 1890 1873 
High strength influent; HRT of two days 
28-May-08 181 1830 1880 1850 1853 
30-May-08 183 1790 1820 1840 1817 
0 1-Jun-08 185 1830 1840 1850 1840 
03-Jun-08 187 1780 1790 1810 1793 






191 1890 1870 1870 1877 
193 1840 1800 1810 1817 
195 1780 1820 1850 1817 
197 1790 1780 1760 1777 
199 1780 1770 1760 1770 
OLR Effluent COD M-UASB (mg/L) Rem. Effluent COD T-UASB (mg/L) Rem. 













































































362 79.61 428 412 415 
339 81.73 412 420 418 
349 81.55 488 500 480 
391 79.15 490 487 483 
346 81.45 477 487 478 
364 80.57 468 466 479 
381 79.12 465 466 468 
372 80.02 480 478 477 
378 79.82 466 461 468 
553 70.14 590 610 609 
521 71.30 710 717 728 
526 71.41 722 732 725 
486 72.92 680 669 673 
481 73.89 640 631 632 
464 75.28 621 618 616 
466 74.33 580 588 578 
427 76.48 560 555 55 I 
424 76.12 539 553 554 






















Table A.2 Influent and effluent COD concentrations, OLR, and COD removal data in the mesophilic and thermophilic HUASB reactors 
Date Days Influent COD (mg/L) OLR Effluent COD M-HUASB (mg!L) Rem. Effluent COD T-HUASB (mg/L) Rem. S I S2 S3 Ave. (g COD/LI.d) Sl S2 S3 Ave. % Sl S2 S3 Ave. % 
Low strength influent; HRT of three days 
3 1-Jan-08 63 520 524 

















High strength influent; HRT of five days 
14-Feb-08 77 2110 2160 
79 2200 2240 
81 2200 2140 
83 2150 2130 
85 2120 2090 
87 2080 1920 

































0 1-Mar-08 93 2160 2160 2190 2170 
High strength influent; HRT of four days 
05-Mar-08 97 I 980 2060 
09-Mar-08 10 I 2020 2040 
I 1-Mar-08 103 2120 2100 
13-Mar-08 105 2010 2000 








I 09 2030 I 950 
I 17 2010 2020 
I 2 I 2050 2040 
125 1890 1950 
129 2030 2080 
133 1880 1910 
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323 83.65 N o-. 
Table A.2 (Continued) 
Date Da Influent COD (mg/L) ys S I S2 S3 Ave. 
High strength influent; HRT of four days (continued) 
18-Apr-08 141 1850 1840 1870 
22-Apr-08 145 1990 2010 1940 
High strength influent; HRT of three days 
27-Apr-08 150 1960 1990 1980 
29-Apr-08 152 1970 1960 1950 
0 1-May-08 154 1950 1930 1920 
05-May-08 158 1830 1850 1830 
07-May-08 160 1780 1880 1860 
09-May-08 162 1810 1760 1750 
11-May-08 164 1830 1860 1870 
13-May-08 166 1900 1910 1870 
15-May-08 168 1860 1890 1870 
17-May-08 170 1830 1860 1910 
20-May-08 173 1850 1890 1880 
22-May-08 175 1820 1830 1830 
24-May-08 177 1880 1850 1860 
26-May-08 179 1870 1860 1890 
High strength influent; HRT of two days 
28-May-08 181 1830 1880 1850 
30-May-08 183 1790 1820 1840 








187 1780 1790 1810 
189 1810 1850 1870 
191 1890 1870 1870 
193 1840 1800 1810 
195 1780 1820 1850 
197 1790 1780 1760 



























OLR Effluent COD M-HUASB (mg!L) Rem. Effluent COD T-HUASB (mg/L) Rem. 




































































































































































































































































448 74.71 N _, 
Table A.3 Influent and effluent BODs concentrations and BODs removal data in the mesophilic and thermophilic UASB reactors 
Date Influent BODs (mg/L) Days S I S2 S3 Ave. 
Low strength influent; HRT of five days 
04-Dec-07 5 305 310 318 
08-Dec-07 9 310 307 279 
12-Dec-07 13 315 296 
Low strength influent; HRT of three days 





























































12-Feb-08 75 374 396 
High strength influent; HRT of five days 





83 1512 1561 
87 1405 1435 
89 1450 1514 

















































Effluent BODs M-UASB (mg!L) Rem. Effluent BODs T-UASB (mg!L) 























































































































































































































































Table A.3 (Continued) 
Date Days 
Influent BODs (mg!L) Effluent BODs M-UASB (mg/L) 
Sl S2 S3 Ave. Sl S2 S3 Ave. 
High strength influent; HRT of four days 
05-Mar-08 97 1497 1513 1523 1511 122 134 131 
09-Mar-08 101 1454 1489 1487 1477 146 140 147 







109 1482 1463 
121 1415 1428 
129 1360 1414 
137 1366 1433 
141 1401 1388 
145 1401 1456 
High strength influent; HRT of three days 
29-Apr-08 152 1438 1490 
0 1-May-08 154 1367 1388 
05-May-08 158 1409 1459 
09-May-08 162 1385 1367 
13-May-08 166 1344 1365 
15-May-08 168 1336 1318 
17-May-08 170 1208 1283 
20-May-08 173 1184 1247 
24-May-08 177 1222 1277 
High strength influent; HRT of two days 
28-May-08 181 1281 1272 





189 1231 1314 
193 1270 1260 
197 1243 1223 
199 1264 1186 
1394 1446 133 119 112 
1394 1412 392 383 371 
1394 1389 295 315 380 
1365 1388 216 181 240 
1397 1395 123 128 118 




































































































Rem. Effluent BOD, T-UASB (mg!L) Rem. 
% S I S2 S3 Ave. % 
91 213 207 204 
90 221 225 213 
93 214 159 169 
92 251 241 192 
73 220 224 197 
76 172 185 183 
85 175 180 158 
91 188 178 167 















































































































Table A.4 Influent and effluent BODs concentrations and BODs removal data in the mesophilic and thermophilic HUASB reactors 
Date Influent BODs (mg!L) Effiuent BODs M-HUASB (mg/L) Rem. Effiuent BODs T-HUASB (mg/L) Rem. Days 
Sl S2 S3 Ave. Sl S2 S3 Ave. % Sl S2 S3 Ave. % 
Low strength influent; HRT of three days 
04-Feb-08 67 319 322 334 325 29 37 32 33 90 101 98 92 97 70 
06-Feb-08 69 377 383 384 381 34 38 31 34 91 83 78 81 81 79 
I 0-Feb-08 73 388 383 367 379 18 22 20 20 95 78 85 72 78 79 
12-Feb-08 75 374 396 380 383 23 21 18 21 95 87 72 73 77 80 
High strength influent; HRT of five days 
16-Feb-08 79 1581 1632 1588 1600 40 44 36 40 97 179 170 164 171 89 
20-Feb-08 83 1512 1561 1604 1559 47 41 39 42 97 167 159 161 162 90 
24-Feb-08 87 1405 1435 1440 1427 55 51 47 51 96 148 143 142 144 90 
26-Feb-08 89 1450 1514 1534 1499 58 45 51 51 97 135 147 131 138 91 
01-Mar-08 93 1525 1612 1590 1576 78 69 66 71 95 142 141 136 140 91 
High strength influent; HRT of four days 
05-Mar-08 97 1497 1513 1523 1511 99 96 87 94 94 271 266 263 267 82 
09-Mar-08 101 1454 1489 1487 1477 85 79 77 81 95 264 256 238 253 83 
13-Mar-08 105 1487 1560 1573 1540 98 106 94 99 94 204 183 173 187 88 
17-Mar-08 109 1482 1463 1394 1446 89 88 92 90 94 202 209 215 209 86 
29-Mar-08 121 1415 1428 1394 1412 119 125 116 120 92 149 147 182 159 89 
06-Apr-08 129 1360 1414 1394 1389 116 104 115 112 92 150 164 179 164 88 
14-Apr-08 137 1366 1433 1365 1388 94 87 82 88 94 125 131 118 125 91 
18-Apr-08 141 1401 1388 1397 1395 84 88 91 88 94 123 127 119 123 91 
22-Apr-08 145 1401 1456 1366 1408 99 88 83 90 94 110 144 124 126 91 
w 
0 
Table A.4 (Continued) 
Influent BODs (mg/L) Effiuent BODs M-HUASB (mg/L) Rem. Effiuent BODs T-HUASB (mg/L) Rem. 
Date Days Sl S2 S3 Ave. Sl S2 S3 Ave. % Sl S2 S3 Ave. % 
High strength influent; HRT of three days 
29-Apr-08 152 1438 1490 1521 1483 104 89 115 103 93 198 196 206 200 87 
01-May-08 154 1367 1388 1371 1375 88 97 107 97 93 166 161 151 159 88 
05-May-08 158 1409 1459 1425 1431 120 100 96 106 93 133 141 121 132 91 
09-May-08 162 1385 1367 1348 1367 121 103 Ill Ill 92 125 138 144 136 90 
13-May-08 166 1344 1365 1351 1353 109 Ill 105 108 92 135 134 143 137 90 
15-May-08 168 1336 1318 1321 1325 127 114 108 116 91 141 185 158 161 88 
17-May-08 170 1208 1283 1280 1257 137 135 120 131 90 135 168 144 149 88 
20-May-08 173 1184 1247 1203 1212 130 136 123 130 89 163 171 159 165 86 
24-May-08 177 1222 1277 1246 1248 135 133 135 134 89 172 174 175 173 86 
High strength influent; HRT of two days 
28-May-08 181 1281 1272 1288 1280 141 124 120 128 90 275 294 260 276 78 
01-Jun-08 185 1186 1211 1199 1198 163 146 160 156 87 233 226 236 231 81 
05-Jun-08 189 1231 1314 1290 1278 146 117 124 129 90 185 193 209 196 85 
09-Jun-08 193 1270 1260 1285 1272 118 95 108 107 92 199 204 178 194 85 
13-Jun-08 197 1243 1223 1255 1240 108 100 99 102 92 216 194 200 204 84 
15-Jun-08 199 1264 1186 1162 1204 115 100 112 109 91 215 214 185 205 83 
w 
Table A.S Influent and effluent NH3-N concentrations data in the UASB and HUASB reactors 
Influent NH 3-N 





Sl S2 S3 Ave Sl S2 S3 Ave Sl S2 S3 Ave 
Low strength influent; HRT of five days 





5 2.4 3.3 3.2 
9 3.7 2.5 3.2 
II 3.5 3.4 3.0 
13 3.6 3.7 3.8 
Low strength influent; HRT of three days 


















19 2.4 2.5 2.5 
21 2.7 3.1 3.0 
23 2.6 3.6 3.0 
25 6.3 5.5 5.8 
27 5.4 5.1 6.3 
29 6.0 5.9 6.0 
33 4.3 4.0 4.8 
35 4.8 4.6 4.4 
39 4.9 5.5 4.7 
41 5.1 5.0 4.8 
43 5.5 5.2 5.1 
45 4.8 4.8 5.1 
47 4.5 4.6 4.8 
49 4.7 4.6 4.4 
53 4.9 5.1 5.2 
55 4.4 4.7 4.5 
59 4.5 4.5 4.6 
3.2 12.8 12.5 13.8 
3.0 12.7 12.5 12.8 
13.0 17.6 11.7 11.9 
12.7 12.3 12.6 12.5 
13.7 
12.5 
3.1 12.2 11.9 12.0 12.0 11.4 11.5 11.6 11.5 
3.3 12.8 13.2 13.1 13.0 11.9 12.1 11.8 11.9 

























3.1 6.6 7.4 6.2 6.7 3.6 4.2 3.9 
5.9 9.3 10.5 11.8 10.5 7.5 6.8 6.6 
5.6 10.3 9.8 10.2 
6.0 9.6 12.6 10.2 
4.4 9.9 10.3 10.7 
4.6 10.0 10.5 10.8 
5.0 9.6 9.9 9.1 
5.0 9.0 8.5 8.2 
5.3 8.8 8.7 8.5 
4.9 8.9 8.8 9.4 
4.6 7.8 8.1 8.5 
4.6 8.5 9.3 8.8 
5.1 8.7 8.9 8.4 
4.5 9.1 9.3 9.8 
4.5 9.2 8.8 8.9 
10.1 8.5 8.7 8.4 
10.8 9.4 10.2 9.7 
I 0.3 6.3 6.8 6.9 
10.4 7.5 7.8 7.7 
9.5 6.5 6.9 7.2 
8.6 6.6 6.3 7.0 
8.7 8.8 8.1 8.2 
9.0 7.6 7.4 7.7 
8.1 7.5 8.2 7.7 
8.9 7.9 8.5 8.7 
8.7 8.5 8.1 8.7 
9.4 7.4 7.5 7.3 



















Effluent NH 3-N 
M-HUASB (mg!L) 
S I S2 S3 Ave 
Effluent NH3-N 
T-HUASB (mg!L) 
S I S2 S3 Ave 
w 
N 
Table A.5 (Continued) 
Influent NH,-N 









S I S2 S3 Ave Sf S2 S3 Ave Sf S2 S3 Ave Sl S2 S3 Ave Sl S2 S3 Ave 
Low strength influent; HRT of three days (continued) 
31-Jan-08 63 5.1 5.3 5.0 5.1 8.7 
04-Feb-08 67 4.4 4.7 4.8 4.6 8.9 
10-Feb-08 
12-Feb-08 
73 4.9 4.8 4.6 
75 4.6 4.8 5.0 
































79 II. 9 12.3 11.5 
83 13.3 13.4 13.6 
87 16.0 16.4 16.3 
93 19.6 19.4 18.9 
11.9 19.1 18.9 18.7 18.9 10.5 11.0 11.3 
13.4 19.9 20.0 20.0 20.0 13.9 14.2 14.3 
16.2 18.9 19.7 18.8 19.1 15.2 16.0 15.7 
19.3 17.7 17.5 18.0 17.7 14.2 13.9 13.5 
High strength influent; HRT of four days 
09-Mar-08 101 16.3 16.1 16.2 16.2 15.4 15.2 15.3 
.13-Mar-08 105 16.2 16.0 16.3 
17-Mar-08 109 15.2 15.7 16.0 
29-Mar-08 121 15.0 14.4 14.8 
06-Apr-08 129 14.6 14.4 14.2 
14-Apr-08 137 14.4 14.3 14.3 
16.2 16.3 16.2 16.6 
15.6 17.5 17.5 17.2 
14.7 14.8 14.7 14.6 
14.4 13.3 13.7 13.6 
14.3 12.9 12.6 12.6 
22-Apr-08 145 12.5 13.1 12.5 12.7 15.9 15.7 15.2 
High strength influent; HRT of three days 
29-Apr-08 152 12.6 12.7 12.1 12.5 13.5 14.0 14.3 
05-May-08 158 12.1 12.4 12.5 12.3 14.2 14.5 14.6 
09-May-08 162 11.3 11.7 11.0 11.3 14.9 14.7 14.8 
15-May-08 168 12.4 11.5 11.6 11.8 15.5 16.3 16.0 
17-May-08 170 11.8 11.5 11.5 11.6 16.7 16.4 17.2 
20-May-08 173 12.6 12.9 12.3 12.6 15.7 15.6 15.4 
24-May-08 177 12.7 12.8 12.8 12.8 16.2 15.8 15.4 
26-May-08 179 11.7 11.5 12.0 11.7 16.0 16.1 16.5 
15.3 11.9 12.0 12.2 
16.4 14.0 13.9 13.9 
17.4 13.8 13.3 13.0 
14.7 12.9 12.3 13.1 
13.5 11.8 11.7 11.9 
12.7 13.7 13.8 14.0 
15.6 12.9 12.7 13.2 
14.0 13.7 13.5 13.0 
14.4 13.5 13.9 13.8 
14.8 13.7 13.8 14.0 
15.9 13.6 13.8 14.0 
16.8 13.2 13.8 13.2 
15.6 14.1 13.3 13.8 
15.8 13.8 14.2 13.4 
16.2 14.2 13.9 13.9 
7.6 18.9 19.0 18.9 
7.6 19.0 18.2 19.4 
7.8 19.5 19.3 19.4 
7.9 18.7 18.1 18.5 
18.9 13.2 13.6 13.5 
18.9 14.4 13.8 14.2 
19.4 13.7 13.6 14.0 





8.8 13.9 13.7 13.6 13.7 11.6 11.5 11.4 11.5 
10.9 15.0 14.0 14.6 14.5 13.9 13.7 13.8 13.8 
14.1 13.7 14.5 14.2 14.1 16.2 17.0 16.1 16.4 
15.6 15.6 15.3 14.9 15.3 16.0 15.7 15.3 15.7 
13.9 18.7 19.5 18.6 18.9 16.7 15.7 16.3 16.2 
12.0 16.5 16.3 15.8 
13.9 17.8 18.4 17.8 
13.4 17.5 16.9 17.7 
12.8 18.6 18.4 18.2 
11.8 19.1 19.0 19.2 
13.8 18.6 18.5 18.9 
12.9 18.6 18.5 18.4 
13.4 17.8 17.9 18.1 
13.7 17.8 17.8 17.7 
13.8 17.5 17.9 17.8 
13.8 16.7 16.8 17.0 
13.4 17.5 16.6 16.7 
13.7 17.3 17.4 16.8 
13.8 17.1 17.4 17.5 
14.0 16.9 17.2 17.3 
16.2 15.7 15.6 15.8 15.7 
18.0 18.0 17.1 17.2 17.4 
17.4 15.1 16.3 15.6 15.7 
18.4 16.3 16.1 16.0 16.1 
19.1 14.1 14.2 14.4 14.2 
18.7 14.3 13.5 14.0 13.9 
18.5 13.8 14.1 13.5 13.8 
17.9 12.7 12.8 13.2 12.9 
17.8 13.5 13.3 13.6 13.5 
17.7 13.8 13.4 13.0 13.4 
16.8 13.9 14.3 13.5 13.9 
16.9 14.3 14.0 14.0 14.1 
17.2 14.1 13.8 14.6 14.2 
17.3 14.7 14.6 14.6 14.6 
17.1 14.7 14.8 14.8 14.8 
w 
w 
Table A.5 (Continued) 
Influent NH3-N Effluent NH,-N 
Date Days (mg/L) M-UASB (mg/L) 
Sl S2 S3 Ave Sl S2 S3 Ave 
High strength influent; HRT of two days 
28-May-08 181 12.7 12.5 12.6 12.6 15.8 15.9 16.1 15.9 
30-May-08 183 11.5 11.4 11.8 11.6 15.3 14.5 15.7 15.2 
01-Jun-08 185 II. I 11.2 11.4 11.2 15.2 14.7 14.4 14.8 
05-Jun-08 189 10.9 11.2 11.3 11.1 13.8 13.9 14.1 13.9 
07-Jun-08 191 11.8 11.8 11.5 11.7 14.4 15.0 14.4 14.6 
09-Jun-08 193 11.7 11.4 11.3 11.5 14.6 14.0 14.8 14.5 
11-Jun-08 195 11.3 10.5 11.0 10.9 15.0 14.7 14.6 14.8 
13-Jun-08 197 10.0 11.2 10.5 10.6 15.0 15.1 15.3 15.1 
15-Jun-08 199 10.6 10.7 11.1 10.8 15.4 15.2 15.1 15.2 
Effluent NH,-N Effluent NH,-N 
T-UASB (mg/L) M-HUASB (mg/L) 
Sl S2 S3 Ave Sl S2 S3 Ave 
14.5 14.2 15.0 14.6 17.5 18.0 18.3 17.9 
13.9 14.0 14.4 14.1 17.9 17.1 17.6 17.5 
13.3 13.4 13.6 13.4 17.3 17.0 17.0 17.1 
13.9 13.8 13.6 13.8 16.4 16.2 16.7 16.4 
14.3 13.9 13.5 13.9 16.1 15.8 16.6 16.2 
13.6 13.7 13.7 13.7 16.3 16.4 16.6 16.4 
12.7 13.9 13.2 13.3 16.2 16.1 15.9 16.1 
13.4 13.2 13.3 13.3 16.0 15.9 15.9 15.9 
13.3 13.6 13.0 13.3 15.6 15.7 15.7 15.7 
Effluent NH,-N 
T-HUASB (mg/L) 
Sl S2 S3 Ave 
14.7 14.9 15.1 14.9 
15.0 14.8 14.3 14.7 
13.9 14.0 13.4 13.8 
14.0 13.8 13.9 13.9 
12.7 12.8 13.0 12.8 
13.1 13.4 13.5 13.3 
13.6 12.8 14.0 13.5 
13.8 14.3 14.6 14.2 
14.5 14.3 14.8 14.5 
w 
... 
Table A.6 Influent and effluent N03-N concentrations data in the UASB and HUASB reactors 
Influent N03-N Effluent N03-N M-UASB Effluent NO,-N T-UASB Effluent N03-N M-HUASB Effluent N03-N T-HUASB 
Date Days (mg!L) (mg!L) (mg!L) (mg!L) (mg!L) 
Sl S2 S3 Ave Sl S2 S3 Ave. Sl S2 S3 Ave. Sl S2 S3 Ave. Sl S2 S3 Ave. 
Low strength influent; HRT of five days 





5 0.7 0.7 0.5 0.6 0.5 0.6 0.6 
9 0.7 0.4 1.0 0.7 0.9 0.6 0.7 
II 0.5 0.7 0.6 0.6 0.3 0.5 0.4 
13 0.7 0.8 1.1 0.9 0.6 0.7 0.4 
Low strength influent; HRT of three days 
16-Dec-07 17 0.3 0.4 0.2 0.3 0.4 0.5 0.4 
18-Dec-07 19 0.4 0.2 0.3 0.3 0.2 0.2 0.1 
















23 0.8 0.8 0.7 0.8 0.6 0.7 0.7 
25 0.7 0.8 0.7 0.7 0.7 0.7 0.7 
27 0.8 0.9 0.9 0.9 0.7 0.7 0.9 
29 0.7 0.9 0.9 0.8 1.0 0.7 1.0 
33 1.2 0.9 1.2 
35 0.6 0.7 0.6 
39 0.5 0.6 0.6 
41 0.5 0.5 0.5 
43 0.6 0.6 0.4 
45 0.3 0.3 0.4 
47 0.4 0.5 0.3 
49 0.4 0.4 0.4 
53 0.3 0.4 0.4 
55 0.5 0.5 0.4 
59 0.3 0.4 0.5 
1.1 1.2 1.0 1.0 
0.6 0.4 0.5 0.6 
0.6 0.6 0.3 0.5 
0.5 0.4 0.5 0.5 
0.5 0.4 0.5 0.3 
0.3 0.1 0.1 0.2 
0.4 0.1 0.1 0.3 
0.4 0.2 0.1 0.2 
0.4 0.1 0.3 0.1 
0.5 0.0 0.1 0.1 
0.4 0.2 0.1 0.2 
0.6 0.4 0.2 0.5 0.4 
0.6 0.3 0.3 0.3 0.3 
0.7 0.3 0.3 0.3 0.3 
0.4 0.1 0.1 0.2 0.1 
0.6 0.2 0.1 0.3 0.2 
0.4 0.5 0.5 0.5 0.5 
0.2 0.3 0.6 0.5 0.5 
0.5 0.4 0.4 0.4 0.4 
0. 7 0.9 1.1 1.0 1.0 
0.7 1.0 1.0 0.8 0.9 
0.8 0.9 0.8 0.8 0.8 
0.9 1.0 0.9 1.1 
1.1 0.9 0.9 1.0 
0.5 1.1 1.3 1.0 
0.5 0.6 0.7 0.7 
0.5 0.8 0.6 0.5 
0.4 0.7 0.8 0.7 
0.1 0.3 0.4 0.5 
0.2 0.4 0.4 0.6 
0.2 0.5 0.3 0.3 
0.2 0.4 0.5 0.5 
0.1 0.3 0.4 0.7 















Table A.6 (Continued) 
Influent N03-N Effluent N03-N M-UASB Effluent N03-N T-UASB Effluent N03-N M-HUASB Effluent N03-N T-HUASB 
Date Days (mg/L) (mg/L) (mg/L) (mg!L) (mg/L) 
S I S2 S3 Ave S I S2 S3 Ave. S I S2 S3 Ave. S I S2 S3 Ave. S I S2 S3 Ave. 
Low strength influent; HRT of three days (continued) 
31-Jan-08 63 0.4 0.4 0.5 0.4 0.1 0.2 0.1 0.1 0.4 0.4 0.4 
04-Feb-08 67 0.5 0.4 0.5 0.5 0.3 0.2 0.3 0.3 0.4 0.3 0.4 
10-Feb-08 73 0.5 0.5 0.4 0.5 0.1 0.1 0.2 0.1 0.2 0.1 0.2 
12-Feb-08 75 0.3 0.4 0.4 0.4 0.2 0.2 0.1 0.2 0.2 0.3 0.2 
High strength influent; HRT of five days 
14-Feb-08 77 0.4 0.6 0.8 0.6 0.7 0.6 0.5 0.6 0.5 0.6 0.4 
16-Feb-08 79 0.5 0.6 0.6 0.6 0.4 0.5 0.5 0.5 0.3 0.3 0.2 
20-Feb-08 83 0.4 0.8 0.7 0.6 0.5 0.4 0.5 0.5 0.4 0.3 0.5 
24-Feb-08 87 0.7 0.8 0.6 0.7 0.4 0.5 0.6 0.5 0.6 0.5 0.5 
01-Mar-08 93 0.4 0.3 0.1 0.3 0.6 0.6 0.7 0.6 0.2 0.1 0.5 
High strength influent; HRT of four days 
09-Mar-08 101 0.5 0.4 0.3 0.4 0.5 0.3 0.2 0.3 0.2 0.4 0.4 
13-Mar-08 105 0.5 0.6 0.6 0.6 0.1 0.2 0.4 0.2 0.5 0.4 0.3 
17-Mar-08 109 0.6 0.7 0.5 0.6 0.4 0.4 0.1 0.3 0.2 0.3 0.3 
29-Mar-08 121 0.4 0.5 0. 7 0.5 0.5 0.2 0.1 0.3 0.4 0.3 0.4 
06-Apr-08 129 0.5 0.6 0.5 0.5 0.3 0.1 0.2 0.2 0.4 0.3 0.3 
14-Apr-08 137 0.7 0.6 0.6 0.6 0.2 0.4 0.3 0.3 0.4 0.5 0.5 
22-Apr-08 145 0.6 0.3 0.3 0.4 0.1 0.2 0.4 0.2 0.4 0.3 0.4 
High strength influent; HRT of three days 
29-Apr-08 152 0.2 0.3 0.3 0.3 0.1 0.0 0.2 0.1 0.2 0.3 0.4 
05-May-08 158 0.3 0.5 0.4 0.4 0.0 0.3 0.4 0.2 0.4 0.4 0.5 
09-May-08 162 0.7 0.5 0.3 0.5 0.1 0.2 0.3 0.2 0.2 0.5 0.6 
15-May-08 168 0.4 0.4 0.3 0.4 0.4 0.3 0.2 0.3 0.6 0.4 0.3 
17-May-08 170 0.4 0.5 0.4 0.4 0.0 0.3 0.4 0.2 0.4 0.5 0.7 
20-May-08 173 0.5 0.6 0.4 0.5 0.2 0.3 0.5 0.3 0.2 0.4 0.3 
24-May-08 177 0.3 0.4 0.2 0.3 0.2 0.3 0.2 0.2 0.5 0.5 0.2 
26-May-08 179 0.4 0.4 0.3 0.4 0.4 0.2 0.3 0.3 0.6 0.3 0.2 
0.4 0.4 0.2 0.0 
0.4 0.2 0.3 0.1 
0.2 0.2 0.1 0.1 
0.2 0.3 0.1 0.2 
0.5 0.1 0.5 0.4 
0.3 0.2 0.3 0.2 
0.4 0.4 0.2 0.3 
0.5 0.1 0.2 0.4 
0.3 0.3 0.2 0.1 
0.3 0.5 0.6 0.4 
0.4 0.6 0.5 0.4 
0.3 0.6 0.5 0.6 
0.4 0.3 0.4 0.4 
0.3 0.3 0.4 0.6 
0.5 0.2 0.1 0.5 
0.4 0.3 0.4 0.3 
0.3 0.3 0.2 0.1 
0.4 0.3 0.2 0.4 
0.4 0.3 0.2 0.1 
0.4 0.3 0.2 0.2 
0.5 0.2 0.3 0.1 
0.3 0.2 0.3 0.4 
0.4 0.3 0.3 0.4 

























0.3 0.2 0.3 0.3 
0.2 0.3 0.3 0.3 
0.0 0.2 0.4 0.2 
0.2 0.3 0.3 0.3 
0.4 0.4 0.1 0.3 
0.3 0.1 0.4 0.3 
0.3 0.2 0.0 0.2 
0.4 0.1 0.1 0.2 
0.0 0.3 0.4 0.2 
0.4 0.7 0.8 0.6 
0.4 0.5 0.5 0.5 
0.6 0.6 0.5 0.6 
0.4 0.6 0.6 0.5 
0.3 0.5 0.4 0.4 
0.5 0.5 0.4 0.5 
0.4 0.5 0.4 0.4 
0.5 0.3 0.4 0.4 
0.3 0.3 0.2 0.3 
0.2 0.3 0.1 0.2 
0.4 0.3 0.3 0.3 
0.2 0.3 0.3 0.3 
0.0 0.1 0.2 0.1 
0.2 0.3 0.1 0.2 
0.3 0.3 0.4 0.3 
w 
"' 
Table A.6 (Continued) 
Influent NO,-N 
Date Days (m!iL) 
Sf S2 S3 Ave 
High strength influent; HRT of two days 
28-May-08 181 0.3 0.2 0.4 0.3 
30-May-08 183 0.4 0.3 0.3 0.3 
01-Jun-08 185 0.3 0.2 0.6 0.4 
05-Jun-08 189 0.3 0.5 0.5 0.4 
07-Jun-08 191 0.5 0.5 0.6 0.5 
09-Jun-08 193 0.7 0.6 0.5 0.6 
11-Jun-08 195 0.5 0.6 0.6 0.6 
13-Jun-08 197 0.6 0.5 0.6 0.6 
15-Jun-08 199 0.6 0.5 0.5 0.5 
Effluent NO,-N M-UASB Effluent N03-N T-UASB Effluent N03-N M-HUASB 
(mg/L) (m!iL) (mg/L) 
Sf S2 S3 Ave. Sf S2 S3 Ave. Sf S2 S3 Ave. 
0.4 0.4 0.3 0.4 0.4 0.2 0.3 0.3 0.1 0.2 0.3 0.2 
0.2 0.4 0.6 0.4 0.3 0.5 0.4 0.4 0.2 0.3 0.3 0.3 
0.4 0.5 0.5 0.5 0.4 0.1 0.1 0.2 0.4 0.5 0.4 0.4 
0.2 0.3 0.5 0.3 0.3 0.4 0.6 0.4 0.1 0.2 0.4 0.2 
0.1 0.2 0.4 0.2 0.4 0.2 0.5 0.4 0.2 0.4 0.3 0.3 
0.2 0.3 0.1 0.2 0.1 0.5 0.4 0.3 0.4 0.3 0.3 0.3 
0.5 0.4 0.3 0.4 0.4 0.3 0.1 0.3 0.4 0.5 0.3 0.4 
0.4 0.5 0.4 0.4 0.1 0.4 0.5 0.3 0.5 0.5 0.4 0.5 
0.4 0.3 0.2 0.3 0.4 0.4 0.3 0.4 0.5 0.2 0.1 0.3 
Effluent N03-N T-HUASB 
(m!iL) 
Sf S2 S3 Ave. 
0.3 0.2 0.3 0.3 
0.2 0.0 0.1 0.1 
0.2 0.1 0.0 0.1 
0.2 0.3 0.2 0.2 
0.3 0.2 0.1 0.2 
0.1 0.2 0.2 0.2 
0.4 0.3 0.3 0.3 
0.2 0.1 0.5 0.3 
0.1 0.3 0.3 0.2 
w 
-.J 
Table A.7 Influent and effluent TKN concentrations data in the UASB and HUASB reactors 
Titrant Titrant Sample TKN Titrant TKN Titrant TKN Titrant TKN Titrant TKN Date Days (mL) (mL) (mL) (mg/L) (mL) (mg!L) (mL) (mg!L) (mL) (mg/L) (mL) (mg/L) 
Influent Blank Influent M-UASB M-UASB T-UASB T-UASB M-HUASB M-HUASB T-HUASB T-HUASB 
08-Dec-07 9 21.773 1.853 150 37.2 18.836 31.7 20.007 33.9 
12-Dec-07 13 20.592 0.984 150 36.6 19.659 34.9 19.868 35.3 
22-Dec-07 23 20.318 1.312 150 35.5 18.237 31.6 18.864 32.8 
03-Jan-08 35 19.971 1.117 150 35.2 18.783 33.0 18.579 32.6 
17-Jan-08 49 20.787 0.897 150 37.1 19.157 34.1 19.850 35.4 
31-Jan-08 63 21.296 1.223 150 37.S 19.232 33.6 20.113 3S.3 18.263 31.8 19.497 34.1 
20-Feb-08 83 32.321 2.840 ISO ss.o 28.655 48.2 28.880 48.6 26.214 43.6 28.470 47.8 
0 1-Mar-08 93 30.1S2 0.924 ISO 54.6 28.334 Sl.2 29.768 S3.8 27.397 49.4 28.345 Sl.2 
17-Mar-08 109 30.677 0.887 ISO SS.6 26.388 47.6 29.122 S2.7 27.753 SO. I 29.23S S2.9 
06-Apr-08 129 31.879 0.972 ISO S7.7 32.896 S9.6 29.9S7 54.1 28.S20 51.4 29.672 53.6 
22-Apr-08 14S 31.3SI 0.845 ISO S6.9 31.231 56.7 30.481 SS.3 28.863 S2.3 30.294 S5.0 
09-May-08 162 29.431 1.126 ISO 52.8 2S.8S2 46.2 27.337 48.9 26.832 48.0 27.492 49.2 
17-May-08 170 28.4SI 1.223 150 S0.8 25.187 44.7 26.472 47.1 2S.539 4S.4 2S.963 46.2 
24-May-08 177 28.364 1.149 ISO 50.8 2S.944 46.3 27.747 49.6 26.3S4 47.0 26.881 48.0 
OS-Jun-08 189 27.974 1.173 ISO so.o 26.749 47.7 26.948 48.1 26.S39 47.3 26.554 47.4 
13-Jun-08 197 27.738 1.281 ISO 49.4 26.783 47.6 26.977 48.0 26.142 46.4 26.459 47.0 
w 
00 
Table A.8 Influent and effluent TP concentrations data in the UASB and HUASB reactors 
Influent TP (mg/L) Effluent TP M-UASB Effluent TP T-UASB 
Date Days (mg/L) (mg!L) 
Sl S2 S3 Ave. Sl S2 S3 Ave. Sl S2 S3 Ave. 
Low strength influent; HRT of five days 
02-Dec-07 3 4.5 4.7 5.3 4.8 18.6 17.5 18.8 18.3 11.3 10.6 11.2 11.0 
04-Dec-07 5 6.6 6.1 6.9 6.5 17.4 17.2 17.6 17.4 18.5 18.7 18.9 18.7 
08-Dec-07 9 6.9 7.7 7.5 7.4 16.6 16.4 15.9 16.3 20.1 20.2 21.3 20.5 
I 0-Dec-07 II 6.8 7.5 7.6 7.3 17.9 16.8 16.6 17.1 24.6 22.8 25.8 24.4 
12-Dec-07 13 6.8 7.5 7.1 7.1 17.1 17.5 17.3 17.3 22.4 23.8 28.3 24.8 
Low strength intluent; HRT of three days 
16-Dec-07 17 8.9 5.4 4.9 6.4 17.1 17.6 17.3 17.3 22.7 22.1 23.5 22.8 
18-Dec-07 19 8.1 9.5 7.8 8.5 15.4 16.0 14.5 15.3 16.7 15.8 18.1 16.9 
20-Dec-07 21 6.6 7.2 6.2 6.7 20.4 18.9 20.0 19.8 20.2 17.8 17.1 18.4 
22-Dec-07 23 5.2 6.6 5.2 5.7 14.8 15.5 13.7 14.7 14.3 14.0 14.1 14.1 
24-Dec-07 25 5.9 4.9 6.5 5.8 13.5 15.0 15.5 14.7 15.7 14.5 15.9 15.4 
26-Dec-07 27 8.4 6.5 7.7 7.5 15.0 14.2 14.8 14.7 19.2 18.1 19.0 18.8 
28-Dec-07 29 6.1 6.9 6.8 6.6 19.6 17.0 18.3 18.3 16.5 16.3 16.6 16.5 
0 1-Jan-08 33 6.8 6.5 6.8 6.7 16.7 17.7 16.4 16.9 16.2 16.6 15.6 16.1 
03-Jan-08 35 6.8 6.6 7.8 7.1 20.3 17.7 18.8 18.9 20.3 23.2 21.2 21.6 
07-Jan-08 39 7.1 7.3 6.5 7.0 19.8 20.1 22.0 20.6 22.2 23.5 21.2 22.3 
09-Jan-08 41 6.6 5.9 6.1 6.2 17.5 17.8 18.2 17.8 21.5 23.2 22.8 22.5 
11-Jan-08 43 6.8 6.5 6.9 6.7 19.2 18.5 17.2 18.3 22.8 22.2 20.1 21.7 
13-Jan-08 45 7.2 5.8 6.4 6.5 15.5 16.6 18.2 16.8 22.5 24.1 23.8 23.5 
15-Jan-08 47 6.6 6.7 6.8 6.7 17.5 18.5 17.9 18.0 23.5 23.8 24.5 23.9 
17-Jan-08 49 6.8 6.5 7.1 6.8 19.3 17.8 19.9 19.0 23.8 23.9 23.4 23.7 
Effluent TP M-HUASB 
(mg!L) 
Sl S2 S3 Ave. 
Effluent TP T-HUASB 
(mg!L) 
Sl S2 S3 Ave. 
w 
"' 
Table A.8 (Continued) 
Date 
Effluent TP T-HUASB ~s lnfl~TP~) (~) (~ (~ (~) Effluent TP M-UASB Effluent TP T-UASB Effluent TP M-HUASB 
Sl S2 S3 Ave. Sl S2 S3 Ave. Sl S2 S3 Ave. Sl S2 S3 Ave. Sl S2 S3 Ave. 
Low strength influent; HRT of three days (continued) 
21-Jan-08 53 6.8 6.7 5.8 6.4 19.5 18.2 20.1 19.3 22.1 22.3 22.7 22.4 
24.2 23.5 23.9 
20.2 22.1 21.6 
23-Jan-08 55 7.1 6.5 6.2 
27-Jan-08 59 6.4 6.8 5.2 
31-Jan-08 63 6.5 6.2 5.5 
04-Feb-08 67 6.4 6. 7 3.3 
10-Feb-08 73 6.1 6.4 6.1 
12-Feb-08 75 7.1 7.3 6.5 
High strength influent; HRT of five days 
6.6 18.5 19.2 18.7 18.8 24.1 
6.1 19.5 18.7 20.5 19.6 22.5 
6.1 21.2 20.5 19.7 20.5 23.1 
5.5 19.4 19.5 20.1 19.7 22.5 
6.2 18.2 18.7 18.8 18.6 21.5 
7.0 19.5 18.9 20.7 19.7 22.5 
23.5 23.6 23.4 28.5 29.3 
22.4 23.1 22.7 27.4 27.3 
21.2 23.2 22.0 25.4 25.3 
22.4 23.2 22.7 25.7 25.1 
29.0 28.9 26.8 26.7 26.6 26.7 
27.7 27.5 27.4 26.6 27.8 27.3 
25.2 25.3 27.8 27.5 27.1 27.5 
25.5 25.4 27.8 27.4 27.0 27.4 










19.6 21.4 21.5 21.5 
17.2 18.6 18.6 18.3 
16.1 17.0 17.6 17.0 
18.4 17.9 18.0 18.2 
19.5 21.2 22.0 21.1 
21.5 28.3 28.8 29.1 28.7 26.8 26.9 26.9 26.9 
18.5 28.4 28.5 28.7 28.5 31.6 31.6 31.3 31.5 
17.2 29.0 28.5 28.2 28.6 33.8 35.0 34.3 34.4 
18.0 29.8 29.9 30.1 29.9 32.5 33.1 32.5 32.7 
21.4 30.7 30.5 30.4 30.5 35.9 35.7 35.8 35.8 
16-Feb-08 79 12.8 12.7 12.9 12.8 17.1 
20-Feb-08 83 12.7 13.1 12.3 12.7 15.9 
24-Feb-08 87 14.1 13.8 14.6 14.2 18.2 
01-Mar-08 93 13.6 13.8 14.0 13.8 20.0 
High strength influent; HRT of four days 
09-Mar-08 10 I 11.2 11.3 I 0. 7 






109 10.9 11.2 10.6 
121 12.0 12.1 12.1 
129 11.8 11.8 11.5 
137 10.2 10.6 10.5 
145 10.7 10.7 10.6 
11.1 19.3 18.4 18.5 18.7 19.2 19.5 19.6 19.4 28.4 28.2 28.5 28.4 26.6 26.4 26.5 26.5 
12.6 18.5 18.8 18.9 18.7 20.8 21.2 20.4 20.8 25.7 25.5 25.3 25.5 27.9 27.7 27.2 27.6 
10.9 13.9 15.1 14.4 14.5 16.5 16.7 16.9 16.7 22.1 21.7 21.3 21.7 27.3 26.7 27.5 27.2 
12.1 32.6 31.8 33.0 32.5 16.6 16.3 16.3 16.4 22.7 22.6 22.8 22.7 25.6 26.1 25.7 25.8 
11.7 27.6 27.4 27.5 27.5 19.7 19.4 19.4 19.5 23.2 23.6 22.9 23.2 28.4 28.5 28.7 28.5 
10.4 22.2 22.3 22.7 22.4 17.7 17.7 17.6 17.6 21.8 21.6 21.5 21.6 24.9 24.1 24.6 24.5 
10.7 20.9 20.4 20.1 20.5 18.5 19.3 19.0 19.0 19.3 19.0 19.8 19.3 26.6 26.9 27.0 26.8 
.... 
0 
Table A.8 (Continued) 
Effluent TP M-UASB Effluent TP T-HUASB Effluent TP T-UASB Effluent TP M-HUASB 
Days Influent TP (mg!L) (mg!L) (mg/L) (mg!L) (mg/L) Date 
S I S2 S3 Ave. S I S2 S3 Ave. S I S2 S3 Ave. S I S2 S3 Ave. S I S2 S3 Ave. 
High strength influent; HRT of three days 
29-Apr-08 152 11.0 11.3 11.4 11.2 18.1 18.0 18.4 18.2 15.3 
05-May-08 158 12.1 12.9 12.6 12.5 14.7 14.5 14.3 14.5 16.0 
09-May-08 162 11.9 12.4 12.0 12.1 14.9 14.8 14.6 14.8 19.1 
15-May-08 168 10.9 10.8 10.6 10.8 14.3 13.7 14.5 14.2 17.4 
17-May-08 170 11.1 10.9 11.2 11.1 14.1 13.8 14.6 14.2 18.3 
20-May-08 173 12.5 12.3 12.2 12.3 14.3 13.3 13.9 13.8 18.8 
24-May-08 177 11.6 11.7 12.1 11.8 15.6 15.7 15.1 15.5 18.3 
26-May-08 179 11.3 12.1 11.2 11.5 15.4 15.2 14.7 15.1 18.7 
High strength influent; HRT of two days 
28-May-08 181 11.6 12.0 11.3 11.6 14.8 14.7 14.9 14.8 18.6 
30-May-08 183 12.5 12.2 11.8 12.2 14.9 14.7 14.6 14.7 18.3 
01-Jun-08 185 11.4 12.6 11.9 12.0 13.8 13.2 13.6 13.5 18.5 
05-Jun-08 189 10.8 10.9 11.1 10.9 13.2 13.3 13.2 13.2 18.0 
07-Jun-08 191 11.4 11.2 11.3 11.3 12.8 12.7 12.6 12.7 18.1 
































195 11.4 11.3 11.5 
197 12.1 11.9 12.4 
199 11.3 11.7 11.6 
11.4 12.7 13.2 13.5 
12.1 12.8 13.2 13.1 
11.5 12.7 12.7 12.6 
13.1 17.4 17.3 17.1 
13.0 17.6 17.3 17.2 
12.7 18.7 17.8 17.9 
I 5.4 22.5 21.5 22.1 22.0 27.1 27.6 27.2 27.3 
16.1 24.8 24.9 25.1 24.9 28.2 28.7 29.0 28.6 
19.0 24.0 24.3 23.7 24.0 27.3 27.0 26.9 27.1 
17.2 23.6 23.7 23.9 23.7 29.6 29.7 29.9 29.7 
18.5 22.8 22.9 22.3 22.7 27.6 27.4 27.5 27.5 
18.4 21.6 21.9 22.0 21.8 26.7 26.1 26.5 26.4 
18.0 22.2 22.6 21.8 22.2 26.9 26.1 26.6 26.5 
18.7 23.3 23.6 23.7 23.5 25.7 25.8 26.0 25.8 
18.6 24.1 23.3 23.8 23.7 25.6 25.5 25.4 25.5 
18.4 24.6 24.7 25.1 24.8 25.3 25.4 25.6 25.4 




n9 n.2 n.5 
ll.9 D.2 D.l 
26.3 26.6 26.0 26.3 
26.8 26.8 26.7 26.8 
22.7 22.8 23.0 26.8 26.7 26.7 26.7 
17.3 24.4 24.7 24.1 24.4 27.1 26.9 27.4 27.1 
17.4 23.9 23.6 23.6 23.7 27.4 27.2 27.3 27.3 




8.1 One-way ANOV A for COD concentration 
This table provides a comparison of means for each operation of condition against 
each other operation condition. The important aspect to this table is a Sig. column 
that provides the exact significance for the difference between any two means, where 
this is less than 0.05, SPSS places a * symbol next to the value in the Mean 
Difference column, it is indicating a significant difference of the two samples being 
compared at significance level of0.05. 
Table B. I One-way ANOVA Multiple Comparisons with COD removal as dependent 
variable (Tukey HSD Method) 
Mean 95% Confidence 
(I) One way (J) One way Difference Std. Sig. Interval 
(1-J) Error Lower Upper 
Bound Bound 
UASB;5 day-low .7074 .93923 1.000 ·2.7139 4.1286 
~ 1.14156 c::!9 ·8.9327 ·.6162 
.8114 1.17900 1.000 -3.4832 5.1061 
MUASB;3 day-high 7.698WJ 1.06645 .000 3.8142 II. 5835 
MUASB;2 day-high 13. 5754(•) 1.11157 .000 9.5264 17.6244 
TUASB;5 day-low 7.3718(') 1.38250 .000 2.3359 12.4077 
TUASB;3 day-low 4.2043(•) .99056 .006 .5961 7.8125 
TUASB;5 day-high -2.1545 1.14156 .956 -6.3127 l. 0038 
TUASB;4 day-high 4.2764(•) 1.02105 .008 .5571 7.9957 
TUASB;3 day-high 12.7432(•) I.IIIS7 .000 8.6941 16.7922 
TUASB;l day-high 19.7793(•) l.l271S .000 IS.3093 24.2493 
MHUASB;3 day-low -.3740 1.22715 1.000 ·4.8441 4.0960 
MTUASB;5 day-high ·5 9895(•) 1.141S6 .000 -10.1477 -1.8312 
MHUASB;4 day-high -1.1936 I. 021 OS .979 -S.5129 1.92S7 
MHUASB;3 day-high 2.1929 I. 021 OS .862 -I. 5264 5.9121 
MHUASB;2 day-high 5. 2633(•) I. 08699 .001 1.3038 9.2228 
THUASB;3 day-low 21.7818(•) I. 382SO .000 16.7459 26.8177 
THUASB;5 day-high .9955 1.14156 1.000 -3.1627 5.1S38 
THUASB;4 day-high 6.190 I(•) 1.04903 .000 2. 3689 10.0113 
THUASB;3 day-high 8.2785(•) 1.04903 .000 4.4573 12.0997 
THUASB;2 day-high 13.7143(•) 1.08699 .000 9.7548 17.6738 
• The mean difference is significant at the .05 level. 
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Table B. I (Continued) 
Mean 95% Confidence 
(1) One way (J) One way Difference Std. Sig. Interval Error (1-J) Lower Upper 
Bound Bound 
MUASB;3 day-low MUASB;5 day-low -.7074 .93923 1.000 -4.1286 2.7139 
MUASB;5 day-high -5.4818(') .89178 .000 -8.7302 -2.2334 
MUASB;4 day-high .1041 .93923 1.000 -3.3172 3.5253 
MUASB;3 day-high 6.9915(') .79335 .000 4.1016 9.8814 
MUASB;2 day-high 12.8680(') .85305 .000 9.7607 15.9754 
TUASB;5 day-low 6.6644(') 1.18466 .000 2.3492 10.9797 
TUASB;3 day-low 3.4969(') .68797 .000 .9909 6.0029 
TUASB;5 day-high -2.8618 .89178 .169 -6.1102 .3866 
TUASB;4 day-high 3.5691(') .73119 .000 .9056 6.2325 
TUASB;3 day-high 12.0358(') .85305 .000 8.9285 15.1431 
TUASB;2 day-high 19.0719(') .99899 .000 15.4330 22.7109 
MHUASB;3 day-low -1.0814 .99899 1.000 -4.7204 2.5575 
MTUASB;5 day-high -6.6968(') .89178 .000 -9.9452 -3.4484 
MHUASB;4 day-high -2.5009 .73119 .097 -5.1644 .1625 
MHUASB;3 day-high 1.4855 .73119 .913 -1.1779 4.1489 
MHUASB;2 day-high 4.5559(') .82075 .000 1.5662 7.5456 
THUASB;3 day-low 21.0744(') 1.18466 .000 16.7592 25.3897 
THUASB;5 day-high .2882 .89178 1.000 -2.9602 3.5366 
THUASB;4 day-high 5.4828(') .76977 .000 2.6788 8.2867 
THUASB;3 day-high 7.5711(') .76977 .000 4.7671 10.3751 
THUASB;2 day-high 13.0069(') .82075 .000 10.0172 15.9966 
MUASB;5 day-high MUASB;5 day-low 4.7745(') 1.14156 .008 .6162 8.9327 
MUASB;3 day-low 5.4818(') .89178 .000 2.2334 8.7302 
MUASB;4 day-high 5.5859(') 1.14156 .000 1.4276 9.7442 
MUASB;3 day-high 12.4733(') 1.02491 .000 8.7400 16.2066 
MUASB;2 day-high 18.3499(') 1.07178 .000 14.4458 22.2540 
TUASB;5 day-low 12.1462(') 1.35072 .000 7.2261 17.0664 
TUASB;3 day-low 8.9787(') .94569 .000 5.5340 12.4235 
TUASB;5 day-high 2.6200 1.10286 .724 -1.3973 6.6373 
TUASB;4 day-high 9.0509(') .97758 .000 5.4900 12.6118 
TUASB;3 day-high 17.5176(') 1.07178 .000 13.6135 21.4217 
TUASB;2 day-high 24.5537(') 1.19122 .000 20.2146 28.8929 
MHUASB;3 day-low 4.4004(') 1.19122 .043 .0613 8.7396 
MTUASB;5 day-high -1.2150 1.10286 1.000 -5.2323 2.8023 
MHUASB;4 day-high 2.9809 .97758 .246 -.5800 6.5418 
MHUASB;3 day-high 6.9673(') .97758 .000 3.4064 10.5283 
MHUASB;2 day-high 10.0377(') 1.04626 .000 6.2266 13.8489 
THUASB;3 day-low 26.5562(') 1.35072 .000 21.6361 31.4764 
THUASB;5 day-high 5. 7700(') 1.10286 .000 1.7527 9.7873 
THUASB;4 day-high 10.9646(') 1.00677 .000 7.2973 14.6318 
THUASB;3 day-high 13.0529(') 1.00677 .000 9.3857 16.7202 
THUASB;2 day-high 18.4887(') 1.04626 .000 14.6776 22.2999 
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Table B.! (Continued) 
Mean 95% Confidence 
(I) One way (J) One way Difference Std. Sig. Interval 
(1-J) Error Lower Upper 
Bound Bound 
MUASB;4 day-high MUASB;5 day-low -.8114 1.17900 1.000 -5.1061 3.4832 
MUASB;3 day-low -.1041 .93923 1.000 -3.5253 3.3172 
MUASB;5 day-high -5.5859(') 1.14156 .000 -9.7442 -1.4276 
MUASB;3 day-high 6.8874(') 1.06645 .000 3.0027 10.7721 
MUASB;2 day-high 12.7640(') 1.11157 .000 8.7149 16.8130 
TUASB;5 day-low 6.5604(') 1.38250 .001 1.5244 11.5963 
TUASB;3 day-low 3.3929 .99056 .095 -.2154 7.0011 
TUASB;5 day-high -2.9659 1.14156 .557 -7.1242 1.1924 
TUASB;4 day-high 3.4650 1.02105 .104 -.2543 7.1843 
TUASB;3 day-high 11.9317(') 1.11157 .000 7.8827 15.9808 
TUASB;2 day-high 18.9679(') 1.22715 .000 14.4978 23.4379 
MHUASB;3 day-low -1.1855 1.22715 1.000 -5.6555 3.2845 
MTUASB;5 day-high -6.8009(') 1.14156 .000 -10.9592 -2.6426 
MHUASB;4 day-high -2.6050 1.02105 .593 -6.3243 1.1143 
MHUASB;3 day-high 1.3814 1.02105 .999 -2.3379 5.1007 
MHUASB;2 day-high 4.4519(') 1.08699 .011 .4924 8.4113 
THUASB;3 day-low 20.9704(') 1.38250 .000 15.9344 26.0063 
THUASB;5 day-high .1841 1.14156 1.000 -3.9742 4.3424 
THUASB;4 day-high 5.3787(') 1.04903 .000 1.5575 9.1999 
THUASB;3 day-high 7.4670(') 1.04903 .000 3.6458 11.2882 
THUASB;2 day-high 12.9029(') 1.08699 .000 8.9434 16.8623 
MUASB;3 day-high MUASB;5 day-low -7.6988(') 1.06645 .000 -11.5835 -3.8142 
MUASB;3 day-low -6.9915(') .79335 .000 -9.8814 -4.1016 
MUASB;5 day-high -12.4733(') 1.02491 .000 -16.2066 -8.7400 
MUASB;4 day-high -6.8874(') 1.06645 .000 -10.7721 -3.0027 
MUASB;2 day-high 5.8766(') .99139 .000 2.2653 9.4878 
TUASB;5 day-low -.3270 1.28786 1.000 -5.0182 4.3641 
TUASB;3 day-low -3.4945(') .85351 .011 -6.6035 -.3855 
TUASB;5 day-high -9.8533(') 1.02491 .000 -13.5866 -6.1200 
TUASB;4 day-high -3.4224(') .88871 .025 -6.6596 -.1852 
TUASB;3 day-high 5.0443(') .99139 .000 1.4331 8.6556 
TUASB;2 day-high 12.0805(') 1.11944 .000 8.0028 16.1582 
MHUASB;3 day-low -8.0729(') 1.11944 .000 -12.1506 -3.9952 
MTUASB;5 day-high -13.6883(') 1.02491 .000 -17.4216 -9.9550 
MHUASB;4 day-high -9.4924(') .88871 .000 -12.7296 -6.2552 
MHUASB;3 day-high -5.5060(') .88871 .000 -8.7432 -2.2688 
MHUASB;2 day-high -2.4355 .96375 .612 -5.9461 1.0750 
THUASB;3 day-low 14.0830(') 1.28786 .000 9.3918 18.7741 
THUASB;5 day-high -6.7033(') 1.02491 .000 -10.4366 -2.9700 
THUASB;4 day-high -1.5087 .92072 .991 -4.8625 1.8451 
THUASB;3 day-high .5796 .92072 1.000 -2.7742 3.9334 
THUASB;2 day-high 6.0155(') .96375 .000 2.5049 9.5260 
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Table B. I (Continued) 
Mean 95% Confidence 
(I} One way (J) One way Difference Std. Sig. Interval 
(1-J) Error Lower Upper 
Bound Bound 
MUASB;2 day-high MUASB;5 day-low -I 3.5754(') 1.11157 .000 -17.6244 -9.5264 
MUASB;3 day-low -12.8680(') .85305 .000 -15.9754 -9.7607 
MUASB;5 day-high -18.3499(') 1.07178 .000 -22.2540 -14.4458 
MUASB;4 day-high -12. 7640(') 1.11157 .000 -16.8130 -8.7149 
MUASB;3 day-high -5.8766(') .99139 .000 -9.4878 -2.2653 
TUASB;5 day-low -6.2036(') 1.32547 .001 -11.0318 -1.3754 
TUASB;3 day-low -9.3711(') .90926 .000 -12.6832 -6.0590 
TUASB;5 day-high -15. 7299(') 1.07178 .000 -19.6340 -11.8258 
TUASB;4 day-high -9.2990(') .94238 .000 -12.7317 -5.8662 
TUASB;3 day-high -.8322 1.03978 1.000 -4.6198 2.9553 
TUASB;2 day-high 6.2039(') 1.16251 .000 1.9693 I 0.4385 
MHUASB;3 day-low -13.9494(') 1.16251 .000 -18.1840 -9.7149 
MTUASB;5 day-high -19.5649(') 1.07178 .000 -23.4690 -15.6608 
MHUASB;4 day-high -15.3690(') .94238 .000 -18.8017 -11.9362 
MHUASB;3 day-high -11.3825(') .94238 .000 -14.8153 -7.9498 
MHUASB;2 day-high -8.3121 (') 1.01346 .000 -12.0037 -4.6205 
THUASB;3 day-low 8.2064(') 1.32547 .000 3.3782 13.0346 
THUASB;5 day-high -12.5799(') 1.07178 .000 -16.4840 -8.6758 
THUASB;4 day-high -7.3853(') .97263 .000 -10.9282 -3.8424 
THUASB;3 day-high -5.2969(') .97263 .000 -8.8399 -I. 7540 
THUASB;2 day-high .1389 1.01346 1.000 -3.5527 3.8305 
TUASB;5 day-low MUASB;5 day-low -7.3718(') 1.38250 .000 -12.4077 -2.3359 
MUASB;3 day-low -6.6644(') 1.18466 .000 -10.9797 -2.3492 
MUASB;5 day-high -12.1462(') 1.35072 .000 -17.0664 -7.2261 
MUASB;4 day-high -6.5604(') 1.38250 .001 -11.5963 -1.5244 
MUASB;3 day-high .3270 1.28786 1.000 -4.3641 5.0182 
MUASB;2 day-high 6.2036(') 1.32547 .001 1.3754 11.0318 
TUASB;3 day-low -3.1675 1.22576 .568 -7.6325 1.2975 
TUASB;5 day-high -9.5263(') 1.35072 .000 -14.4464 -4.6061 
TUASB;4 day-high -3.0954 1.25052 .651 -7.6505 1.4598 
TUASB;3 day-high 5.3714(') 1.32547 .013 .5432 10.1996 
TUASB;2 day-high 12.4075(') 1.42378 .000 7.2212 17.5938 
MHUASB;3 day-low -7.7458(') 1.42378 .000 -12.9321 -2.5595 
MTUASB;5 day-high -13.3613(') 1.35072 .000 -18.2814 -8.4411 
MHUASB;4 day-high -9.1654(') 1.25052 .000 -13.7205 -4.6102 
MHUASB;3 day-high -5.1789(') 1.25052 .009 -9.7341 -.6238 
MHUASB;2 day-high -2.1085 1.30492 .992 -6.8618 2.6448 
THUASB;3 day-low 14.4100(') 1.55967 .000 8.7287 20.0913 
THUASB;5 day-high -6.3763(') 1.35072 .001 -11.2964 -1.4561 
THUASB;4 day-high -1.1817 1.27347 1.000 -5.8204 3.4571 
THUASB;3 day-high .9067 1.27347 1.000 -3.7321 5.5454 
THUASB;2 day-high 6.3425(') 1.30492 .000 1.5892 11.0958 
146 
Table B.l (Continued) 
Mean 95% Confidence 
(I) One way (J) One way Difference S1d. Sig. Interval Error (1-J) Lower Upper 
Bound Bound 
TUASB;3 day-low MUAS8;5 day-low -4.2043(') .99056 .006 -7.8125 -.5961 
MUAS8;3 day-low -3.4969(') .68797 .000 -6.0029 -.9909 
MUAS8;5 day-high -8.9787(') .94569 .000 -12.4235 -5.5340 
MUASB;4 day-high -3.3929 .99056 .095 -7.0011 .2154 
MUASB;3 day-high 3.4945(') .85351 .Oil .3855 6.6035 
MUASB;2 day-high 9.3711(') .90926 .000 6.0590 12.6832 
TUASB;5 day-low 3.1675 1.22576 .568 -1.2975 7.6325 
TUAS8;5 day-high -6.3588(') .94569 .000 -9.8035 -2.9140 
TUAS8;4 day-high .0721 .79605 1.000 -2.8276 2.9719 
TUAS8;3 day-high 8.5389(') .90926 .000 5.2268 11.8510 
TUAS8;2 day-high 15.5750(') 1.04740 .000 II. 7597 19.3903 
MHUASB;3 day-low -4.5783(') 1.04740 .004 -8.3936 -.7631 
MTUAS8;5 day-high -I 0.1938(') .94569 .000 -13.6385 -6.7490 
MHUAS8;4 day-high -5.9979(') .79605 .000 -8.8976 -3.0981 
MHUAS8;3 day-high -2.0114 .79605 .612 -4.9111 .8883 
MHUAS8;2 day-high 1.0590 .87904 1.000 -2.1430 4.2610 
THUAS8;3 day-low 17.5775(') 1.22576 .000 13.1125 22.0425 
THUAS8;5 day-high -3.2088 .94569 .104 -6.6535 .2360 
THUAS8;4 day-high 1.9858 .83164 .715 -1.0435 5.0152 
THUAS8;3 day-high 4.0742(') .83164 .000 1.0448 7.1035 
THUAS8;2 day-high 9.5100(') .87904 .000 6.3080 12.7120 
TUAS8;5 day-high MUASB;5 day-low 2.1545 1.14156 .956 -2.0038 6.3127 
MUASB;3 day-low 2.8618 .89178 .169 -.3866 6.1102 
MUASB;5 day-high -2.6200 1.10286 .724 -6.6373 1.3973 
MUAS8;4 day-high 2.9659 1.14156 .557 -1.1924 7.1242 
MUAS8;3 day-high 9.8533(') 1.02491 .000 6.1200 13.5866 
MUASB;2 day-high 15.7299(') 1.07178 .000 11.8258 19.6340 
TUASB;5 day-low 9.5263(') 1.35072 .000 4.6061 14.4464 
TUAS8;3 day-low 6.3588(') .94569 .000 2.9140 9.8035 
TUAS8;4 day-high 6.4309(') .97758 .000 2.8700 9.9918 
TUASB;3 day-high 14.8976(') 1.07178 .000 10.9935 18.8017 
TUAS8;2 day-high 21.9338(') 1.19122 .000 17.5946 26.2729 
MHUAS8;3 day-low 1.7804 1.19122 .997 -2.5587 6.1196 
MTUAS8;5 day-high -3.8350 1.10286 .082 -7.8523 .1823 
MHUAS8;4 day-high .3609 .97758 1.000 -3.2000 3.9218 
MHUAS8;3 day-high 4.3473(') .97758 .003 .7864 7.9083 
MHUAS8;2 day-high 7.4178(') 1.04626 .000 3.6066 11.2289 
THUASB;3 day-low 23.9363(') 1.35072 .000 19.0161 28.8564 
THUAS8;5 day-high 3.1500 1.10286 .365 -.8673 7.1673 
THUASB;4 day-high 8.3446(') 1.00677 .000 4.6773 12.0118 
THUAS8;3 day-high I 0.4329(') 1.00677 .000 6.7657 14.1002 
THUAS8;2 day-high 15.8688(') 1.04626 .000 12.0576 19.6799 
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TUASB;4 day-high MUASB;5 day-low -4.2764(') 1.02105 .008 -7.9957 -.5571 
MUASB;3 day-low -3.5691(') .73119 .000 -6.2325 -.9056 
MUASB;5 day-high -9.0509(') .97758 .000 -12.6118 -5.4900 
MUASB;4 day-high -3.4650 1.02105 .104 -7.1843 .2543 
MUASB;3 day-high 3.4224(') .88871 .025 .1852 6.6596 
MUASB;2 day-high 9.2990(') .94238 .000 5.8662 12.7317 
TUASB;5 day-low 3.0954 1.25052 .651 -1.4598 7.6505 
TUASB;3 day-low -.0721 .79605 1.000 -2.9719 2.8276 
TUASB;5 day-high -6.4309(') .97758 .000 -9.9918 -2.8700 
TUASB;3 day-high 8.4667(') .94238 .000 5.0340 11.8995 
TUASB;2 day-high 15.5029(') 1.07628 .000 11.5824 19.4233 
MHUASB;3 day-low -4.6505(') 1.07628 .005 -8.5709 -.7300 
MTUASB;5 day-high -10.2659(') .97758 .000 -13.8268 -6.7050 
MHUASB;4 day-high -6.0700(') .83368 .000 -9.1068 -3.0332 
MHUASB;3 day-high -2.0836 .83368 .633 -5.1204 .9532 
MHUASB;2 day-high .9869 .91325 1.000 -2.3398 4.3135 
THUASB;3 day-low 17.5054(') 1.25052 .000 12.9502 22.0605 
THUASB;5 day-high -3.2809 .97758 . 115 -6.8418 .2800 
THUASB;4 day-high 1.9137 .86772 .832 -1.2471 5.0745 
THUASB;3 day-high 4.0020(') .86772 .001 .8412 7.1628 
THUASB;2 day-high 9.4379(') .91325 .000 6.1112 12.7645 
TUASB;3 day-high MUASB;5 day-low -12. 7432(') 1.11157 .000 -16.7922 -8.6941 
MUASB;3 day-low -12.0358(') .85305 .000 -15.1431 -8.9285 
MUASB;5 day-high -17.5176(') 1.07178 .000 -21.4217 -13.6135 
MUASB;4 day-high -11.9317(') 1.11157 .000 -15.9808 -7.8827 
MUASB;3 day-high -5.0443(') .99139 .000 -8.6556 -1.4331 
MUASB;2 day-high .8322 1.03978 1.000 -2.9553 4.6198 
TUASB;5 day-low -5.3714(') 1.32547 .013 -10.1996 -.5432 
TUASB;3 day-low -8.5389(') .90926 .000 -11.8510 -5.2268 
TUASB;5 day-high -14.8976(') 1.07178 .000 -18.8017 -I 0.9935 
TUASB;4 day-high -8.4667(') .94238 .000 -11.8995 -5.0340 
TUASB;2 day-high 7.0361(') 1.16251 .000 2.8015 11.2707 
MHUASB;3 day-low -13. II 72(') 1.16251 .000 -17.3518 -8.8826 
MTUASB;5 day-high -18. 7326(') 1.07178 .000 -22.6367 -14.8285 
MHUASB;4 day-high -14.5367(') .94238 .000 -17.9695 -11.1040 
MHUASB;3 day-high -10.5503(') .94238 .000 -13.9831 -7.1176 
MHUASB;2 day-high -7.4799(') 1.01346 .000 -11.1715 -3.7883 
THUASB;3 day-low 9.0386(') 1.32547 .000 4.2104 13.8668 
THUASB;5 day-high -II. 7476(') 1.07178 .000 -15.6517 -7.8435 
THUASB;4 day-high -6.5531 (') .97263 .000 -10.0%0 -3.0101 
THUASB;3 day-high -4.4647(') .97263 .002 -8.0076 -.9218 
THUASB;2 da~-hi~h .9711 1.01346 1.000 -2.7205 4.6627 
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TUASB;2 day-high MUASB;5 day-low -19.7793(') 1.22715 .000 -24.2493 -15.3093 
MUASB;3 day-low -19.0719(') .99899 .000 -22.7109 -15.4330 
MUASB;5 day-high -24.5537(') 1.19122 .000 -28.8929 -20.2146 
MUASB;4 day-high -18.9679(') 1.22715 .000 -23.4379 -14.4978 
MUASB;3 day-high -12.0805(') 1.11944 .000 -16.1582 -8.0028 
MUASB;2 day-high -6.2039(') 1.16251 .000 -10.4385 -1.9693 
TUASB;5 day-low -12.4075(') 1.42378 .000 -17.5938 -7.2212 
TUASB;3 day-low -15.5750(') 1.04740 .000 -19.3903 -11.7597 
TUASB;5 day-high -21.9338(') 1.19122 .000 -26.2729 -17.5946 
TUASB;4 day-high -15.5029(') 1.07628 .000 -19.4233 -11.5824 
TUASB;3 day-high -7.0361(') 1.16251 .000 -11.2707 -2.8015 
MHUASB;3 day-low -20.1533(') 1.27347 .000 -24.7921 -15.5146 
MTUASB;5 day-high -25. 7688(') 1.19122 .000 -30.1079 -21.4296 
MHUASB;4 day-high -21.5729(') 1.07628 .000 -25.4933 -17.6524 
MHUASB;3 day-high -17.5864(') 1.07628 .000 -21.5069 -13.6660 
MHUASB;2 day-high -14.5160(') 1.13903 .000 -18.6650 -10.3670 
THUASB;3 day-low 2.0025 1.42378 .999 -3.1838 7.1888 
THUASB;5 day-high -18. 7838(') 1.19122 .000 -23.1229 -14.4446 
THUASB;4 day-high -13.5892(') 1.10286 .000 -17.6064 -9.5719 
THUASB;3 day-high -11.5008(') 1.10286 .000 -15.5181 -7.4836 
THUASB;2 day-high -6.0650(') 1.13903 .000 -10.2140 -1.9160 
MHUASB;3 day-low MUASB;5 day-low .3740 1.22715 1.000 -4.0960 4.8441 
MUASB;3 day-low 1.0814 .99899 1.000 -2.5575 4.7204 
MUASB;5 day-high -4.4004(') 1.19122 .043 -8.7396 -.0613 
MUASB;4 day-high 1.1855 1.22715 1.000 -3.2845 5.6555 
MUASB;3 day-high 8.0729(') 1.11944 .000 3.9952 12.1506 
MUASB;2 day-high 13.9494(') 1.16251 .000 9.7149 18.1840 
TUASB;5 day-low 7.7458(') 1.42378 .000 2.5595 12.9321 
TUASB;3 day-low 4.5783(') 1.04740 .004 .7631 8.3936 
TUASB;5 day-high -I. 7804 1.19122 .997 -6.1196 2.5587 
TUASB;4 day-high 4.6505(') 1.07628 .005 .7300 8.5709 
TUASB;3 day-high 13.1172(') 1.16251 .000 8.8826 17.3518 
TUASB;2 day-high 20.1533(') 1.27347 .000 15.5146 24.7921 
MTUASB;5 day-high -5.6154(') 1.19122 .001 -9.9546 -1.2763 
MHUASB;4 day-high -1.4195 1.07628 .999 -5.3400 2.5009 
MHUASB;3 day-high 2.5669 1.07628 .717 -1.3536 6.4874 
MHUASB;2 day-high 5.6373(') 1.13903 .000 1.4883 9.7864 
THUASB;3 day-low 22.1558(') 1.42378 .000 16.9695 27.3421 
THUASB;5 day-high 1.3696 1.19122 1.000 -2.9696 5.7087 
THUASB;4 day-high 6.5642(') 1.1 0286 .000 2.5469 10.5814 
THUASB;3 day-high 8.6525(') 1.10286 .000 4.6352 12.6698 
THUASB;2 day-high 14.0883(') 1.13903 .000 9.9393 18.2374 
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MTUASB;5 day-high MUASB;5 day-low 5.9895(*) 1.14156 .000 1.8312 10.1477 
MUASB;3 day-low 6.6968(*) .89178 .000 3.4484 9.9452 
MUASB;5 day-high 1.2150 1.10286 1.000 -2.8023 5.2323 
MUASB;4 day-high 6.8009(*) 1.14156 .000 2.6426 I 0.9592 
MUASB;3 day-high 13.6883(*) 1.02491 .000 9.9550 17.4216 
MUASB;2 day-high 19.5649(*) 1.07178 .000 15.6608 23.4690 
TUASB;5 day-low 13.3613(*) 1.35072 .000 8.4411 18.2814 
TUASB;3 day-low 10.1938(*) .94569 .000 6. 7490 13.6385 
TUASB;5 day-high 3.8350 1.10286 .082 -.1823 7.8523 
TUASB;4 day-high 10.2659(*) .97758 .000 6.7050 13.8268 
TUASB;3 day-high 18. 7326(*) 1.07178 .000 14.8285 22.6367 
TUASB;2 day-high 25. 7688(*) 1.19122 .000 21.4296 30.1079 
MHUASB;3 day-low 5.6154(*) 1.19122 .001 1.2763 9.9546 
MHUASB;4 day-high 4.1959(*) .97758 .005 .6350 7.7568 
MHUASB;3 day-high 8.1823(*) .97758 .000 4.6214 11.7433 
MHUASB;2 day-high 11.2528(*) 1.04626 .000 7.4416 15.0639 
THUASB;3 day-low 27.7713(*) 1.35072 .000 22.8511 32.6914 
THUASB;5 day-high 6.9850(*) 1.10286 .000 2.9677 11.0023 
THUASB;4 day-high 12.1796(*) 1.00677 .000 8.5123 15.8468 
THUASB;3 day-high 14.2679(*) 1.00677 .000 10.6007 17.9352 
THUASB;2 day-high 19. 7038(*) 1.04626 .000 15.8926 23.5149 
MHUASB;4 day-high MUASB;5 day-low 1.7936 1.02105 .979 -1.9257 5.5129 
MUASB;3 day-low 2.5009 .73119 .097 -.1625 5.1644 
MUASB;5 day-high -2.9809 .97758 .246 -6.5418 .5800 
MUASB;4 day-high 2.6050 1.02105 .593 -1.1143 6.3243 
MUASB;3 day-high 9.4924(*) .88871 .000 6.2552 12.7296 
MUASB;2 day-high 15.3690(*) .94238 .000 11.9362 18.8017 
TUASB;5 day-low 9.1654(*) 1.25052 .000 4.6102 13.7205 
TUASB;3 day-low 5.9979(*) .79605 .000 3.0981 8.8976 
TUASB;5 day-high -.3609 .97758 1.000 -3.9218 3.2000 
TUASB;4 day-high 6.0700(*) .83368 .000 3.0332 9.1068 
TUASB;3 day-high 14.5367(*) .94238 .000 11.1040 17.9695 
TUASB;2 day-high 21.5729(*) 1.07628 .000 17.6524 25.4933 
MHUASB;3 day-low 1.4195 1.07628 .999 -2.5009 5.3400 
MTUASB;5 day-high -4.1959(*) .97758 .005 -7.7568 -.6350 
MHUASB;3 day-high 3.9864(*) .83368 .001 .9496 7.0232 
MHUASB;2 day-high 7.0569(*) .91325 .000 3.7302 10.3835 
THUASB;3 day-low 23.5754(*) 1.25052 .000 19.0202 28.1305 
THUASB;5 day-high 2.7891 .97758 .367 -.7718 6.3500 
THUASB;4 day-high 7.9837(*) .86772 .000 4.8229 11.1445 
THUASB;3 day-high 10.0720(*) .86772 .000 6.9112 13.2328 
THUASB;2 day-high 15.5079(*) .91325 .000 12.1812 18.8345 
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MHUASB;3 day-high MUASB;5 day-low -2.1929 1.02105 .862 -5.9121 1.5264 
MUASB;3 day-low -1.4855 .73119 .913 -4.1489 1.1779 
MUASB;5 day-high -6.9673(') .97758 .000 -10.5283 -3.4064 
MUASB;4 day-high -1.3814 1.02105 .999 -5.1007 2.3379 
MUASB;3 day-high 5.5060(') .88871 .000 2.2688 8.7432 
MUASB;2 day-high 11.3825(') .94238 .000 7.9498 14.8153 
TUASB;5 day-low 5.1789(') 1.25052 .009 .6238 9.7341 
TUASB;3 day-low 2.0114 .79605 .612 -.8883 4.9111 
TUASB;5 day-high -4.3473(') .97758 .003 -7.9083 -.7864 
TUASB;4 day-high 2.0836 .83368 .633 -.9532 5.1204 
TUASB;3 day-high 10.5503(') .94238 .000 7.1176 13.9831 
TUASB;2 day-high 17.5864(') 1.07628 .000 13.6660 21.5069 
MHUASB;3 day-low -2.5669 1.07628 .717 -6.4874 1.3536 
MTUASB;5 day-high -8.1823(') .97758 .000 -11.7433 -4.6214 
MHUASB;4 day-high -3.9864(') .83368 .001 -7.0232 -.9496 
MHUASB;2 day-high 3.0704 .91325 .113 -.2562 6.3971 
THUASB;3 day-low 19.5889(') 1.25052 .000 15.0338 24.1441 
THUASB;5 day-high -1.1973 .97758 1.000 -4.7583 2.3636 
THUASB;4 day-high 3.9973(') .86772 .001 .8365 7.1580 
THUASB;3 day-high 6.0856(') .86772 .000 2.9248 9.2464 
THUASB;2 day-high 11.5214(') .91325 .000 8.1948 14.8481 
MHUASB;2 day-high MUASB;5 day-low -5.2633(') 1.08699 .001 -9.2228 -1.3038 
MUASB;3 day-low -4.5559(') .82075 .000 -7.5456 -1.5662 
MUASB;5 day-high -I 0.0377(') 1.04626 .000 -13.8489 -6.2266 
MUASB;4 day-high -4.4519(') 1.08699 .011 -8.4113 -.4924 
MUASB;3 day-high 2.4355 .96375 .612 -1.0750 5.9461 
MUASB;2 day-high 8.3121(') 1.01346 .000 4.6205 12.0037 
TUASB;5 day-low 2.1085 1.30492 .992 -2.6448 6.8618 
TUASB;3 day-low -1.0590 .87904 1.000 -4.2610 2.1430 
TUASB;5 day-high -7.4178(') 1.04626 .000 -11.2289 -3.6066 
TUASB;4 day-high -.9869 .91325 1.000 -4.3135 2.3398 
TUASB;3 day-high 7.4799(') 1.01346 .000 3.7883 11.1715 
TUASB;2 day-high 14.5160(') 1.13903 .000 10.3670 18.6650 
MHUASB;3 day-low -5.6373(') 1.13903 .000 -9.7864 -1.4883 
MTUASB;5 day-high -11.2528(') 1.04626 .000 -15.0639 -7.4416 
MHUASB;4 day-high -7.0569(') .91325 .000 -I 0.3835 -3.7302 
MHUASB;3 day-high -3.0704 .91325 .113 -6.3971 .2562 
THUASB;3 day-low 16.5185(') 1.30492 .000 11.7652 21.2718 
THUASB;5 day-high -4.2678(') 1.04626 .011 -8.0789 -.4566 
THUASB;4 day-high .9268 .94443 1.000 -2.5134 4.3670 
THUASB;3 day-high 3.0152 .94443 .176 -.4250 6.4554 
THUASB;2 day-high 8.4510(') .98642 .000 4.8578 12.0442 
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THUASB;3 day-low MUASB;5 day-low -21. 7818(') 1.38250 .000 -26.8177 -16.7459 
MUASB;3 day-low -21.0744(') 1.18466 .000 -25.3897 -16.7592 
MUASB;5 day-high -26.5562(') 1.35072 .000 -31.4764 -21.6361 
MUASB;4 day-high -20.9704(') 1.38250 .000 -26.0063 -15.9344 
MUASB;3 day-high -14.0830(') 1.28786 .000 -18.7741 -9.3918 
MUASB;2 day-high -8.2064(') 1.32547 .000 -13.0346 -3.3782 
TUASB;5 day-low -14.4100(') 1.55967 .000 -20.0913 -8.7287 
TUASB;3 day-low -17.5775(') 1.22576 .000 -22.0425 -13.1125 
TUASB;5 day-high -23.9363(') 1.35072 .000 -28.8564 -19.0161 
TUASB;4 day-high -17.5054(') 1.25052 .000 -22.0605 -12.9502 
TUASB;3 day-high -9.0386(') 1.32547 .000 -13.8668 -4.2104 
TUASB;2 day-high -2.0025 1.42378 .999 -7.1888 3.1838 
MHUASB;3 day-low -22.1558(') 1.42378 .000 -27.3421 -16.9695 
MTUASB;5 day-high -27.7713(') 1.35072 .000 -32.6914 -22.8511 
MHUASB;4 day-high -23.5754(') 1.25052 .000 -28.1305 -19.0202 
MHUASB;3 day-high -19.5889(') 1.25052 .000 -24.1441 -15.0338 
MHUASB;2 day-high -16.5185(') 1.30492 .000 -21.2718 -11.7652 
THUASB;5 day-high -20. 7863(') 1.35072 .000 -25.7064 -15.8661 
THUASB;4 day-high -15.5917(') 1.27347 .000 -20.2304 -10.9529 
THUASB;3 day-high -13.5033(') 1.27347 .000 -18.1421 -8.8646 
THUASB;2 day-high -8.0675(') 1.30492 .000 -12.8208 -3.3142 
THUASB;5 day-high MUASB;5 day-low -.9955 1.14156 1.000 -5.1538 3.1627 
MUASB;3 day-low -.2882 .89178 1.000 -3.5366 2.9602 
MUASB;5 day-high -5. 7700(') 1.10286 .000 -9.7873 -1.7527 
MUASB;4 day-high -.1841 1.14156 1.000 -4.3424 3.9742 
MUASB;3 day-high 6.7033(') 1.02491 .000 2.9700 I 0.4366 
MUASB;2 day-high 12.5799(') 1.07178 .000 8.6758 16.4840 
TUASB;5 day-low 6.3763(') 1.35072 .001 1.4561 11.2964 
TUASB;3 day-low 3.2088 .94569 .104 -.2360 6.6535 
TUASB;5 day-high -3.1500 1.10286 .365 -7.1673 .8673 
TUASB;4 day-high 3.2809 .97758 .115 -.2800 6.8418 
TUASB;3 day-high I 1.7476(') 1.07178 .000 7.8435 15.6517 
TUASB;2 day-high 18.7838(') 1.19122 .000 14.4446 23.1229 
MHUASB;3 day-low -1.3696 1.19122 1.000 -5.7087 2.9696 
MTUASB;5 day-high -6.9850(') 1.10286 .000 -11.0023 -2.9677 
MHUASB;4 day-high -2.7891 .97758 .367 -6.3500 .7718 
MHUASB;3 day-high 1.1973 .97758 1.000 -2.3636 4. 7583 
MHUASB;2 day-high 4.2678(') 1.04626 .011 .4566 8.0789 
THUASB;3 day-low 20.7863(') 1.35072 .000 15.8661 25.7064 
THUASB;4 day-high 5.1946(') 1.00677 .000 1.5273 8.8618 
THUASB;3 day-high 7.2829(') 1.00677 .000 3.6157 I 0.9502 
THUASB;2 day-high 12. 7188(') 1.04626 .000 8.9076 16.5299 
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Table B. I (Continued) 
Mean 95% Confidence 
(I) One way (J) One way Difference Std. Sig. Interval Error (1-J) Lower Upper 
Bound Bound 
THUASB;4 day-high MUASB;5 day-low -6.1901 (') 1.04903 .000 -10.0113 -2.3689 
MUASB;3 day-low -5.4828(') .76977 .000 -8.2867 -2.6788 
MUASB;5 day-high -10.9646(') 1.00677 .000 -14.6318 -7.2973 
MUASB;4 day-high -5.3787(') 1.04903 .000 -9.1999 -1.5575 
MUASB;3 day-high 1.5087 .92072 .991 -1.8451 4.8625 
MUASB;2 day-high 7.3853(') .97263 .000 3.8424 I 0.9282 
TUASB;5 day-low 1.1817 1.27347 1.000 -3.4571 5.8204 
TUASB;3 day-low -1.9858 .83164 .715 -5.0152 1.0435 
TUASB;5 day-high -8.3446(') 1.00677 .000 -12.0118 -4.6773 
TUASB;4 day-high -1.9137 .86772 .832 -5.0745 1.2471 
TUASB;3 day-high 6.5531 (') .97263 .000 3.0101 I 0.0960 
TUASB;2 day-high 13.5892(') 1.10286 .000 9.5719 17.6064 
MHUASB;3 day-low -6.5642(') 1.10286 .000 -10.5814 -2.5469 
MTUASB;5 day-high -12.1796(') 1.00677 .000 -15.8468 -8.5123 
MHUASB;4 day-high -7.9837(') .86772 .000 -11.1445 -4.8229 
MHUASB;3 day-high -3.9973(') .86772 .001 -7.1580 -.8365 
MHUASB;2 day-high -.9268 .94443 1.000 -4.3670 2.5134 
THUASB;3 day-low 15.5917(') 1.27347 .000 10.9529 20.2304 
THUASB;5 day-high -5.1946(') 1.00677 .000 -8.8618 -1.5273 
THUASB;3 day-high 2.0883 .90048 .762 -1.1918 5.3684 
THUASB;2 day-high 7.5242(') .94443 .000 4.0840 10.9644 
THUASB;3 day-high MUASB;5 day-low -8.2785(') 1.04903 .000 -12.0997 -4.4573 
MUASB;3 day-low -7.5711(') .76977 .000 -10.3751 -4.7671 
MUASB;5 day-high -13.0529(') 1.00677 .000 -16.7202 -9.3857 
MUASB;4 day-high -7.4670(') 1.04903 .000 -11.2882 -3.6458 
MUASB;3 day-high -.5796 .92072 1.000 -3.9334 2.7742 
MUASB;2 day-high 5.2969(') .97263 .000 1.7540 8.8399 
TUASB;5 day-low -.9067 1.27347 1.000 -5.5454 3.7321 
TUASB;3 day-low -4.0742(') .83164 .000 -7.1035 -1.0448 
TUASB;5 day-high -I 0.4329(') 1.00677 .000 -14.1002 -6.7657 
TUASB;4 day-high -4.0020(') .86772 .001 -7.1628 -.8412 
TUASB;3 day-high 4.4647(') .97263 .002 .9218 8.0076 
TUASB;2 day-high I 1.5008(') 1.10286 .000 7.4836 15.5181 
MHUASB;3 day-low -8.6525(') 1.10286 .000 -12.6698 -4.6352 
MTUASB;5 day-high -14.2679(') 1.00677 .000 -17.9352 -10.6007 
MHUASB;4 day-high -I 0.0720(') .86772 .000 -13.2328 -6.9112 
MHUASB;3 day-high -6.0856(') .86772 .000 -9.2464 -2.9248 
MHUASB;2 day-high -3.0152 .94443 .176 -6.4554 .4250 
THUASB;3 day-low 13.5033(') 1.27347 .000 8.8646 18.1421 
THUASB;5 day-high -7.2829(') 1.00677 .000 -I 0.9502 -3.6157 
THUASB;4 day-high -2.0883 .90048 .762 -5.3684 1.1918 
THUASB;2 day-high 5.4358(') .94443 .000 1.9956 8.8760 
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Table B.l (Continued) 
Mean 95% Confidence 
(I) One way (J) One way Difference S1d. Sig. Interval 
(1-J) Error Lower Upper 
Bound Bound 
THUASB;2 day-high MUASB;5 day-low -13.7143(') 1.08699 .000 -17.6738 -9.7548 
MUASB;3 day-low -13.0069(') .82075 .000 -15.9966 -10.0172 
MUASB;5 day-high -18.4887(') 1.04626 .000 -22.2999 -14.6776 
MUASB;4 day-high -12.9029(') 1.08699 .000 -16.8623 -8.9434 
MUASB;3 day-high -6.0 155(') .96375 .000 -9.5260 -2.5049 
MUASB;2 day-high -.1389 1.01346 1.000 -3.8305 3.5527 
TUASB;5 day-low -6.3425(') 1.30492 .000 -11.0958 -1.5892 
TUASB;3 day-low -9.5100(') .87904 .000 -12.7120 -6.3080 
TUASB;5 day-high -15.8688(') 1.04626 .000 -19.6799 -12.0576 
TUASB;4 day-high -9.4379(') .91325 .000 -12.7645 -6.1112 
TUASB;3 day-high -.9711 1.01346 1.000 -4.6627 2.7205 
TUASB;2 day-high 6.0650(') 1.13903 .000 1.9160 10.2140 
MHUASB;3 day-low -14.0883(') 1.13903 .000 -18.2374 -9.9393 
MTUASB;5 day-high -19.7038(') 1.04626 .000 -23.5149 -15.8926 
MHUASB;4 day-high -15.5079(') .91325 .000 -18.8345 -12.1812 
MHUASB;3 day-high -11.5214(') .91325 .000 -14.8481 -8.1948 
MHUASB;2 day-high -8.4510(') .98642 .000 -12.0442 -4.8578 
THUASB;3 day-low 8.0675(') 1.30492 .000 3.3142 12.8208 
THUASB;5 day-high -12.7188(') 1.04626 .000 -16.5299 -8.9076 
THUASB;4 day-high -7.5242(') .94443 .000 -I 0.9644 -4.0840 
THUASB;3 day-high -5.4358(') .94443 .000 -8.8760 -1.9956 
8.2 Two ways ANOV A for COD concentration 
From the two-way ANOVA result, it found that there was a significant effect of 
reactor type, HRT, and temperature, so it implied that the mean of COD removal 
varied between the HRT of five, four, three, and two days and the temperature of 
mesophilic and thermophilic. In addition, there was statistical indication of 
interaction between HRT and the type of reactor, thus the effect of HRT on the COD 
removal varied significantly with the variation of reactor. The COD removal differed 
due to the effect between HRT with temperature and reactor with temperature. The 
two-way ANOV A result showed the COD removal varied with the effect of three 
variable operation conditions. 
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Table 8.2 Two-way ANOV A Test of between subject effects with COD removal as 
dependent variable 
Source Type III Sum of df Mean Square F Sig. S uares 
Corrected Model 8557.152(a) 21 407.483 83.755 .000 
Intercept I 154941.707 I 154941.707 237389.860 .000 
REACTOR 19.691 19.691 4.047 .046 
TEMP 2433.521 I 2433.52 I 500.193 .000 
HRT 4944.458 5 988.892 203.259 .000 
REACTOR * TEMP 428.646 428.646 88.105 .000 
REACTOR* HRT 1199.891 4 299.973 61.657 .000 
TEMP* HRT 360.665 5 72.133 14.826 .000 
REACTOR* TEMP* 419.805 4 104.951 21.572 .000 HRT 
Error 982.764 202 4.865 
Total 1566581.381 224 
Corrected Total 9539.9I6 223 
a R Squared = .897 (Adjusted R Squared= .886) 
APPENDIXC 
PHOTOS 
Figure C.l Anaerobic reactors (Armfield Anaerobic Digester W8) 
Figure C.2 Hach pH meter (Model Sension 4) using Platinum Series pH Electrode 
(Model51910) 
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Figure C.3 Solids measurement apparatus 
Figure C.4 Analytical balance (Mettler Toledo AB204-S) 
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Figure C.5 Muffle furnace (Naberthenn L15/12/P320) 
Figure C.6 (a) Hach digestion reactor, (b) Hach spectrophotometer DR 2000 and high 
range COD digestion reagent vials 
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Figure C.7 YSI 5100 Dissolved Oxygen Meter 
Figure C.8 (a) Buchi K-424 Digestion Unit and (b) Buchi B-414 Scrubber Unit 
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Figure C.9 Buchi K-314 Distillation Unit 
Figure C.lO Auto titration unit (Metrohrn 702 SM Titrino) 
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Figure C.ll Seed biomass from sludge thickener 
a b 
Figure C.12 (a) Mesophilic UASB sludge and (b) thermophilic UASB sludge 
a b 
Figure C.l3 (a) Mesophilic HUASB sludge and (b) thermophilic HUASB sludge 
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